##fileformat=VCFv4.2
##fileDate=2024-01-11
##reference=GRCh38
##INFO=<ID=arup_classification,Number=1,Type=String,Description="Pathogenicity classification from the ARUP database (1: not pathogenic or of no clinical significance; 2: likely not pathogenic or of little clinical significance; 3: uncertain; 4: likely pathogenic; 5: definitely pathogenic) (version: -, version date: 2022-04-01 )">
##INFO=<ID=bayesdel,Number=1,Type=String,Description="Missense variant functional predictions by BayesDel tool (Feng 2017) used without allele frequency. Score bigger or equal to 0.16: damaging; Score smaller than 0.16: tolerated. Scores were imported from dbNSFP. (version: 4.4, version date: 2023-05-06 )">
##INFO=<ID=brca_exchange_clinical_significance,Number=1,Type=String,Description="Variant pathogenicity as displayed in the Summary view of the BRCA exchange database (version: 54, version date: 2022-02-22 )">
##INFO=<ID=cadd_scaled,Number=1,Type=String,Description="The scaled CADD scores: PHRED-like (-10*log10(rank/total)) scaled C-score ranking a variant relative to all possible substitutions of the human genome (8.6x10^9). These scores range from 1 to 99. A cutoff for deleteriousness can be set to 10-15, but the choice remains arbitrary. (version: v1.6, version date: 2020-04-11 )">
##INFO=<ID=cancerhotspots_ac,Number=1,Type=String,Description="Number of samples showing the variant from cancerhotspots (version: v2, version date: 2017-12-15 )">
##INFO=<ID=cancerhotspots_af,Number=1,Type=String,Description="Allele Frequency of the variant (AC / num samples cancerhotspots) (version: v2, version date: 2017-12-15 )">
##INFO=<ID=cancerhotspots_cancertypes,Number=1,Type=String,Description="A | delimited list of all cancertypes associated to this variant according to cancerhotspots. FORMAT: tumortype:tissue (version: v2, version date: 2017-12-15 )">
##INFO=<ID=clinvar,Number=1,Type=String,Description="The Variation ID from ClinVar (version: -, version date: 2023-02-26 )">
##INFO=<ID=clinvar_submissions,Number=.,Type=String,Description="An & separated list of clinvar submissions. Format:interpretation|last_evaluated|review_status|submission_condition|submitter|comment">
##INFO=<ID=clinvar_summary,Number=.,Type=String,Description="summary of the clinvar submissions. FORMAT: review_status:interpretation_summary">
##INFO=<ID=consensus_classification,Number=1,Type=String,Description="The recent consensus classification by the VUS-task-force. Format: consensus_class|consensus_comment|submission_date|consensus_scheme|consensus_scheme_class|consensus_criteria_string. The consensus criteria string itself is a $ separated list with the Format: criterium_name+criterium_strength+criterium_evidence+is_selecteds ">
##INFO=<ID=consequences,Number=.,Type=String,Description="An & separated list of variant consequences from vep. Format:Transcript|hgvsc|hgvsp,consequence|impact|exonnr|intronnr|genesymbol|proteindomain|isgencodebasic|ismaneselect|ismaneplusclinical|isensemblcanonical|transcript_biotype|transcript_length">
##INFO=<ID=cosmic,Number=1,Type=String,Description="The COSV ID from COSMIC (version: -, version date: 2023-06-06 )">
##INFO=<ID=flossies_num_afr,Number=1,Type=String,Description="Number of individuals with this variant in the african american cohort. (n=2559) (version: -, version date: 2022-03-25 )">
##INFO=<ID=flossies_num_eur,Number=1,Type=String,Description="Number of individuals with this variant in the european american cohort. (n=7325) (version: -, version date: 2022-03-25 )">
##INFO=<ID=gnomad_ac,Number=1,Type=String,Description="gnomAD alternate allele count for samples (version: v3.1.2, version date: 2021-10-22 )">
##INFO=<ID=gnomad_af,Number=1,Type=String,Description="gnomAD frequency of alternate allele in samples (version: v3.1.2, version date: 2021-10-22 )">
##INFO=<ID=gnomad_het,Number=1,Type=String,Description="gnomAD number of heterozygous individuals in samples (version: v3.1.2, version date: 2021-10-22 )">
##INFO=<ID=gnomad_hom,Number=1,Type=String,Description="gnomAD number of homozygous individuals in samples (version: v3.1.2, version date: 2021-10-22 )">
##INFO=<ID=gnomad_popmax,Number=1,Type=String,Description="gnomAD population with maximum allele frequency (AF) (version: v3.1.2, version date: 2021-10-22 )">
##INFO=<ID=gnomad_popmax_AC,Number=1,Type=String,Description="The allele count from the popmax population from GnomAD (version: v3.1.2, version date: 2021-10-22 )">
##INFO=<ID=gnomad_popmax_AF,Number=1,Type=String,Description="The allele frequency of the "popmax" population (version: v3.1.2, version date: 2021-10-22 )">
##INFO=<ID=hci_prior,Number=1,Type=String,Description="The prior probability of pathogenicity as reported in the priors HCI website. These range from 0.97 for variants with high probability to damage a donor or acceptor to 0.02 for exonic variants that do not impact a splice junction and are unlikely to create a de novo donor. (version: 1, version date: 2022-11-15 )">
##INFO=<ID=heredicare_annotation,Number=.,Type=String,Description="An & separated list of the variant annotations from heredicare. Format:vid|n_fam|n_pat|vustf_selected_class|vustf_comment|vustf_classification_date. n_fam is the number of families having the variant and n_pat is the number of individuals having the variant.">
##INFO=<ID=heredicare_vid,Number=1,Type=String,Description="The VID from HerediCare.The version_date is inaccurate. They are always up to date when reimporting from heredicare. (version: -, version date: 2023-01-01 )">
##INFO=<ID=hexplorer,Number=1,Type=String,Description="The HEXplorer delta score (HZEI mutant - HZEI wildtype). HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=hexplorer_mut,Number=1,Type=String,Description="The HEXplorer score for the mutant sequence. HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=hexplorer_rev,Number=1,Type=String,Description="The HEXplorer delta score for the reverse complement of the original sequence (HZEI mutant rev - HZEI wildtype rev). HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=hexplorer_rev_mut,Number=1,Type=String,Description="The HEXplorer score for the reverse complement of the mutant sequence. HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=hexplorer_rev_wt,Number=1,Type=String,Description="The HEXplorer score for the reverse complement of the reference sequence. HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=hexplorer_wt,Number=1,Type=String,Description="The HEXplorer score for the reference sequence. HZEI scores were normalized by the total number of nucleotide positions which contribute to the score. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=max_hbond,Number=1,Type=String,Description="The HBond delta score (max HBond mutant - max HBond wildtype). This score shows the change in binding affinity of the U1 snRNA to the splice site motiv, i. e. its ability to form hbonds with the sequence motiv. Negative values show that the mutant sequence is less probable to bind the U1 snRNA (This is a "worse" binding site). Positive values mean that the mutant sequence is more likely to bind the U1 snRNA. If there are multiple possible splice sites only the max values are considered. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=max_hbond_mut,Number=1,Type=String,Description="The max HBond score for the mutant sequence.  (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=max_hbond_rev,Number=1,Type=String,Description="The max HBond delta score for the reverse complement of the original sequence (HZEI mutant rev - HZEI wildtype rev). This score shows the change in binding affinity of the U1 snRNA to the splice site motiv, i. e. its ability to form hbonds with the sequence motiv. Negative values show that the mutant sequence is less probable to bind the U1 snRNA (This is a "worse" binding site). Positive values mean that the mutant sequence is more likely to bind the U1 snRNA. If there are multiple possible splice sites only the max values are considered. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=max_hbond_rev_mut,Number=1,Type=String,Description="This is the max HBond score for the reverse complement of the mutant sequence. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=max_hbond_rev_wt,Number=1,Type=String,Description="This is the max HBond score for the reverse complement of the reference sequence. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=max_hbond_wt,Number=1,Type=String,Description="This is the max HBond score for the reference sequence. (version: 1.0, version date: 2022-06-30 )">
##INFO=<ID=maxentscan,Number=1,Type=String,Description="The transcript specific MaxEntScan scores calculated from ngs-bits. Each value is of the form: ref|alt. A | separated list of transcript$value pairs. (version: v1.0.0, version date: 2023-09-27 )">
##INFO=<ID=maxentscan_alt,Number=1,Type=String,Description="MaxEntScan alternate sequence score calculated though VEP release-104.3 using the MaxEntScan plugin (version: -, version date: 2018-08-29 )">
##INFO=<ID=maxentscan_ref,Number=1,Type=String,Description="MaxEntScan reference sequence score. The lower the score, the more difference one would expect the input (ie mutated) sequence is from the reference. Whenever the difference between ref and alt is positive it predicts a functional splice site. A negative difference predicts that this position is not a functional splice site. (version: -, version date: 2018-08-29 )">
##INFO=<ID=maxentscan_swa,Number=1,Type=String,Description="The transcript specific MaxEntScan SWA scores calculated from ngs-bits. A special application of the MaxEntScan algorithm to discover de-novo spliceing variants. Each value is of the form maxentscan_ref_donor|maxentscan_alt_donor|maxentscan_donor_comp|maxentscan_ref_acceptor|maxentscan_alt_acceptor|maxentscan_acceptor_comp. A | separated list of transcript$value pairs. (version: v1.0.0, version date: 2023-09-27 )">
##INFO=<ID=phylop_100way,Number=1,Type=String,Description="PhyloP 100 vertebrates (100-way) conservation scores. These scores measure evolutionary conservation at individual alignment sites. Interpretations of the scores are compared to the evolution that is expected under neutral drift. Positive scores: Measure conservation, which is slower evolution than expected, at sites that are predicted to be conserved. Negative scores: Measure acceleration, which is faster evolution than expected, at sites that are predicted to be fast-evolving.  (version: -, version date: 2013-12-01 )">
##INFO=<ID=pubmed,Number=.,Type=String,Description="An & separated list of pubmed ids relevant for this variant.">
##INFO=<ID=revel,Number=1,Type=String,Description="The REVEL pathogenicity score of this variant. This score can range from 0 to 1, which reflects the number of trees in the random forest that classified the variant as pathogenic. Thus, higher values represent a more "certain" decision. When choosing a cutoff one should keep in mind that higher cutoffs will result in a higher specificity, but lower sensitivity.. A | separated list of transcript$value pairs. (version: v1.3, version date: 2021-05-03 )">
##INFO=<ID=rsid,Number=1,Type=String,Description="The rs-number of a variant from dbSNP (version summary: https://www.ncbi.nlm.nih.gov/projects/SNP/snp_summary.cgi) (version: 155, version date: 2021-06-16 )">
##INFO=<ID=spliceai_details,Number=1,Type=String,Description="Details about the SpliceAI predictions: These include delta scores (DS) and delta positions (DP) for acceptor gain (AG), acceptor loss (AL), donor gain (DG), and donor loss (DL). Format: GENE|DS_AG|DS_AL|DS_DG|DS_DL|DP_AG|DP_AL|DP_DG|DP_DL (version: v1.3.1, version date: 2021-09-07 )">
##INFO=<ID=spliceai_max_delta,Number=1,Type=String,Description="Max of delta scores for acceptor gain, acceptor loss, donor gain and donor loss. A value of 0.5 or more can be assumed to have an impact on splicing. (version: v1.3.1, version date: 2021-09-07 )">
##INFO=<ID=task_force_protein_domain,Number=1,Type=String,Description="The description of the protein domain from a hand-crafted table by the VUS-Task-Force. (version: -, version date: 2022-06-01 )">
##INFO=<ID=task_force_protein_domain_source,Number=1,Type=String,Description="The source of the task force protein domain. (version: -, version date: 2022-06-01 )">
##INFO=<ID=tp53db_DNE_LOF_class,Number=1,Type=String,Description="Functional classification for loss of growth-suppression and dominant-negative activities based on Z-scores (version: r20, version date: 2019-07-01 )">
##INFO=<ID=tp53db_bayes_del,Number=1,Type=String,Description="Missense variant functional predictions by BayesDel tool (Feng 2017) used without allele frequency. Score bigger or equal to 0.16: damaging; Score smaller than 0.16: tolerated (version: r20, version date: 2019-07-01 )">
##INFO=<ID=tp53db_class,Number=1,Type=String,Description="Family classification: LFS = strict clinical definition of Li-Fraumeni syndrome, LFL = Li-Fraumeni like for the extended clinical definition of Li-Fraumeni, FH: family history of cancer which does not fulfil LFS or any of the LFL definitions, No FH: no family history of cancer, FH= Family history of cancer (not fulfilling the definition of LFS/LFL),  No= no family history of cancer, ?= unknown (version: r20, version date: 2019-07-01 )">
##INFO=<ID=tp53db_domain_function,Number=1,Type=String,Description="Function of the domain in which the mutated residue is located. (version: r20, version date: 2019-07-01 )">
##INFO=<ID=tp53db_transactivation_class,Number=1,Type=String,Description="Functional classification based on the overall transcriptional activity (version: r20, version date: 2019-07-01 )">
##INFO=<ID=user_classification,Number=1,Type=String,Description="The recent consensus classification by the VUS-task-force. Format: consensus_class|consensus_comment|submission_date|consensus_scheme|consensus_scheme_class|consensus_criteria_string. The consensus criteria string itself is a $ separated list with the Format: criterium_name+criterium_strength+criterium_evidence+is_selecteds ">
##INFO=<ID=variation_id,Number=1,Type=Integer,Description="The ClinVar variation id of the variant.">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO
chr16	23638131	11508	T	A	.	.	phylop_100way=3.187;cadd_scaled=34;spliceai_details=PALB2%7C0.71%7C0.97%7C0.00%7C0.00%7C-8%7C-2%7C24%7C0;spliceai_max_delta=0.97;maxentscan_ref=9.283;maxentscan_alt=0.916;maxentscan=ENST00000261584$9.28%7C0.92|ENST00000561514$9.28%7C0.92|ENST00000566069$9.28%7C0.92|ENST00000697377$9.28%7C0.92|ENST00000697379$9.28%7C0.92;maxentscan_swa=ENST00000261584$1.15%7C-2.75%7C1.15%7C9.28%7C8.49%7C1.37|ENST00000561514$1.15%7C-2.75%7C1.15%7C9.28%7C8.49%7C1.37|ENST00000566069$1.15%7C-2.75%7C1.15%7C9.28%7C8.49%7C1.37|ENST00000568219$1.15%7C-2.75%7C1.15%7C9.28%7C8.49%7C1.37|ENST00000697374$1.15%7C-2.75%7C1.15%7C9.28%7C8.49%7C1.37|ENST00000697376$1.15%7C-2.75%7C1.15%7C9.28%7C8.49%7C1.37|ENST00000697377$1.15%7C-2.75%7C1.15%7C9.28%7C8.49%7C1.37|ENST00000697379$1.15%7C-2.75%7C1.15%7C9.28%7C8.49%7C1.37|ENST00000697383$1.15%7C-2.75%7C1.15%7C9.28%7C8.49%7C1.37;task_force_protein_domain=DNA_binding_and_Interaction_with_BRCA1;task_force_protein_domain_source=https://pubmed.ncbi.nlm.nih.gov/19369211/;hexplorer=-1.33;hexplorer_mut=5.14;hexplorer_wt=6.48;hexplorer_rev=-4.46;hexplorer_rev_mut=-5.27;hexplorer_rev_wt=-0.81;max_hbond_rev=0.00;max_hbond_rev_mut=1.90;max_hbond_rev_wt=1.90;bayesdel=0.63;heredicare_vid=11576991;clinvar=186820;rsid=786203245;variation_id=186820;clinvar_summary=reviewed_by_expert_panel:Uncertain_significance;clinvar_submissions=Uncertain_significance|2023-04-05|reviewed_by_expert_panel|C0346153:Familial_cancer_of_breast|ClinGen_Hereditary_Breast,_Ovarian_and_Pancreatic_Cancer_Variant_Curation_Expert_Panel,_ClinGen|description:_The_c.49-2A>T_variant_in_PALB2_occurs_within_the_canonical_splice_acceptor_site_(-1,2)_of_intron_1._The_computational_splicing_predictor_SpliceAI_gives_a_score_of_0.97_for_acceptor_loss_and_0.71_score_for_an_acceptor_gain,_predicting_that_the_variant_disrupts_the_acceptor_splice_site._This_alteration_is_predicted_to_result_in_an_in-frame_loss_impacting_two_amino_acids_from_of_exon_2_in_the_coiled-coiled_domain_with_unknown_functional_impact_(PMID:_30890586,_30289697,_31159747,_Ambry_Genetics)._This_variant_is_absent_in_gnomAD_v2.1.1._In_summary,_this_variant_meets_the_criteria_to_be_classified_as_a_variant_of_uncertain_significance_for_autosomal_dominant_hereditary_breast_and_pancreatic_cancer_and_autosomal_recessive_FANCN_based_on_the_ACMG/AMP_criteria_applied,_as_specified_by_the_HBOP_VCEP._(PVS1_Moderate,_PM2_Supporting)&Likely_pathogenic|2023-01-25|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_The_c.49-2A>T_intronic_variant_results_from_an_A_to_T_substitution_two_nucleotides_upstream_from_coding_exon_2_in_the_PALB2_gene._This_alteration_was_identified_in_1/1824_triple-negative_breast_cancer_patients_unselected_for_family_history_of_breast_or_ovarian_cancer_(Couch_FJ_et_al._J._Clin._Oncol._2015_Feb%3B_33(4):304-11)._This_nucleotide_position_is_highly_conserved_in_available_vertebrate_species._In_silico_splice_site_analysis_predicts_that_this_alteration_will_weaken_the_native_splice_acceptor_site_and_will_result_in_the_creation_or_strengthening_of_a_novel_splice_acceptor_site._Usage_of_this_novel_acceptor_site_would_result_in_an_in-frame_transcript_lacking_two_highly_conserved_amino_acids_in_the_coiled-coiled_domain_and_is_predicted_to_significantly_disrupt_a_protein-protein_interface_(Ambry_internal_data)._RNA_studies_have_demonstrated_that_this_alteration_results_in_abnormal_splicing_in_the_set_of_samples_tested_(Ambry_internal_data)._Based_on_the_majority_of_available_evidence_to_date,_this_variant_is_likely_to_be_pathogenic.&Uncertain_significance|2022-03-13|criteria_provided,_single_submitter|C0346153:Familial_cancer_of_breast|Invitae|description:_This_sequence_change_affects_an_acceptor_splice_site_in_intron_1_of_the_PALB2_gene._RNA_analysis_indicates_that_disruption_of_this_splice_site_induces_altered_splicing_and_likely_results_in_the_loss_of_2_amino_acid_residue(s),_but_is_expected_to_preserve_the_integrity_of_the_reading-frame._This_variant_is_not_present_in_population_databases_(gnomAD_no_frequency)._Disruption_of_this_splice_site_has_been_observed_in_individual(s)_with_PALB2-related_conditions_(PMID:_25452441,_29478780)._ClinVar_contains_an_entry_for_this_variant_(Variation_ID:_186820)._Studies_have_shown_disruption_of_this_splice_site_is_associated_with_skipping_of_2_amino_acids,_but_one_or_more_of_the_resulting_mRNA_isoform(s)_may_be_naturally_occurring_(PMID:_30890586)._In_summary,_the_available_evidence_is_currently_insufficient_to_determine_the_role_of_this_variant_in_disease._Therefore,_it_has_been_classified_as_a_Variant_of_Uncertain_Significance.&Likely_pathogenic|2019-05-13|no_assertion_criteria_provided|C0346153:Familial_cancer_of_breast|Leiden_Open_Variation_Database|description:_Curators:_Marc_Tischkowitz,_Arleen_D._Auerbach._Submitter_to_LOVD:_Marc_Tischkowitz.&Likely_pathogenic|2018-02-06|criteria_provided,_single_submitter|C0346153:Familial_cancer_of_breast|Counsyl|None&Uncertain_significance|2022-05-27|criteria_provided,_single_submitter|C0346153:Familial_cancer_of_breast|MGZ_Medical_Genetics_Center|None;heredicare_annotation=11576991|2|3|13|Class_3_da_Effekt_auf_RNA-Ebene_eine_inframe_Deletion_von_2_AS_ist_deren_Effekt_auf_die_Proteinfunktion_unklar_bleibt.|2022-09-20;consequences=ENST00000261584|c.49-2A>T|None|splice_acceptor_variant|high|None|1|PALB2|None|True|True|False|True|protein_coding|3548&ENST00000300087|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|True|False|True|protein_coding|543&ENST00000561514|c.-837-2A>T|None|splice_acceptor_variant|high|None|1|PALB2|None|True|False|False|False|protein_coding|3554&ENST00000563188|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|nonsense_mediated_decay|224&ENST00000563998|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|False|False|False|protein_coding|453&ENST00000565038|None|None|upstream_gene_variant|modifier|None|None|PALB2|None|False|False|False|False|nonsense_mediated_decay|212&ENST00000566053|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|nonsense_mediated_decay|159&ENST00000566298|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|protein_coding|295&ENST00000567003|n.327-2A>T|None|splice_acceptor_variant_%26_non_coding_transcript_variant|high|None|2|PALB2|None|False|False|False|False|protein_coding_CDS_not_defined|784&ENST00000568219|c.-837-2A>T|None|splice_acceptor_variant|high|None|1|PALB2|None|True|False|False|False|protein_coding|2666&ENST00000568272|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|False|False|False|protein_coding|252&ENST00000568589|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|False|False|False|protein_coding|463&ENST00000697374|c.-837-2A>T|None|splice_acceptor_variant|high|None|1|PALB2|None|True|False|False|False|protein_coding|2666&ENST00000697375|n.1394A>T|None|non_coding_transcript_exon_variant|modifier|1|None|PALB2|None|False|False|False|False|protein_coding_CDS_not_defined|5165&ENST00000697376|c.-873-2A>T|None|splice_acceptor_variant|high|None|2|PALB2|None|True|False|False|False|protein_coding|2322&ENST00000697377|c.-837-2A>T|None|splice_acceptor_variant|high|None|2|PALB2|None|True|False|False|False|protein_coding|3393&ENST00000697378|n.569-2A>T|None|splice_acceptor_variant_%26_non_coding_transcript_variant|high|None|1|PALB2|None|False|False|False|False|protein_coding_CDS_not_defined|4327&ENST00000697379|c.-837-2A>T|None|splice_acceptor_variant|high|None|2|PALB2|None|True|False|False|False|protein_coding|3554&ENST00000697382|c.-837-2A>T|None|splice_acceptor_variant_%26_NMD_transcript_variant|high|None|2|PALB2|None|False|False|False|False|nonsense_mediated_decay|2242&ENST00000697383|c.48%2B2979A>T|None|intron_variant|modifier|None|1|PALB2|None|True|False|False|False|protein_coding|1086&ENST00000697384|n.203-2A>T|None|splice_acceptor_variant_%26_non_coding_transcript_variant|high|None|1|PALB2|None|False|False|False|False|retained_intron|2858&NM_001199011|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|False|False|False|mRNA|252&NM_001199743|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|False|False|False|mRNA|453&NM_024675|c.49-2A>T|None|splice_acceptor_variant|high|None|1|PALB2|None|True|True|False|True|mRNA|3548&NM_032486|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|True|False|True|mRNA|543&NR_037573|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|misc_RNA|11048&XM_011545946|c.55-2A>T|None|splice_acceptor_variant|high|None|1|PALB2|None|False|False|False|False|mRNA|3554&XM_011545947|c.55-2A>T|None|splice_acceptor_variant|high|None|1|PALB2|None|False|False|False|False|mRNA|3210&XM_011545948|c.-837-2A>T|None|splice_acceptor_variant|high|None|2|PALB2|None|False|False|False|False|mRNA|2666&XM_017023671|c.55-2A>T|None|splice_acceptor_variant|high|None|1|PALB2|None|False|False|False|False|None|None&XM_017023672|c.49-2A>T|None|splice_acceptor_variant|high|None|1|PALB2|None|False|False|False|False|None|None&XM_017023673|c.49-2A>T|None|splice_acceptor_variant|high|None|1|PALB2|None|False|False|False|False|mRNA|3204&XR_001752006|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|misc_RNA|9078&XR_001752007|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|misc_RNA|9108;literature=25452441&29478780&30890586&34846068
chr16	23637849	1524	C	A	.	.	phylop_100way=3.838;cadd_scaled=33;spliceai_details=PALB2%7C0.00%7C0.00%7C0.47%7C1.00%7C-48%7C28%7C-47%7C1;spliceai_max_delta=1.0;maxentscan_ref=8.764;maxentscan_alt=0.260;maxentscan=ENST00000261584$8.76%7C0.26|ENST00000561514$8.76%7C0.26|ENST00000566069$8.76%7C0.26|ENST00000697377$8.76%7C0.26|ENST00000697379$8.76%7C0.26;maxentscan_swa=ENST00000261584$8.76%7C0.26%7C8.76%7C-0.38%7C-2.59%7C-5.34|ENST00000561514$8.76%7C0.26%7C8.76%7C-0.38%7C-2.59%7C-5.34|ENST00000566069$8.76%7C0.26%7C8.76%7C-0.38%7C-2.59%7C-5.34|ENST00000568219$8.76%7C0.26%7C8.76%7C-0.38%7C-2.59%7C-5.34|ENST00000697374$8.76%7C0.26%7C8.76%7C-0.38%7C-2.59%7C-5.34|ENST00000697376$8.76%7C0.26%7C8.76%7C-0.38%7C-2.59%7C-5.34|ENST00000697377$8.76%7C0.26%7C8.76%7C-0.38%7C-2.59%7C-5.34|ENST00000697379$8.76%7C0.26%7C8.76%7C-0.38%7C-2.59%7C-5.34|ENST00000697383$8.76%7C0.26%7C8.76%7C-0.38%7C-2.59%7C-5.34;task_force_protein_domain=DNA_binding_and_Interaction_with_BRCA1;task_force_protein_domain_source=https://pubmed.ncbi.nlm.nih.gov/19369211/;hexplorer=-5.87;hexplorer_mut=-8.58;hexplorer_wt=-2.70;hexplorer_rev=-0.28;hexplorer_rev_mut=-6.00;hexplorer_rev_wt=-5.72;max_hbond_rev=-14.10;max_hbond_rev_mut=1.90;max_hbond_rev_wt=16.00;bayesdel=0.63;rsid=1555462026;heredicare_vid=6077282;clinvar=650958;variation_id=650958;clinvar_summary=criteria_provided,_multiple_submitters,_no_conflicts:Pathogenic/Likely_pathogenic;clinvar_submissions=Likely_pathogenic|2022-10-17|criteria_provided,_single_submitter|C0346153:Familial_cancer_of_breast|Invitae|description:_This_sequence_change_affects_a_donor_splice_site_in_intron_3_of_the_PALB2_gene._It_is_expected_to_disrupt_RNA_splicing._Variants_that_disrupt_the_donor_or_acceptor_splice_site_typically_lead_to_a_loss_of_protein_function_(PMID:_16199547),_and_loss-of-function_variants_in_PALB2_are_known_to_be_pathogenic_(PMID:_17200668,_17200671,_17200672,_24136930,_25099575)._This_variant_is_not_present_in_population_databases_(gnomAD_no_frequency)._Disruption_of_this_splice_site_has_been_observed_in_individual(s)_with_PALB2-related_conditions_(PMID:_32068069)._ClinVar_contains_an_entry_for_this_variant_(Variation_ID:_650958)._Algorithms_developed_to_predict_the_effect_of_sequence_changes_on_RNA_splicing_suggest_that_this_variant_may_disrupt_the_consensus_splice_site._In_summary,_the_currently_available_evidence_indicates_that_the_variant_is_pathogenic,_but_additional_data_are_needed_to_prove_that_conclusively._Therefore,_this_variant_has_been_classified_as_Likely_Pathogenic.&Likely_pathogenic|2021-12-13|criteria_provided,_single_submitter|C0346153:Familial_cancer_of_breast|MGZ_Medical_Genetics_Center|None&Pathogenic|2021-02-01|criteria_provided,_single_submitter|C3661900:not_provided|Institute_of_Medical_Genetics_and_Applied_Genomics,_University_Hospital_Tübingen|None;heredicare_annotation=6077282|5|10|15|eigene_RNA_Analysen_(36155):_Skipping_von_Exon_3_durch_Verlust_der_invarianten_Donor-Spleißstelle_r.109_211del%3B_p.(Arg37Asnfs*106)%3B_CAVE:_Patientin_zeigt_keine_Wildtyp-Bande,_evl._methodische_Problematik_durch_bevorzugte_Amplifikation_des_kleineren_Fragments!?_Quantitative_Aussage_nicht_möglich!|2016-09-08;consequences=ENST00000261584|c.211%2B1G>T|None|splice_donor_variant|high|None|3|PALB2|None|True|True|False|True|protein_coding|3548&ENST00000300087|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|True|False|True|protein_coding|543&ENST00000561514|c.-675%2B1G>T|None|splice_donor_variant|high|None|3|PALB2|None|True|False|False|False|protein_coding|3554&ENST00000563188|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|nonsense_mediated_decay|224&ENST00000563998|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|False|False|False|protein_coding|453&ENST00000565038|c.86%2B1G>T|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|1|PALB2|None|False|False|False|False|nonsense_mediated_decay|212&ENST00000566053|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|nonsense_mediated_decay|159&ENST00000566298|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|protein_coding|295&ENST00000567003|n.489%2B1G>T|None|splice_donor_variant_%26_non_coding_transcript_variant|high|None|4|PALB2|None|False|False|False|False|protein_coding_CDS_not_defined|784&ENST00000568219|c.-675%2B1G>T|None|splice_donor_variant|high|None|3|PALB2|None|True|False|False|False|protein_coding|2666&ENST00000568272|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|False|False|False|protein_coding|252&ENST00000568589|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|False|False|False|protein_coding|463&ENST00000697374|c.-675%2B1G>T|None|splice_donor_variant|high|None|3|PALB2|None|True|False|False|False|protein_coding|2666&ENST00000697375|n.1558%2B1G>T|None|splice_donor_variant_%26_non_coding_transcript_variant|high|None|2|PALB2|None|False|False|False|False|protein_coding_CDS_not_defined|5165&ENST00000697376|c.-675%2B1G>T|None|splice_donor_variant|high|None|4|PALB2|None|True|False|False|False|protein_coding|2322&ENST00000697377|c.-675%2B1G>T|None|splice_donor_variant|high|None|4|PALB2|None|True|False|False|False|protein_coding|3393&ENST00000697378|n.731%2B1G>T|None|splice_donor_variant_%26_non_coding_transcript_variant|high|None|3|PALB2|None|False|False|False|False|protein_coding_CDS_not_defined|4327&ENST00000697379|c.-675%2B1G>T|None|splice_donor_variant|high|None|4|PALB2|None|True|False|False|False|protein_coding|3554&ENST00000697382|c.-675%2B1G>T|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|4|PALB2|None|False|False|False|False|nonsense_mediated_decay|2242&ENST00000697383|c.48%2B3261G>T|None|intron_variant|modifier|None|1|PALB2|None|True|False|False|False|protein_coding|1086&ENST00000697384|n.365%2B1G>T|None|splice_donor_variant_%26_non_coding_transcript_variant|high|None|3|PALB2|None|False|False|False|False|retained_intron|2858&NM_001199011|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|False|False|False|mRNA|252&NM_001199743|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|False|False|False|mRNA|453&NM_024675|c.211%2B1G>T|None|splice_donor_variant|high|None|3|PALB2|None|True|True|False|True|mRNA|3548&NM_032486|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|True|False|True|mRNA|543&NR_037573|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|misc_RNA|11048&XM_011545946|c.217%2B1G>T|None|splice_donor_variant|high|None|3|PALB2|None|False|False|False|False|mRNA|3554&XM_011545947|c.217%2B1G>T|None|splice_donor_variant|high|None|3|PALB2|None|False|False|False|False|mRNA|3210&XM_011545948|c.-675%2B1G>T|None|splice_donor_variant|high|None|4|PALB2|None|False|False|False|False|mRNA|2666&XM_017023671|c.217%2B1G>T|None|splice_donor_variant|high|None|3|PALB2|None|False|False|False|False|None|None&XM_017023672|c.211%2B1G>T|None|splice_donor_variant|high|None|3|PALB2|None|False|False|False|False|None|None&XM_017023673|c.211%2B1G>T|None|splice_donor_variant|high|None|3|PALB2|None|False|False|False|False|mRNA|3204&XR_001752006|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|misc_RNA|9078&XR_001752007|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|misc_RNA|9108;literature=25099575&17200668&24136930&16199547
chr16	23638125	9110	T	C	.	.	phylop_100way=4.847;cadd_scaled=25.1;revel=ENST00000261584$0.181;spliceai_details=PALB2%7C0.04%7C0.02%7C0.00%7C0.00%7C-1%7C4%7C6%7C-2;spliceai_max_delta=0.04;maxentscan_swa=ENST00000261584$1.15%7C2.58%7C1.15%7C1.37%7C4.21%7C-4.55|ENST00000561514$1.15%7C2.58%7C1.15%7C1.37%7C4.21%7C-4.55|ENST00000566069$1.15%7C2.58%7C1.15%7C1.37%7C4.21%7C-4.55|ENST00000568219$1.15%7C2.58%7C1.15%7C1.37%7C4.21%7C-4.55|ENST00000697374$1.15%7C2.58%7C1.15%7C1.37%7C4.21%7C-4.55|ENST00000697376$1.15%7C2.58%7C1.15%7C1.37%7C4.21%7C-4.55|ENST00000697377$1.15%7C2.58%7C1.15%7C1.37%7C4.21%7C-4.55|ENST00000697379$1.15%7C2.58%7C1.15%7C1.37%7C4.21%7C-4.55|ENST00000697383$1.15%7C2.58%7C1.15%7C1.37%7C4.21%7C-4.55;gnomad_ac=740;gnomad_af=0.00486413;gnomad_hom=3;gnomad_het=734;gnomad_popmax=AFR;gnomad_popmax_AF=0.0165379;gnomad_popmax_AC=685;flossies_num_afr=105;flossies_num_eur=8;task_force_protein_domain=DNA_binding_and_Interaction_with_BRCA1;task_force_protein_domain_source=https://pubmed.ncbi.nlm.nih.gov/19369211/;hexplorer=1.20;hexplorer_mut=-8.80;hexplorer_wt=-10.00;hexplorer_rev=-6.32;hexplorer_rev_mut=-1.96;hexplorer_rev_wt=4.36;max_hbond_rev=0.00;max_hbond_rev_mut=1.90;max_hbond_rev_wt=1.90;bayesdel=-0.304024;clinvar=126758;rsid=138789658;heredicare_vid=6028265;cosmic=COSV55162534;variation_id=126758;clinvar_summary=criteria_provided,_conflicting_interpretations:Conflicting_interpretations_of_pathogenicity%7CUncertain_significance(1)%7CBenign(11)%7CLikely_benign(4);clinvar_submissions=Benign|2022-04-19|criteria_provided,_single_submitter|C0677776:Hereditary_breast_ovarian_cancer_syndrome|National_Health_Laboratory_Service,_Universitas_Academic_Hospital_and_University_of_the_Free_State|None&not_provided|2013-09-19|no_assertion_provided|CN169374:not_specified|ITMI|None&Benign|2023-08-15|criteria_provided,_single_submitter|CN169374:not_specified|Center_for_Genomic_Medicine,_Rigshospitalet,_Copenhagen_University_Hospital|None&Benign|2014-11-25|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_This_alteration_is_classified_as_benign_based_on_a_combination_of_the_following:_population_frequency,_intact_protein_function,_lack_of_segregation_with_disease,_co-occurrence,_RNA_analysis,_in_silico_models,_amino_acid_conservation,_lack_of_disease_association_in_case-control_studies,_and/or_the_mechanism_of_disease_or_impacted_region_is_inconsistent_with_a_known_cause_of_pathogenicity.&Benign|2016-11-22|criteria_provided,_single_submitter|CN169374:not_specified|PreventionGenetics,_PreventionGenetics|None&Benign|2022-11-04|criteria_provided,_single_submitter|C0346153:Familial_cancer_of_breast|Invitae|None&Likely_benign|2018-03-04|criteria_provided,_single_submitter|CN169374:not_specified|Eurofins_Ntd_Llc_(ga)|None&Benign|None|no_assertion_criteria_provided|CN169374:not_specified|Genome_Diagnostics_Laboratory,_Amsterdam_University_Medical_Center|None&Likely_benign|2017-07-12|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Institute_for_Biomarker_Research,_Medical_Diagnostic_Laboratories,_L.L.C.|None&Uncertain_significance|2015-06-01|criteria_provided,_single_submitter|C0346153:Familial_cancer_of_breast|Cancer_Genetics_Laboratory,_Peter_MacCallum_Cancer_Centre|None&Benign|2015-01-20|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Color_Diagnostics,_LLC_DBA_Color_Health|None&Benign|2019-07-14|criteria_provided,_single_submitter|CN169374:not_specified|Genetic_Services_Laboratory,_University_of_Chicago|None&Likely_benign|2016-06-14|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Illumina_Laboratory_Services,_Illumina|None&Benign|2014-11-06|no_assertion_criteria_provided|C0346153:Familial_cancer_of_breast|Pathway_Genomics|None&Likely_benign|2017-04-27|criteria_provided,_single_submitter|C1835817:Fanconi_anemia_complementation_group_N|Illumina_Laboratory_Services,_Illumina|description:_This_variant_was_observed_as_part_of_a_predisposition_screen_in_an_ostensibly_healthy_population._A_literature_search_was_performed_for_the_gene,_cDNA_change,_and_amino_acid_change_(where_applicable)._No_publications_were_found_based_on_this_search._Allele_frequency_data_from_public_databases_allowed_determination_this_variant_is_unlikely_to_cause_disease._Therefore,_this_variant_is_classified_as_likely_benign.&Benign|2014-01-15|criteria_provided,_single_submitter|CN169374:not_specified|GeneDx|description:_This_variant_is_considered_likely_benign_or_benign_based_on_one_or_more_of_the_following_criteria:_it_is_a_conservative_change,_it_occurs_at_a_poorly_conserved_position_in_the_protein,_it_is_predicted_to_be_benign_by_multiple_in_silico_algorithms,_and/or_has_population_frequency_not_consistent_with_disease.&Benign|None|no_assertion_criteria_provided|CN169374:not_specified|Genome_Diagnostics_Laboratory,_University_Medical_Center_Utrecht|None&Benign|None|no_assertion_criteria_provided|CN169374:not_specified|Clinical_Genetics_Laboratory,_Department_of_Pathology,_Netherlands_Cancer_Institute|None&Benign|2020-07-07|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Sema4,_Sema4|None&Benign|2017-01-05|criteria_provided,_single_submitter|C3661900:not_provided|Center_for_Pediatric_Genomic_Medicine,_Children's_Mercy_Hospital_and_Clinics|None&Benign|None|no_assertion_criteria_provided|CN169374:not_specified|Joint_Genome_Diagnostic_Labs_from_Nijmegen_and_Maastricht,_Radboudumc_and_MUMC%2B|None&Benign|2020-04-27|criteria_provided,_single_submitter|C3661900:not_provided|ARUP_Laboratories,_Molecular_Genetics_and_Genomics,_ARUP_Laboratories|None&Likely_benign|None|no_assertion_criteria_provided|C3661900:not_provided|Department_of_Pathology_and_Laboratory_Medicine,_Sinai_Health_System|description:_The_PALB2_p.Lys18Arg_variant_was_identified_in_20_of_8974_proband_chromosomes_(frequency:_0.002)_from_German,_Russian,_French,_(African)_American_and_Australian_individuals_or_families_with_breast_cancer_(BRCA1/2_negative_or_familial_or_early_onset)_and_early_onset_prostate_cancer,_and_was_identified_in_2_of_6682_chromosomes_from_healthy_individuals_(frequency:_0.0003)_(Bogdanova_2011_21165770,_Damiola_2015_26564480,_Ding_2011_21113654_,_Nguyen_Dumont_2015,_Thompson_2015_26283626,_Zheng_2012_21932393,_Tischkowitz_2008_18288683,_Bodian_2014_24728327)._The_variant_was_found_in_1_proband_with_prostate_cancer_as_well_as_his_unaffected_brother_(Tischkowitz_2008_18288683)._Functional_analysis_of_PALB2_interaction_with_BRCA1_showed_the_variant_did_not_significantly_affect_complex_formation,_while_partially_impairing_HR_(homologous_recombination)_DNA_repair_activity_of_PALB2_(Foo_2017__28319063)._The_variant_was_also_identified_in_dbSNP_(ID:_rs138789658)_â€šÃ„ÃºWith_other_alleleâ€šÃ„Ã¹,_ClinVar_(classified_with_conflicting_interpretations_of_pathogencity%3B_submitters:_benign_by_GeneDx,_Ambry_Genetics,_Invitae,_Color_Genomics,_Center_for_Pediatric_Genomic_Medicine_(Children's_Mercy_Hospital_and_Clinics)_and_Pathway_Genomics%3B_likely_benign_by_PALB2_database,_Genetic_Services_Laboratory_(University_of_Chicago),_Illumina%3B_uncertain_significance_by_Cancer_Genetics_Laboratoy_(Peter_MacCallum_Cancer_Center),_and_classification_not_provided_by_ITMI),_Clinvitae_(5x),_LOVD_3.0_(1x),_Zhejiang_Colon_Cancer_Database_(1x)_and_was_not_identified_in_MutDB._The_variant_was_identified_in_control_databases_in_489_(3_homozygous)_of_277224_chromosomes_at_a_frequency_of_0.002_increasing_the_likelihood_this_could_be_a_low_frequency_benign_variant_(Genome_Aggregation_Database_Feb_27,_2017)._Observations_by_population_include_African_in_440_(3_homozygous)_of_24030_chromosomes_(freq:_0.02),_Other_in_4_of_6464_chromosomes_(freq:_0.0006),_Latino_in_32_of_34420_chromosomes_(freq:_0.0009),_European_Non-Finnish_in_12_of_126714_chromosomes_(freq:_0.0001),_East_Asian_in_1_of_18868_chromosomes_(freq:_0.00005)%3B_it_was_not_observed_in_the_Ashkenazi_Jewish,_European_Finnish,_and_South_Asian_populations._The_p.Lys18_residue_is_conserved_in_in_mammals_but_not_in_more_distantly_related_organisms_however_computational_analyses_(PolyPhen-2,_SIFT,_AlignGVGD,_BLOSUM,_MutationTaster)_do_not_suggest_a_high_likelihood_the_variant_Arg_impacts_the_protein%3B_this_information_is_not_predictive_enough_to_rule_out_pathogenicity._The_variant_occurs_outside_of_the_splicing_consensus_sequence_and_1_of_5_in_silico_or_computational_prediction_software_programs_(SpliceSiteFinder,_MaxEntScan,_NNSPLICE,_GeneSplicer,_HumanSpliceFinder)_predict_a_greater_than_10%_difference_in_splicing%3B_this_is_not_very_predictive_of_pathogenicity._In_summary,_based_on_the_above_information_the_clinical_significance_of_this_variant_cannot_be_determined_with_certainty_at_this_time_although_we_would_lean_towards_a_more_benign_role_for_this_variant._This_variant_is_classified_as_likely_benign.&Likely_benign|2019-05-13|no_assertion_criteria_provided|C3661900:not_provided|Leiden_Open_Variation_Database|description:_Curators:_Marc_Tischkowitz,_Arleen_D._Auerbach._Submitters_to_LOVD:_Marc_Tischkowitz,_Melissa_DeRycke.;heredicare_annotation=6028265|6|6|11|Class_1_da_hohe_Frequenz_in_AFR_und_Flossies|2022-03-08;consequences=ENST00000261584|c.53A>G|p.Lys18Arg|missense_variant|moderate|2|None|PALB2|None|True|True|False|True|protein_coding|3548&ENST00000300087|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|True|False|True|protein_coding|543&ENST00000561514|c.-833A>G|None|5_prime_UTR_variant|modifier|2|None|PALB2|None|True|False|False|False|protein_coding|3554&ENST00000563188|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|nonsense_mediated_decay|224&ENST00000563998|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|False|False|False|protein_coding|453&ENST00000565038|None|None|upstream_gene_variant|modifier|None|None|PALB2|None|False|False|False|False|nonsense_mediated_decay|212&ENST00000566053|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|nonsense_mediated_decay|159&ENST00000566298|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|protein_coding|295&ENST00000567003|n.331A>G|None|non_coding_transcript_exon_variant|modifier|3|None|PALB2|None|False|False|False|False|protein_coding_CDS_not_defined|784&ENST00000568219|c.-833A>G|None|5_prime_UTR_variant|modifier|2|None|PALB2|None|True|False|False|False|protein_coding|2666&ENST00000568272|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|False|False|False|protein_coding|252&ENST00000568589|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|False|False|False|protein_coding|463&ENST00000697374|c.-833A>G|None|5_prime_UTR_variant|modifier|2|None|PALB2|None|True|False|False|False|protein_coding|2666&ENST00000697375|n.1400A>G|None|non_coding_transcript_exon_variant|modifier|1|None|PALB2|None|False|False|False|False|protein_coding_CDS_not_defined|5165&ENST00000697376|c.-869A>G|None|5_prime_UTR_variant|modifier|3|None|PALB2|None|True|False|False|False|protein_coding|2322&ENST00000697377|c.-833A>G|None|5_prime_UTR_variant|modifier|3|None|PALB2|None|True|False|False|False|protein_coding|3393&ENST00000697378|n.573A>G|None|non_coding_transcript_exon_variant|modifier|2|None|PALB2|None|False|False|False|False|protein_coding_CDS_not_defined|4327&ENST00000697379|c.-833A>G|None|5_prime_UTR_variant|modifier|3|None|PALB2|None|True|False|False|False|protein_coding|3554&ENST00000697382|c.-833A>G|None|5_prime_UTR_variant_%26_NMD_transcript_variant|modifier|3|None|PALB2|None|False|False|False|False|nonsense_mediated_decay|2242&ENST00000697383|c.48%2B2985A>G|None|intron_variant|modifier|None|1|PALB2|None|True|False|False|False|protein_coding|1086&ENST00000697384|n.207A>G|None|non_coding_transcript_exon_variant|modifier|2|None|PALB2|None|False|False|False|False|retained_intron|2858&NM_001199011|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|False|False|False|mRNA|252&NM_001199743|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|False|False|False|mRNA|453&NM_024675|c.53A>G|p.Lys18Arg|missense_variant|moderate|2|None|PALB2|None|True|True|False|True|mRNA|3548&NM_032486|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|True|False|True|mRNA|543&NR_037573|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|misc_RNA|11048&XM_011545946|c.59A>G|p.Lys20Arg|missense_variant|moderate|2|None|PALB2|None|False|False|False|False|mRNA|3554&XM_011545947|c.59A>G|p.Lys20Arg|missense_variant|moderate|2|None|PALB2|None|False|False|False|False|mRNA|3210&XM_011545948|c.-833A>G|None|5_prime_UTR_variant|modifier|3|None|PALB2|None|False|False|False|False|mRNA|2666&XM_017023671|c.59A>G|p.Lys20Arg|missense_variant|moderate|2|None|PALB2|None|False|False|False|False|None|None&XM_017023672|c.53A>G|p.Lys18Arg|missense_variant|moderate|2|None|PALB2|None|False|False|False|False|None|None&XM_017023673|c.53A>G|p.Lys18Arg|missense_variant|moderate|2|None|PALB2|None|False|False|False|False|mRNA|3204&XR_001752006|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|misc_RNA|9078&XR_001752007|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|misc_RNA|9108;literature=25741868&24728327&32039725&23555315&18288683&21932393&21113654&26283626&21165770&25575445&33195396&28569743&26420498&28719003&33169439&30289697&23675308&32185139&26934580&26740555&31415627&29254223&28404951&28319063&31586400&28944238&28779002&32444794&31757951
chr16	23638091	22422	G	GCGATTCACTTACCTGAAGGCGGGCTAGTGTCTTGC	.	.	maxentscan_swa=ENST00000261584$-1.79%7C10.86%7C-1.79%7C-9.83%7C0.90%7C-9.83|ENST00000561514$-1.79%7C10.86%7C-1.79%7C-9.83%7C0.90%7C-9.83|ENST00000566069$-1.79%7C10.86%7C-1.79%7C-9.83%7C0.90%7C-9.83|ENST00000568219$-1.79%7C10.86%7C-1.79%7C-9.83%7C0.90%7C-9.83|ENST00000697374$-1.79%7C10.86%7C-1.79%7C-9.83%7C0.90%7C-9.83|ENST00000697376$-1.79%7C10.86%7C-1.79%7C-9.83%7C0.90%7C-9.83|ENST00000697377$-1.79%7C10.86%7C-1.79%7C-9.83%7C0.90%7C-9.83|ENST00000697379$-1.79%7C10.86%7C-1.79%7C-9.83%7C0.90%7C-9.83|ENST00000697383$-1.79%7C10.86%7C-1.79%7C-9.83%7C0.90%7C-9.83;task_force_protein_domain=DNA_binding_and_Interaction_with_BRCA1;task_force_protein_domain_source=https://pubmed.ncbi.nlm.nih.gov/19369211/;hexplorer=3.94;hexplorer_mut=-1.16;hexplorer_wt=-5.1;hexplorer_rev=-6.97;hexplorer_rev_mut=2.04;hexplorer_rev_wt=9.01;max_hbond=0;max_hbond_mut=4.5;max_hbond_wt=4.5;max_hbond_rev=20.8;max_hbond_rev_mut=20.8;heredicare_vid=8029835;heredicare_annotation=8029835|1|1|13||2017-05-11;consequences=ENST00000261584|c.86_87insGCAAGACACTAGCCCGCCTTCAGGTAAGTGAATCG|p.Ser29ArgfsTer11|stop_gained_%26_frameshift_variant|high|2|None|PALB2|None|True|True|False|True|protein_coding|3548&ENST00000300087|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|True|False|True|protein_coding|543&ENST00000561514|c.-800_-799insGCAAGACACTAGCCCGCCTTCAGGTAAGTGAATCG|None|5_prime_UTR_variant|modifier|2|None|PALB2|None|True|False|False|False|protein_coding|3554&ENST00000563188|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|nonsense_mediated_decay|224&ENST00000563998|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|False|False|False|protein_coding|453&ENST00000565038|None|None|upstream_gene_variant|modifier|None|None|PALB2|None|False|False|False|False|nonsense_mediated_decay|212&ENST00000566053|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|nonsense_mediated_decay|159&ENST00000566298|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|protein_coding|295&ENST00000567003|n.364_365insGCAAGACACTAGCCCGCCTTCAGGTAAGTGAATCG|None|non_coding_transcript_exon_variant|modifier|3|None|PALB2|None|False|False|False|False|protein_coding_CDS_not_defined|784&ENST00000568219|c.-800_-799insGCAAGACACTAGCCCGCCTTCAGGTAAGTGAATCG|None|5_prime_UTR_variant|modifier|2|None|PALB2|None|True|False|False|False|protein_coding|2666&ENST00000568272|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|False|False|False|protein_coding|252&ENST00000568589|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|False|False|False|protein_coding|463&ENST00000697374|c.-800_-799insGCAAGACACTAGCCCGCCTTCAGGTAAGTGAATCG|None|5_prime_UTR_variant|modifier|2|None|PALB2|None|True|False|False|False|protein_coding|2666&ENST00000697375|n.1433_1434insGCAAGACACTAGCCCGCCTTCAGGTAAGTGAATCG|None|non_coding_transcript_exon_variant|modifier|1|None|PALB2|None|False|False|False|False|protein_coding_CDS_not_defined|5165&ENST00000697376|c.-836_-835insGCAAGACACTAGCCCGCCTTCAGGTAAGTGAATCG|None|5_prime_UTR_variant|modifier|3|None|PALB2|None|True|False|False|False|protein_coding|2322&ENST00000697377|c.-800_-799insGCAAGACACTAGCCCGCCTTCAGGTAAGTGAATCG|None|5_prime_UTR_variant|modifier|3|None|PALB2|None|True|False|False|False|protein_coding|3393&ENST00000697378|n.606_607insGCAAGACACTAGCCCGCCTTCAGGTAAGTGAATCG|None|non_coding_transcript_exon_variant|modifier|2|None|PALB2|None|False|False|False|False|protein_coding_CDS_not_defined|4327&ENST00000697379|c.-800_-799insGCAAGACACTAGCCCGCCTTCAGGTAAGTGAATCG|None|5_prime_UTR_variant|modifier|3|None|PALB2|None|True|False|False|False|protein_coding|3554&ENST00000697382|c.-800_-799insGCAAGACACTAGCCCGCCTTCAGGTAAGTGAATCG|None|5_prime_UTR_variant_%26_NMD_transcript_variant|modifier|3|None|PALB2|None|False|False|False|False|nonsense_mediated_decay|2242&ENST00000697383|c.48%2B3018_48%2B3019insGCAAGACACTAGCCCGCCTTCAGGTAAGTGAATCG|None|intron_variant|modifier|None|1|PALB2|None|True|False|False|False|protein_coding|1086&ENST00000697384|n.240_241insGCAAGACACTAGCCCGCCTTCAGGTAAGTGAATCG|None|non_coding_transcript_exon_variant|modifier|2|None|PALB2|None|False|False|False|False|retained_intron|2858&NM_001199011|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|False|False|False|mRNA|252&NM_001199743|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|False|False|False|mRNA|453&NM_024675|c.86_87insGCAAGACACTAGCCCGCCTTCAGGTAAGTGAATCG|p.Ser29ArgfsTer11|stop_gained_%26_frameshift_variant|high|2|None|PALB2|None|True|True|False|True|mRNA|3548&NM_032486|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|True|True|False|True|mRNA|543&NR_037573|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|misc_RNA|11048&XM_011545946|c.92_93insGCAAGACACTAGCCCGCCTTCAGGTAAGTGAATCG|p.Ser31ArgfsTer11|stop_gained_%26_frameshift_variant|high|2|None|PALB2|None|False|False|False|False|mRNA|3554&XM_011545947|c.92_93insGCAAGACACTAGCCCGCCTTCAGGTAAGTGAATCG|p.Ser31ArgfsTer11|stop_gained_%26_frameshift_variant|high|2|None|PALB2|None|False|False|False|False|mRNA|3210&XM_011545948|c.-800_-799insGCAAGACACTAGCCCGCCTTCAGGTAAGTGAATCG|None|5_prime_UTR_variant|modifier|3|None|PALB2|None|False|False|False|False|mRNA|2666&XM_017023671|c.92_93insGCAAGACACTAGCCCGCCTTCAGGTAAGTGAATCG|p.Ser31ArgfsTer11|stop_gained_%26_frameshift_variant|high|2|None|PALB2|None|False|False|False|False|None|None&XM_017023672|c.86_87insGCAAGACACTAGCCCGCCTTCAGGTAAGTGAATCG|p.Ser29ArgfsTer11|stop_gained_%26_frameshift_variant|high|2|None|PALB2|None|False|False|False|False|None|None&XM_017023673|c.86_87insGCAAGACACTAGCCCGCCTTCAGGTAAGTGAATCG|p.Ser29ArgfsTer11|stop_gained_%26_frameshift_variant|high|2|None|PALB2|None|False|False|False|False|mRNA|3204&XR_001752006|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|misc_RNA|9078&XR_001752007|None|None|upstream_gene_variant|modifier|None|None|DCTN5|None|False|False|False|False|misc_RNA|9108
chr16	68811717	8775	C	T	.	.	phylop_100way=0.945;cadd_scaled=19.58;revel=ENST00000261769$0.153|ENST00000268794$0.153|ENST00000379120$0.153|ENST00000422392$0.153;spliceai_details=CDH1%7C0.00%7C0.00%7C0.00%7C0.00%7C-9%7C-33%7C-17%7C10;spliceai_max_delta=0.0;maxentscan_swa=ENST00000261769$-3.99%7C-6.17%7C-3.99%7C-8.27%7C-8.02%7C-8.27|ENST00000422392$-3.99%7C-6.17%7C-3.99%7C-8.27%7C-8.02%7C-8.27;cancerhotspots_cancertypes=Colorectal_Adenocarcinoma:bowel;cancerhotspots_ac=1;cancerhotspots_af=4.125923175310476e-05;hexplorer=2.60;hexplorer_mut=10.75;hexplorer_wt=8.15;hexplorer_rev=0.64;hexplorer_rev_mut=5.52;hexplorer_rev_wt=4.88;max_hbond=4.90;max_hbond_mut=4.90;max_hbond_rev=-1.20;max_hbond_rev_mut=1.80;max_hbond_rev_wt=3.00;bayesdel=-0.30615;heredicare_vid=12840648;clinvar=216597;rsid=780399325;cosmic=COSV55730737;variation_id=216597;clinvar_summary=reviewed_by_expert_panel:Likely_benign;clinvar_submissions=Likely_benign|2022-08-01|criteria_provided,_single_submitter|C1708349:Hereditary_diffuse_gastric_adenocarcinoma|European_Reference_Network_on_Genetic_Tumour_Risk_Syndromes_(ERN-GENTURIS),_i3s_-_Instituto_de_Investigação_e_Inovação_em_Saúde,_University_of_Porto|description:_BS2_(PMID:_30311375)&Uncertain_significance|2022-09-28|criteria_provided,_single_submitter|C1708349:Hereditary_diffuse_gastric_adenocarcinoma|Invitae|description:_This_sequence_change_replaces_alanine,_which_is_neutral_and_non-polar,_with_valine,_which_is_neutral_and_non-polar,_at_codon_289_of_the_CDH1_protein_(p.Ala289Val)._This_variant_is_present_in_population_databases_(rs780399325,_gnomAD_0.01%)._This_missense_change_has_been_observed_in_individual(s)_with_breast_cancer_(PMID:_30287823)._ClinVar_contains_an_entry_for_this_variant_(Variation_ID:_216597)._Algorithms_developed_to_predict_the_effect_of_missense_changes_on_protein_structure_and_function_(SIFT,_PolyPhen-2,_Align-GVGD)_all_suggest_that_this_variant_is_likely_to_be_tolerated._In_summary,_the_available_evidence_is_currently_insufficient_to_determine_the_role_of_this_variant_in_disease._Therefore,_it_has_been_classified_as_a_Variant_of_Uncertain_Significance.&Likely_benign|2023-08-17|reviewed_by_expert_panel|CN311521:CDH1-related_diffuse_gastric_and_lobular_breast_cancer_syndrome|ClinGen_CDH1_Variant_Curation_Expert_Panel|description:_The_c.866C>T_(p.Ala289Val)_missense_variant_has_a_frequency_of_0.00002_(6_of_251,472)_in_gnomAD,_with_a_maximum_allele_frequency_of_0.00010_(3_of_30,616)_in_the_South_Asian_subpopulation_(http://gnomad.broadinstitute.org)._This_variant_has_been_observed_in_at_least_10_individuals_without_DGC,_SRC_tumours_or_LBC_and_whose_families_do_not_suggest_HDGC_(BS2%3B_SCV000669016.2,_SCV000254833.6)._In_summary,_the_clinical_significance_of_this_variant_is_classified_as_of_likely_benign_based_the_ACMG/AMP_criteria_applied,_as_specified_by_the_CDH1_Variant_Curation_Expert_Panel_(Variant_Interpretation_Guidelines_Version_3.1):_BS2.&Uncertain_significance|2022-02-27|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_The_p.A289V_variant_(also_known_as_c.866C>T),_located_in_coding_exon_7_of_the_CDH1_gene,_results_from_a_C_to_T_substitution_at_nucleotide_position_866._The_alanine_at_codon_289_is_replaced_by_valine,_an_amino_acid_with_similar_properties._This_alteration_was_observed_with_an_allele_frequency_of_0.00014_in_7,051_unselected_female_breast_cancer_patients_and_was_observed_with_an_allele_frequency_of_0.00009_in_11,241_female_controls_of_Japanese_ancestry._In_addition,_it_was_not_observed_in_unselected_male_breast_cancer_patients_and_was_observed_with_an_allele_frequency_of_0.0001_in_12,490_male_controls_of_Japanese_ancestry_(Momozawa_Y_et_al._Nat_Commun,_2018_10%3B9:4083)._This_amino_acid_position_is_not_well_conserved_in_available_vertebrate_species._In_addition,_this_alteration_is_predicted_to_be_tolerated_by_in_silico_analysis._Since_supporting_evidence_is_limited_at_this_time,_the_clinical_significance_of_this_alteration_remains_unclear.&Uncertain_significance|2021-11-03|criteria_provided,_single_submitter|C3661900:not_provided|Institute_for_Clinical_Genetics,_University_Hospital_TU_Dresden,_University_Hospital_TU_Dresden|None;heredicare_annotation=12840648|2|3|||;consequences=ENST00000261769|c.866C>T|p.Ala289Val|missense_variant|moderate|7|None|CDH1|PF00028|True|True|False|True|protein_coding|2633&ENST00000422392|c.866C>T|p.Ala289Val|missense_variant|moderate|7|None|CDH1|PF00028|True|False|False|False|protein_coding|2451&ENST00000561751|c.*22C>T|None|3_prime_UTR_variant_%26_NMD_transcript_variant|modifier|4|None|CDH1|None|False|False|False|False|nonsense_mediated_decay|462&ENST00000562836|n.937C>T|None|non_coding_transcript_exon_variant|modifier|6|None|CDH1|None|False|False|False|False|protein_coding_CDS_not_defined|2744&ENST00000563916|None|None|downstream_gene_variant|modifier|None|None|None|None|False|False|False|False|None|None&ENST00000564676|None|None|downstream_gene_variant|modifier|None|None|CDH1|None|False|False|False|False|protein_coding_CDS_not_defined|965&ENST00000564745|None|None|downstream_gene_variant|modifier|None|None|CDH1|None|False|False|False|False|protein_coding_CDS_not_defined|577&ENST00000565810|None|None|upstream_gene_variant|modifier|None|None|CDH1|None|False|False|False|False|retained_intron|280&ENST00000566510|c.710C>T|p.Ala237Val|missense_variant_%26_NMD_transcript_variant|moderate|6|None|CDH1|None|False|False|False|False|nonsense_mediated_decay|1236&ENST00000566612|c.866C>T|p.Ala289Val|missense_variant_%26_NMD_transcript_variant|moderate|7|None|CDH1|None|False|False|False|False|nonsense_mediated_decay|1603&ENST00000567320|None|None|downstream_gene_variant|modifier|None|None|CDH1|None|False|False|False|False|retained_intron|350&NM_001317184|c.866C>T|p.Ala289Val|missense_variant|moderate|7|None|CDH1|None|True|False|False|False|mRNA|2451&NM_001317185|c.-750C>T|None|5_prime_UTR_variant|modifier|7|None|CDH1|None|False|False|False|False|mRNA|1094&NM_001317186|c.-954C>T|None|5_prime_UTR_variant|modifier|7|None|CDH1|None|False|False|False|False|mRNA|680&NM_004360|c.866C>T|p.Ala289Val|missense_variant|moderate|7|None|CDH1|None|True|True|False|True|mRNA|2633;literature=30287823&27397505&31925297&30850842&32579932
chr16	68738334	24125	ACCCTGGCTTTGACG	A	.	.	phylop_100way=4.714;maxentscan_swa=ENST00000261769$-4.70%7C-3.41%7C-4.70%7C-2.99%7C-8.33%7C-2.99|ENST00000422392$-4.70%7C-3.41%7C-4.70%7C-2.99%7C-8.33%7C-2.99;hexplorer=-2.88;hexplorer_mut=0.66;hexplorer_wt=3.55;hexplorer_rev=-8.47;hexplorer_rev_mut=-9.73;hexplorer_rev_wt=-1.27;max_hbond_rev=0;max_hbond_rev_mut=8;max_hbond_rev_wt=8;heredicare_vid=11139598;heredicare_annotation=11139598|1|2|15||2019-10-08;consequences=ENST00000261769|c.89_102del|p.Pro30ArgfsTer24|frameshift_variant|high|2|None|CDH1|PF08758|True|True|False|True|protein_coding|2633&ENST00000363688|None|None|upstream_gene_variant|modifier|None|None|RNA5SP429|None|True|False|False|True|rRNA_pseudogene|108&ENST00000422392|c.89_102del|p.Pro30ArgfsTer24|frameshift_variant|high|2|None|CDH1|PF08758|True|False|False|False|protein_coding|2451&ENST00000566510|c.89_102del|p.Pro30ArgfsTer24|frameshift_variant_%26_NMD_transcript_variant|high|2|None|CDH1|None|False|False|False|False|nonsense_mediated_decay|1236&ENST00000566612|c.89_102del|p.Pro30ArgfsTer24|frameshift_variant_%26_NMD_transcript_variant|high|2|None|CDH1|None|False|False|False|False|nonsense_mediated_decay|1603&ENSR00000540753|None|None|regulatory_region_variant|modifier|None|None|None|None|False|False|False|False|None|None&ENSR00000540754|None|None|regulatory_region_variant|modifier|None|None|None|None|False|False|False|False|None|None&NM_001317184|c.89_102del|p.Pro30ArgfsTer24|frameshift_variant|high|2|None|CDH1|None|True|False|False|False|mRNA|2451&NM_001317185|c.-1527_-1514del|None|5_prime_UTR_variant|modifier|2|None|CDH1|None|False|False|False|False|mRNA|1094&NM_001317186|c.-1731_-1718del|None|5_prime_UTR_variant|modifier|2|None|CDH1|None|False|False|False|False|mRNA|680&NM_004360|c.89_102del|p.Pro30ArgfsTer24|frameshift_variant|high|2|None|CDH1|None|True|True|False|True|mRNA|2633
chr16	68810343	5533	T	G	.	.	phylop_100way=5.197;cadd_scaled=34;spliceai_details=CDH1%7C0.00%7C0.00%7C0.56%7C0.99%7C31%7C-41%7C-14%7C-2;spliceai_max_delta=0.99;maxentscan_ref=7.878;maxentscan_alt=0.231;maxentscan=ENST00000261769$7.88%7C0.23|ENST00000422392$7.88%7C0.23;maxentscan_swa=ENST00000261769$7.88%7C0.23%7C7.88%7C3.81%7C2.84%7C3.81|ENST00000422392$7.88%7C0.23%7C7.88%7C3.81%7C2.84%7C3.81;hexplorer=1.66;hexplorer_mut=-0.87;hexplorer_wt=-2.54;hexplorer_rev=-1.44;hexplorer_rev_mut=4.96;hexplorer_rev_wt=6.39;max_hbond=-14.00;max_hbond_wt=14.00;bayesdel=0.307177;heredicare_vid=11843893;heredicare_annotation=11843893|2|2|||;consequences=ENST00000261769|c.832%2B2T>G|None|splice_donor_variant|high|None|6|CDH1|None|True|True|False|True|protein_coding|2633&ENST00000422392|c.832%2B2T>G|None|splice_donor_variant|high|None|6|CDH1|None|True|False|False|False|protein_coding|2451&ENST00000561751|c.455-1341T>G|None|intron_variant_%26_NMD_transcript_variant|modifier|None|3|CDH1|None|False|False|False|False|nonsense_mediated_decay|462&ENST00000562836|n.903%2B2T>G|None|splice_donor_variant_%26_non_coding_transcript_variant|high|None|5|CDH1|None|False|False|False|False|protein_coding_CDS_not_defined|2744&ENST00000563916|None|None|downstream_gene_variant|modifier|None|None|None|None|False|False|False|False|None|None&ENST00000564676|None|None|downstream_gene_variant|modifier|None|None|CDH1|None|False|False|False|False|protein_coding_CDS_not_defined|965&ENST00000564745|None|None|downstream_gene_variant|modifier|None|None|CDH1|None|False|False|False|False|protein_coding_CDS_not_defined|577&ENST00000565810|None|None|upstream_gene_variant|modifier|None|None|CDH1|None|False|False|False|False|retained_intron|280&ENST00000566510|c.676%2B2T>G|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|5|CDH1|None|False|False|False|False|nonsense_mediated_decay|1236&ENST00000566612|c.832%2B2T>G|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|6|CDH1|None|False|False|False|False|nonsense_mediated_decay|1603&ENST00000567320|None|None|downstream_gene_variant|modifier|None|None|CDH1|None|False|False|False|False|retained_intron|350&NM_001317184|c.832%2B2T>G|None|splice_donor_variant|high|None|6|CDH1|None|True|False|False|False|mRNA|2451&NM_001317185|c.-784%2B2T>G|None|splice_donor_variant|high|None|6|CDH1|None|False|False|False|False|mRNA|1094&NM_001317186|c.-988%2B2T>G|None|splice_donor_variant|high|None|6|CDH1|None|False|False|False|False|mRNA|680&NM_004360|c.832%2B2T>G|None|splice_donor_variant|high|None|6|CDH1|None|True|True|False|True|mRNA|2633
chr16	68810246	9742	TG	T	.	.	phylop_100way=7.696;spliceai_details=CDH1%7C0.00%7C0.03%7C0.00%7C0.00%7C-22%7C-49%7C-49%7C16;spliceai_max_delta=0.03;maxentscan_swa=ENST00000261769$-5.00%7C-4.45%7C-5.00%7C-8.97%7C-6.66%7C-8.97|ENST00000422392$-5.00%7C-4.45%7C-5.00%7C-8.97%7C-6.66%7C-8.97;hexplorer=1.13;hexplorer_mut=9.59;hexplorer_wt=8.47;hexplorer_rev=0.24;hexplorer_rev_mut=3.80;hexplorer_rev_wt=3.56;heredicare_vid=15691279;heredicare_annotation=15691279|1|1|||;consequences=ENST00000261769|c.739del|p.Glu247ArgfsTer3|frameshift_variant|high|6|None|CDH1|PF00028|True|True|False|True|protein_coding|2633&ENST00000422392|c.739del|p.Glu247ArgfsTer3|frameshift_variant|high|6|None|CDH1|PF00028|True|False|False|False|protein_coding|2451&ENST00000561751|c.454%2B1400del|None|intron_variant_%26_NMD_transcript_variant|modifier|None|3|CDH1|None|False|False|False|False|nonsense_mediated_decay|462&ENST00000562836|n.810del|None|non_coding_transcript_exon_variant|modifier|5|None|CDH1|None|False|False|False|False|protein_coding_CDS_not_defined|2744&ENST00000563916|None|None|downstream_gene_variant|modifier|None|None|None|None|False|False|False|False|None|None&ENST00000564676|None|None|downstream_gene_variant|modifier|None|None|CDH1|None|False|False|False|False|protein_coding_CDS_not_defined|965&ENST00000564745|None|None|downstream_gene_variant|modifier|None|None|CDH1|None|False|False|False|False|protein_coding_CDS_not_defined|577&ENST00000565810|None|None|upstream_gene_variant|modifier|None|None|CDH1|None|False|False|False|False|retained_intron|280&ENST00000566510|c.583del|p.Glu195ArgfsTer3|frameshift_variant_%26_NMD_transcript_variant|high|5|None|CDH1|None|False|False|False|False|nonsense_mediated_decay|1236&ENST00000566612|c.739del|p.Glu247ArgfsTer3|frameshift_variant_%26_NMD_transcript_variant|high|6|None|CDH1|None|False|False|False|False|nonsense_mediated_decay|1603&ENST00000567320|None|None|downstream_gene_variant|modifier|None|None|CDH1|None|False|False|False|False|retained_intron|350&NM_001317184|c.739del|p.Glu247ArgfsTer3|frameshift_variant|high|6|None|CDH1|None|True|False|False|False|mRNA|2451&NM_001317185|c.-877del|None|5_prime_UTR_variant|modifier|6|None|CDH1|None|False|False|False|False|mRNA|1094&NM_001317186|c.-1081del|None|5_prime_UTR_variant|modifier|6|None|CDH1|None|False|False|False|False|mRNA|680&NM_004360|c.739del|p.Glu247ArgfsTer3|frameshift_variant|high|6|None|CDH1|None|True|True|False|True|mRNA|2633
chr10	87925513	23412	GT	G	.	.	phylop_100way=7.425;spliceai_details=PTEN%7C0.00%7C0.00%7C0.00%7C0.00%7C0%7C1%7C44%7C48;spliceai_max_delta=0.0;maxentscan_swa=ENST00000371953$3.43%7C1.56%7C3.43%7C10.29%7C10.29%7C10.29|ENST00000472832$3.43%7C1.56%7C3.43%7C10.29%7C10.29%7C10.29|ENST00000688308$3.43%7C1.56%7C3.43%7C10.29%7C10.29%7C10.29|ENST00000693560$3.43%7C1.56%7C3.43%7C10.29%7C10.29%7C10.29|ENST00000700021$3.43%7C1.56%7C3.43%7C10.29%7C10.29%7C10.29|ENST00000700029$3.43%7C1.56%7C3.43%7C10.29%7C10.29%7C10.29;cancerhotspots_cancertypes=Cutaneous_Melanoma:skin;cancerhotspots_ac=1;cancerhotspots_af=4.125923175310476e-05;task_force_protein_domain=phosphatase_domain;task_force_protein_domain_source=PMID:_24656806,_PMID:_34140896;hexplorer=-1.07;hexplorer_mut=-15.45;hexplorer_wt=-14.38;hexplorer_rev=-0.67;hexplorer_rev_mut=-1.67;hexplorer_rev_wt=-1.00;max_hbond=0.00;max_hbond_mut=10.10;max_hbond_wt=10.10;clinvar=1778529;heredicare_vid=9612709;cosmic=COSV64290332;variation_id=1778529;clinvar_summary=criteria_provided,_multiple_submitters,_no_conflicts:Pathogenic;clinvar_submissions=Pathogenic|2022-01-11|criteria_provided,_single_submitter|C1959582:PTEN_hamartoma_tumor_syndrome|Invitae|description:_This_sequence_change_creates_a_premature_translational_stop_signal_(p.Leu57Trpfs*42)_in_the_PTEN_gene._It_is_expected_to_result_in_an_absent_or_disrupted_protein_product._Loss-of-function_variants_in_PTEN_are_known_to_be_pathogenic_(PMID:_9467011,_21194675)._This_variant_is_not_present_in_population_databases_(gnomAD_no_frequency)._This_premature_translational_stop_signal_has_been_observed_in_individual(s)_with_PTEN_hamartoma_tumor_syndrome_(PMID:_11668501,_23335809)._For_these_reasons,_this_variant_has_been_classified_as_Pathogenic.&Pathogenic|2015-11-16|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_The_c.170delT_pathogenic_mutation,_located_in_coding_exon_3_of_the_PTEN_gene,_results_from_a_deletion_of_one_nucleotide_at_nucleotide_position_170,_causing_a_translational_frameshift_with_a_predicted_alternate_stop_codon._One_study_identified_this_mutation_in_1_of_146_individuals_with_a_deleterious_germline_PTEN_mutation_recruited_from_the_Institut_Bergoni%26eacute%3B_genetic_laboratory_to_better_define_cancer_risks_in_PTEN-hamartoma_tumor_syndrome_(PHTS)._The_authors_reported_this_individual_to_be_affected_with_colon_and_ovarian_cancer,_oral_mucosal_papillomas,_acral_keratoses%3B_macrocephaly,_gastrointestinal_polyps,_thyroid_cancer_and_benign_thyroid_lesions_(Bubien_V_et_al._J_Med_Genet._2013%3B50(4):255-63)._Different_deletions,_c.179delA_and_c.180delG,_resulting_in_a_stop_codon_at_the_same_position_(amino_acid_98),_have_also_been_reported_in_individuals_affected_with_PHTS_(Delatycki_et_al._J_Med_Genet._2003%3B_40(8)%3B_Marchese_et_al._Am._J._Med._Genet._2003%3B_120A(2):_286-8)._In_addition_to_the_clinical_data_presented_in_the_literature,_since_frameshifts_are_typically_deleterious_in_nature,_this_alteration_is_interpreted_as_a_disease-causing_mutation_(ACMG_Recommendations_for_Standards_for_Interpretation_and_Reporting_of_Sequence_Variations._Revision_2007._Genet_Med._2008%3B10:294).;heredicare_annotation=9612709|1|1|||;consequences=ENST00000371953|c.170del|p.Leu57TrpfsTer42|frameshift_variant_%26_splice_region_variant|high|3|None|PTEN|None|True|True|False|True|protein_coding|1203&ENST00000472832|c.170del|p.Leu57TrpfsTer42|frameshift_variant_%26_splice_region_variant|high|3|None|PTEN|None|True|False|False|False|protein_coding|1027&ENST00000498703|None|None|upstream_gene_variant|modifier|None|None|PTEN|None|False|False|False|False|retained_intron|551&ENST00000686459|c.170del|p.Leu57TrpfsTer42|frameshift_variant_%26_splice_region_variant_%26_NMD_transcript_variant|high|3|None|PTEN|None|False|False|False|False|nonsense_mediated_decay|567&ENST00000688158|n.905del|None|splice_region_variant_%26_non_coding_transcript_exon_variant|low|5|None|PTEN|None|False|False|False|False|protein_coding_CDS_not_defined|8394&ENST00000688308|c.170del|p.Leu57TrpfsTer42|frameshift_variant_%26_splice_region_variant|high|4|None|PTEN|None|True|False|False|False|protein_coding|1203&ENST00000688922|c.170del|p.Leu57TrpfsTer20|frameshift_variant_%26_splice_region_variant_%26_NMD_transcript_variant|high|3|None|PTEN|None|False|False|False|False|nonsense_mediated_decay|218&ENST00000693560|c.689del|p.Leu230TrpfsTer42|frameshift_variant_%26_splice_region_variant|high|4|None|PTEN|None|True|False|False|False|protein_coding|1721&ENST00000700021|c.165-5528del|None|intron_variant|modifier|None|2|PTEN|None|True|False|False|False|protein_coding|1159&ENST00000700022|c.170del|p.Leu57TrpfsTer42|frameshift_variant_%26_splice_region_variant_%26_NMD_transcript_variant|high|3|None|PTEN|None|False|False|False|False|nonsense_mediated_decay|513&ENST00000700029|None|None|upstream_gene_variant|modifier|None|None|PTEN|None|True|False|False|False|protein_coding|1295&ENSR00000411049|None|None|regulatory_region_variant|modifier|None|None|None|None|False|False|False|False|None|None&NM_000314|c.170del|p.Leu57TrpfsTer42|frameshift_variant_%26_splice_region_variant|high|3|None|PTEN|None|True|True|False|True|mRNA|1203&NM_001304717|c.689del|p.Leu230TrpfsTer42|frameshift_variant_%26_splice_region_variant|high|4|None|PTEN|None|False|False|False|False|mRNA|1721&NM_001304718|c.-540-5528del|None|intron_variant|modifier|None|2|PTEN|None|False|False|False|False|mRNA|617
chr10	87933165	19444	T	C	.	.	phylop_100way=7.615;cadd_scaled=28.7;revel=ENST00000371953$0.991;spliceai_details=PTEN%7C0.01%7C0.00%7C0.00%7C0.00%7C-44%7C36%7C4%7C-36;spliceai_max_delta=0.01;maxentscan_swa=ENST00000371953$0.17%7C1.71%7C0.17%7C-1.46%7C-1.59%7C-1.46|ENST00000472832$0.17%7C1.71%7C0.17%7C-1.46%7C-1.59%7C-1.46|ENST00000688308$0.17%7C1.71%7C0.17%7C-1.46%7C-1.59%7C-1.46|ENST00000693560$0.17%7C1.71%7C0.17%7C-1.46%7C-1.59%7C-1.46|ENST00000700021$0.17%7C1.71%7C0.17%7C-1.46%7C-1.59%7C-1.46|ENST00000700029$0.17%7C1.71%7C0.17%7C-1.46%7C-1.59%7C-1.46;cancerhotspots_cancertypes=RENALCLEARCELLCARCINOMA:kidney%7CGlioblastoma_Multiforme:cnsbrain%7CEndometrial_Carcinoma:uterus%7CUTERINEENDOMETRIOIDCARCINOMA:uterus%7CCutaneous_Melanoma:skin%7CSmall_Cell_Lung_Cancer:lung%7CHead_and_Neck_Squamous_Cell_Carcinoma:headandneck%7CBREASTINVASIVEDUCTALCARCINOMA:breast;cancerhotspots_ac=9;cancerhotspots_af=0.0003713330857779428;task_force_protein_domain=phosphatase_domain;task_force_protein_domain_source=PMID:_24656806,_PMID:_34140896;hexplorer=3.34;hexplorer_mut=-0.56;hexplorer_wt=-3.90;hexplorer_rev=1.99;hexplorer_rev_mut=-0.76;hexplorer_rev_wt=-2.75;max_hbond=0.00;max_hbond_mut=5.00;max_hbond_wt=5.00;max_hbond_rev=9.30;max_hbond_rev_mut=9.30;bayesdel=0.598079;heredicare_vid=11079218;clinvar=183726;rsid=786201044;cosmic=COSV64288670;variation_id=183726;clinvar_summary=criteria_provided,_multiple_submitters,_no_conflicts:Pathogenic;clinvar_submissions=Pathogenic|2022-03-23|criteria_provided,_single_submitter|C1959582:PTEN_hamartoma_tumor_syndrome|Invitae|description:_This_sequence_change_replaces_cysteine,_which_is_neutral_and_slightly_polar,_with_arginine,_which_is_basic_and_polar,_at_codon_136_of_the_PTEN_protein_(p.Cys136Arg)._This_variant_is_not_present_in_population_databases_(gnomAD_no_frequency)._This_missense_change_has_been_observed_in_individuals_with_Cowden_syndrome_(PMID:_10848731,_20600018,_21343951,_21659347,_22520842,_23335809,_23886400,_24778394)._ClinVar_contains_an_entry_for_this_variant_(Variation_ID:_183726)._Algorithms_developed_to_predict_the_effect_of_missense_changes_on_protein_structure_and_function_(SIFT,_PolyPhen-2,_Align-GVGD)_all_suggest_that_this_variant_is_likely_to_be_disruptive._Experimental_studies_have_shown_that_this_missense_change_affects_PTEN_function_(PMID:_23475934)._For_these_reasons,_this_variant_has_been_classified_as_Pathogenic.&Pathogenic|2022-09-02|criteria_provided,_single_submitter|C1959582:PTEN_hamartoma_tumor_syndrome|Victorian_Clinical_Genetics_Services,_Murdoch_Childrens_Research_Institute|description:_Based_on_the_classification_scheme_VCGS_Germline_v1.3.4,_this_variant_is_classified_as_Pathogenic._Following_criteria_are_met:_0103_-_Dominant_negative_and_loss_of_function_are_known_mechanisms_of_disease_in_this_gene_and_are_associated_with_­hamartoma_tumour_syndrome_(MONDO%230017623)._Loss_of_function_is_the_mechanism_for_null_variants_while_missense_variants_have_been_demonstrated_to_exert_either_a_loss_of_function_or_dominant-negative_mechanism_(GeneReviews)._(I)_0107_-_This_gene_is_associated_with_autosomal_dominant_disease._(I)_0115_-_Variants_in_this_gene_are_known_to_have_variable_expressivity._In_particular,_PTEN-related_Proteus_syndrome_has_been_described_to_be_a_highly_variable_disorder_(GeneReviews)._(I)_0200_-_Variant_is_predicted_to_result_in_a_missense_amino_acid_change_from_cysteine_to_arginine._(I)_0251_-_This_variant_is_heterozygous._(I)_0301_-_Variant_is_absent_from_gnomAD_(both_v2_and_v3)._(SP)_0501_-_Missense_variant_consistently_predicted_to_be_damaging_by_multiple_in_silico_tools_and_highly_conserved_with_a_major_amino_acid_change._0603_-_Missense_variant_in_a_region_that_is_highly_intolerant_to_missense_variation_(high_constraint_region_in_DECIPHER)._(SP)_0801_-_This_variant_has_very_strong_previous_evidence_of_pathogenicity_in_unrelated_individuals._This_variant_has_been_classified_as_pathogenic_by_multiple_clinical_diagnostic_laboratories_and_has_been_reported_in_multiple_unrelated_individuals_or_families_with_PTEN_hamartoma_tumour_syndrome_(ClinVar%3B_PMIDs:_10848731,_17941496,_21343951,_23886400,_35227301)._(SP)_1204_-_This_variant_has_been_shown_to_be_de_novo_in_the_proband_(parental_status_not_tested_but_assumed)_(by_segregation_testing)._(SP)_Legend:_(SP)_-_Supporting_pathogenic,_(I)_-_Information,_(SB)_-_Supporting_benign&Pathogenic|2017-08-21|criteria_provided,_single_submitter|C0018553:Cowden_syndrome|Women's_Health_and_Genetics/Laboratory_Corporation_of_America,_LabCorp|description:_Variant_summary:_The_PTEN_c.406T>C_(p.Cys136Arg)_variant_located_in_the_Protein-tyrosine_phosphatase-like_domain_involves_the_alteration_of_a_conserved_nucleotide_and_5/5_in_silico_tools_predict_a_damaging_outcome_for_this_variant._This_variant_is_absent_in_121500_control_chromosomes._Multiple_publications_have_cited_the_variant_in_affected_indivdiuals_diagnosed_with_Cowden_Syndrome,_BRRS,_and_PHTS,_which_was_found_to_cosegregate_with_disease_in_multiple_families._In_addition,_multiple_clinical_diagnostic_laboratories/reputable_databases_classified_this_variant_as_pathogenic._Functional_studies_have_demonstrated_an_impact_of_this_variant_on_protein_stability_leading_to_increased_proteasome_activity_which_has_been_reported_as_a_hallmark_of_human_cancers._Taken_together,_this_variant_is_classified_as_pathogenic.&Pathogenic|2023-08-11|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_The_p.C136R_pathogenic_mutation_(also_known_as_c.406T>C),_located_in_coding_exon_5_of_the_PTEN_gene,_results_from_a_T_to_C_substitution_at_nucleotide_position_406._The_cysteine_at_codon_136_is_replaced_by_arginine,_an_amino_acid_with_highly_dissimilar_properties._This_alteration_was_described_as_a_de_novo_mutation_in_a_Japanese_patient_with_Cowden_disease_(Kubo_Y_et_al._Br._J._Dermatol._2000_Jun%3B142(6):1100-5)._In_one_PTEN_Hamartoma_Tumor_Syndrome_(PHTS)_family,_this_mutation_segregated_with_disease_in_a_mother_and_her_two_daughters._Clinical_features_included_macrocephaly_and_thyroid_lesions_(follicular_carcinoma_and_adenoma)_in_all_three_individuals,_breast_cancer_in_the_mother,_vertebral_hemangioma_in_one_daughter,_and_cortical_dysplasia_in_the_other_daughter_(Jenny_B_et_al._J._Neurosurg._2007_Oct%3B107(4_Suppl):307-13%3B_Venturini_G_et_al._Ophthalmology_2012_Apr%3B119(4):857-64)._This_mutation_has_also_been_observed_in_other_individuals_with_PHTS_(Bubien_V_et_al._J._Med._Genet.,_2013_Apr%3B50:255-63%3B_Galatola_M_et_al._BMC_Med._Genet.,_2012_Apr%3B13:28)_including_those_with_neurological_features_of_PHTS_such_as_autism_and_developmental_delay_(He_X_et_al._Cancer_Res._2013_May%3B73(10):3029-40)._This_amino_acid_position_is_highly_conserved_in_available_vertebrate_species._In_addition,_this_alteration_is_predicted_to_be_deleterious_by_in_silico_analysis._Based_on_the_supporting_evidence,_this_alteration_is_interpreted_as_a_disease-causing_mutation.&Pathogenic|2015-10-22|no_assertion_criteria_provided|C0023462:Acute_megakaryocytic_leukemia$C1334655:Mediastinal_germ_cell_tumor|McDonnell_Genome_Institute,_Washington_University_in_St._Louis|None&Likely_pathogenic|2018-12-01|no_assertion_criteria_provided|C0919267:Neoplasm_of_ovary|German_Consortium_for_Hereditary_Breast_and_Ovarian_Cancer,_University_Hospital_Cologne|None&Pathogenic|2022-03-14|criteria_provided,_single_submitter|C3661900:not_provided|PerkinElmer_Genomics|None&Pathogenic|2022-01-14|criteria_provided,_single_submitter|C3661900:not_provided|GeneDx|description:_Published_functional_studies_demonstrate_a_damaging_effect:_impaired_phosphatase_activity,_reduced_PTEN_protein_levels_and_stability_(He_et_al.,_2013%3B_Mighell_et_al.,_2018%3B_Matreyek_et_al.,_2018)%3B_Not_observed_in_large_population_cohorts_(gnomAD)%3B_In_silico_analysis_supports_that_this_missense_variant_has_a_deleterious_effect_on_protein_structure/function%3B_This_variant_is_associated_with_the_following_publications:_(PMID:_21659347,_31965297,_28380455,_29663862,_23335809,_32601921,_17941496,_22281088,_10848731,_27148581,_25461771,_23886400,_22520842,_15211648,_18558293,_23475934,_21343951,_20600018,_24778394,_21194675,_26376867,_31006514,_29785012,_19457929,_24475377,_29706350,_30787465,_32003824);heredicare_annotation=11079218|1|1|15|He_et_al.,_Cancer_Res,_2013_(reduzierte_PTEN-Protein_im_Westernblot_in_Zelllinie)%3B_Kubo_et_al.,_Br.J.Dermatol_2000_(Fallbericht_CowdenDisease_mit_schwächerem_Phänotyp)%3B_Tan_et_al.,_Am_J,_Hum_Genet._2011_(4x_in_3042_Fällen_die_die_relaxed_International_Cowden_Consortium_(ICC)_criteria´_erfüllen)%3B_Mester_et_al.,_Eur._J._Hum_Genet_2011_(1x_in_2827_Fällen_mit_Verdacht_auf_Cowdensyndrom,_Fall_hat_Brust-_und_UterusCa)%3B_Paparo_et_al.,_Hered_Cancer_Clin_Pract._2013_(Familie_mit_PTEN_Hamartoma_Tumour_Syndrome)%3B_Bubien_et_al.,_J_Med_Genet._2013_3x_in_146_PTEN-Mutationsträgern_mit_PTEN_Hamartoma_Tumour_Syndrome)%3B_Ngeow_et_al.,_J_Clin_Oncol|2019-10-08;consequences=ENST00000371953|c.406T>C|p.Cys136Arg|missense_variant|moderate|5|None|PTEN|None|True|True|False|True|protein_coding|1203&ENST00000472832|c.406T>C|p.Cys136Arg|missense_variant|moderate|5|None|PTEN|None|True|False|False|False|protein_coding|1027&ENST00000498703|n.232T>C|None|non_coding_transcript_exon_variant|modifier|3|None|PTEN|None|False|False|False|False|retained_intron|551&ENST00000686459|c.406T>C|p.Cys136Arg|missense_variant_%26_NMD_transcript_variant|moderate|5|None|PTEN|None|False|False|False|False|nonsense_mediated_decay|567&ENST00000688158|n.1141T>C|None|non_coding_transcript_exon_variant|modifier|7|None|PTEN|None|False|False|False|False|protein_coding_CDS_not_defined|8394&ENST00000688308|c.406T>C|p.Cys136Arg|missense_variant|moderate|6|None|PTEN|None|True|False|False|False|protein_coding|1203&ENST00000688922|c.*236T>C|None|3_prime_UTR_variant_%26_NMD_transcript_variant|modifier|6|None|PTEN|None|False|False|False|False|nonsense_mediated_decay|218&ENST00000693560|c.925T>C|p.Cys309Arg|missense_variant|moderate|6|None|PTEN|None|True|False|False|False|protein_coding|1721&ENST00000700021|c.361T>C|p.Cys121Arg|missense_variant|moderate|4|None|PTEN|None|True|False|False|False|protein_coding|1159&ENST00000700022|c.406T>C|p.Cys136Arg|missense_variant_%26_NMD_transcript_variant|moderate|5|None|PTEN|None|False|False|False|False|nonsense_mediated_decay|513&ENST00000700029|c.241T>C|p.Cys81Arg|missense_variant|moderate|3|None|PTEN|None|True|False|False|False|protein_coding|1295&ENSR00001180418|None|None|regulatory_region_variant|modifier|None|None|None|None|False|False|False|False|None|None&NM_000314|c.406T>C|p.Cys136Arg|missense_variant|moderate|5|None|PTEN|None|True|True|False|True|mRNA|1203&NM_001304717|c.925T>C|p.Cys309Arg|missense_variant|moderate|6|None|PTEN|None|False|False|False|False|mRNA|1721&NM_001304718|c.-345T>C|None|5_prime_UTR_variant|modifier|4|None|PTEN|None|False|False|False|False|mRNA|617;literature=21194675&23335809&21659347&23475934&24778394&21343951&17941496&29663862&23886400&20600018&22520842&10848731&32601921&26376867&22281088&27397505&30212483&30787465&28569743&26527384&27148581&35227301&28380455&31898539&32664367&37216304&31925297&36289336&35763645&30867008&29026114&23243591&32959437&25326804&33595736&23917401&32579932&29604063&29263839&31959902&31034466&28677221&25794154&31854063&24205039&32003824&21727090&25975284&26689913&26110843&34184188
chr10	87933252	15517	G	T	.	.	phylop_100way=9.525;cadd_scaled=35;spliceai_details=PTEN%7C0.00%7C0.00%7C0.74%7C0.99%7C-2%7C-16%7C-2%7C-1;spliceai_max_delta=0.99;maxentscan_ref=10.998;maxentscan_alt=2.494;maxentscan=ENST00000371953$11.00%7C2.49|ENST00000472832$11.00%7C2.49|ENST00000688308$11.00%7C2.49|ENST00000693560$11.00%7C2.49|ENST00000700021$11.00%7C2.49|ENST00000700029$11.00%7C2.49;maxentscan_swa=ENST00000371953$11.00%7C2.49%7C11.00%7C-8.56%7C-7.98%7C-8.56|ENST00000472832$11.00%7C2.49%7C11.00%7C-8.56%7C-7.98%7C-8.56|ENST00000688308$11.00%7C2.49%7C11.00%7C-8.56%7C-7.98%7C-8.56|ENST00000693560$11.00%7C2.49%7C11.00%7C-8.56%7C-7.98%7C-8.56|ENST00000700021$11.00%7C2.49%7C11.00%7C-8.56%7C-7.98%7C-8.56|ENST00000700029$11.00%7C2.49%7C11.00%7C-8.56%7C-7.98%7C-8.56;cancerhotspots_cancertypes=Glioblastoma_Multiforme:cnsbrain;cancerhotspots_ac=1;cancerhotspots_af=4.125923175310476e-05;task_force_protein_domain=phosphatase_domain;task_force_protein_domain_source=PMID:_24656806,_PMID:_34140896;hexplorer=-0.35;hexplorer_mut=-5.76;hexplorer_wt=-5.41;hexplorer_rev=-2.95;hexplorer_rev_mut=-15.16;hexplorer_rev_wt=-12.22;max_hbond=-16.80;max_hbond_mut=2.30;max_hbond_wt=19.10;bayesdel=0.274638;rsid=1554898242;clinvar=427619;heredicare_vid=9000902;variation_id=427619;clinvar_summary=reviewed_by_expert_panel:Likely_pathogenic;clinvar_submissions=Pathogenic|2020-11-25|criteria_provided,_single_submitter|C3551915:Familial_meningioma|Baylor_Genetics|description:_This_variant_was_determined_to_be_pathogenic_according_to_ACMG_Guidelines,_2015_[PMID:25741868]._This_c.492%2B1G>T_variant_in_PTEN_has_been_previously_reported_as_disease-causing_in_a_patient_with_Cowden_syndrome_[PMID_28677221].&Likely_pathogenic|2022-06-24|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_The_c.492%2B1G>T_intronic_variant_results_from_a_G_to_T_substitution_one_nucleotide_after_coding_exon_5_of_the_PTEN_gene._This_alteration_was_identified_in_a_7-year-old_individual_with_macrocephaly_(Chen_HJ_et_al._Hum_Mutat,_2017_10%3B38:1372-1377)._This_variant_is_considered_to_be_rare_based_on_population_cohorts_in_the_Genome_Aggregation_Database_(gnomAD)._This_nucleotide_position_is_highly_conserved_in_available_vertebrate_species._In_silico_splice_site_analysis_predicts_that_this_alteration_will_weaken_the_native_splice_donor_site_and_will_result_in_the_creation_or_strengthening_of_a_novel_splice_donor_site._RNA_studies_have_demonstrated_that_this_alteration_results_in_abnormal_splicing_in_the_set_of_samples_tested_(Ambry_internal_data%3B_Chen_HJ_et_al._Hum_Mutat,_2017_10%3B38:1372-1377)._Another_alteration_impacting_the_same_donor_site_(c.492%2B1G>A)_has_been_shown_to_have_a_similar_impact_on_splicing_and_reported_as_a_de_novo_occurrence_twice_in_unrelated_individuals_with_features_of_PTEN_hamartoma_tumor_syndrome_(external_communication_with_outside_laboratory)._Based_on_the_majority_of_available_evidence_to_date,_this_variant_is_likely_to_be_pathogenic.&Pathogenic|2017-05-26|no_assertion_criteria_provided|CN072330:Cowden_syndrome_1|Cancer_Genomic_Medicine_Translational_Research_Lab,_Cleveland_Clinic_Genomic_Medicine_Institute|None&Pathogenic|2023-08-01|criteria_provided,_single_submitter|C3661900:not_provided|CeGaT_Center_for_Human_Genetics_Tuebingen|description:_Criteria_applied:_PVS1,_PM2&Likely_pathogenic|2022-09-13|criteria_provided,_single_submitter|C1959582:PTEN_hamartoma_tumor_syndrome|Invitae|description:_This_sequence_change_affects_a_donor_splice_site_in_intron_5_of_the_PTEN_gene._RNA_analysis_indicates_that_disruption_of_this_splice_site_induces_altered_splicing_and_may_result_in_an_absent_or_disrupted_protein_product._This_variant_is_not_present_in_population_databases_(gnomAD_no_frequency)._Disruption_of_this_splice_site_has_been_observed_in_individual(s)_with_clinical_features_of_Cowden_syndrome_(PMID:_28677221,_33876391)._ClinVar_contains_an_entry_for_this_variant_(Variation_ID:_427619)._Studies_have_shown_that_disruption_of_this_splice_site_results_in_skipping_of_exon_5_and_introduces_a_premature_termination_codon_(PMID:_28677221)._The_resulting_mRNA_is_expected_to_undergo_nonsense-mediated_decay._In_summary,_the_currently_available_evidence_indicates_that_the_variant_is_pathogenic,_but_additional_data_are_needed_to_prove_that_conclusively._Therefore,_this_variant_has_been_classified_as_Likely_Pathogenic.&Likely_pathogenic|2020-03-23|reviewed_by_expert_panel|C1959582:PTEN_hamartoma_tumor_syndrome|Clingen_PTEN_Variant_Curation_Expert_Panel,_Clingen|description:_PTEN_c.492%2B1G>T_(IVS5%2B1G>T)_meets_criteria_to_be_classified_as_likely_pathogenic_for_PTEN_Hamartoma_Tumor_syndrome_in_an_autosomal_dominant_manner_using_modified_ACMG_criteria_(PMID_30311380)._Please_see_a_summary_of_the_rules_and_criteria_codes_in_the_"PTEN_ACMG_Specifications_Summary"_document_(assertion_method_column)._PVS1:_Null_variant_predicted_to_result_in_nonsense-mediated_decay_or_causing_truncation/frameshift_at_or_5'_to_c.1121_(NM_000314.4)._PM2:_Absent_in_large_sequenced_populations;heredicare_annotation=9000902|1|1|14|Chen_(2017)_Hum_Mutat._RNA-Analyse_(47513):_Es_sind_zwei_Spleißeffekte_nachweisbar:_1._Skipping_von_Exon_5,_r.254_492del,_p.(Val85Glyfs*15),_frameshift_2._Skipping_von_Exon_5%2B6,_r.254_634del,_p.(Val85_Asn212delinsAsp),_in-frame|2018-04-17;consequences=ENST00000371953|c.492%2B1G>T|None|splice_donor_variant|high|None|5|PTEN|None|True|True|False|True|protein_coding|1203&ENST00000472832|c.492%2B1G>T|None|splice_donor_variant|high|None|5|PTEN|None|True|False|False|False|protein_coding|1027&ENST00000498703|n.319G>T|None|non_coding_transcript_exon_variant|modifier|3|None|PTEN|None|False|False|False|False|retained_intron|551&ENST00000686459|c.492%2B1G>T|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|5|PTEN|None|False|False|False|False|nonsense_mediated_decay|567&ENST00000688158|n.1227%2B1G>T|None|splice_donor_variant_%26_non_coding_transcript_variant|high|None|7|PTEN|None|False|False|False|False|protein_coding_CDS_not_defined|8394&ENST00000688308|c.492%2B1G>T|None|splice_donor_variant|high|None|6|PTEN|None|True|False|False|False|protein_coding|1203&ENST00000688922|c.*322%2B1G>T|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|6|PTEN|None|False|False|False|False|nonsense_mediated_decay|218&ENST00000693560|c.1011%2B1G>T|None|splice_donor_variant|high|None|6|PTEN|None|True|False|False|False|protein_coding|1721&ENST00000700021|c.447%2B1G>T|None|splice_donor_variant|high|None|4|PTEN|None|True|False|False|False|protein_coding|1159&ENST00000700022|c.492%2B1G>T|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|5|PTEN|None|False|False|False|False|nonsense_mediated_decay|513&ENST00000700029|c.326%2B1G>T|None|splice_donor_variant|high|None|3|PTEN|None|True|False|False|False|protein_coding|1295&NM_000314|c.492%2B1G>T|None|splice_donor_variant|high|None|5|PTEN|None|True|True|False|True|mRNA|1203&NM_001304717|c.1011%2B1G>T|None|splice_donor_variant|high|None|6|PTEN|None|False|False|False|False|mRNA|1721&NM_001304718|c.-258%2B1G>T|None|splice_donor_variant|high|None|4|PTEN|None|False|False|False|False|mRNA|617;literature=28677221
chr17	7673700	29154	C	T	.	.	phylop_100way=2.457;cadd_scaled=33;spliceai_details=TP53%7C0.00%7C0.00%7C0.02%7C0.99%7C-38%7C15%7C-38%7C1;spliceai_max_delta=0.99;maxentscan_ref=9.846;maxentscan_alt=1.664;maxentscan=ENST00000269305$9.85%7C1.66|ENST00000359597$9.85%7C1.66|ENST00000420246$9.85%7C1.66|ENST00000445888$9.85%7C1.66|ENST00000455263$9.85%7C1.66|ENST00000504290$9.85%7C1.66|ENST00000504937$9.85%7C1.66|ENST00000510385$9.85%7C1.66|ENST00000604348$9.85%7C1.66|ENST00000610292$9.85%7C1.66|ENST00000610538$9.85%7C1.66|ENST00000610623$9.85%7C1.66|ENST00000618944$9.85%7C1.66|ENST00000619186$9.85%7C1.66|ENST00000619485$9.85%7C1.66|ENST00000620739$9.85%7C1.66|ENST00000622645$9.85%7C1.66;maxentscan_swa=ENST00000269305$9.85%7C1.66%7C9.85%7C-12.95%7C-12.91%7C-12.95|ENST00000359597$9.85%7C1.66%7C9.85%7C-12.95%7C-12.91%7C-12.95|ENST00000413465$9.85%7C1.66%7C9.85%7C-12.95%7C-12.91%7C-12.95|ENST00000420246$9.85%7C1.66%7C9.85%7C-12.95%7C-12.91%7C-12.95|ENST00000445888$9.85%7C1.66%7C9.85%7C-12.95%7C-12.91%7C-12.95|ENST00000455263$9.85%7C1.66%7C9.85%7C-12.95%7C-12.91%7C-12.95|ENST00000504290$9.85%7C1.66%7C9.85%7C-12.95%7C-12.91%7C-12.95|ENST00000504937$9.85%7C1.66%7C9.85%7C-12.95%7C-12.91%7C-12.95|ENST00000510385$9.85%7C1.66%7C9.85%7C-12.95%7C-12.91%7C-12.95|ENST00000604348$9.85%7C1.66%7C9.85%7C-12.95%7C-12.91%7C-12.95|ENST00000610292$9.85%7C1.66%7C9.85%7C-12.95%7C-12.91%7C-12.95|ENST00000610538$9.85%7C1.66%7C9.85%7C-12.95%7C-12.91%7C-12.95|ENST00000610623$9.85%7C1.66%7C9.85%7C-12.95%7C-12.91%7C-12.95|ENST00000618944$9.85%7C1.66%7C9.85%7C-12.95%7C-12.91%7C-12.95|ENST00000619186$9.85%7C1.66%7C9.85%7C-12.95%7C-12.91%7C-12.95|ENST00000619485$9.85%7C1.66%7C9.85%7C-12.95%7C-12.91%7C-12.95|ENST00000620739$9.85%7C1.66%7C9.85%7C-12.95%7C-12.91%7C-12.95|ENST00000622645$9.85%7C1.66%7C9.85%7C-12.95%7C-12.91%7C-12.95;cancerhotspots_cancertypes=INTRAHEPATICCHOLANGIOCARCINOMA:biliarytract%7CInvasive_Breast_Carcinoma:breast%7CChromophobe_Renal_Cell_Carcinoma:kidney%7CLARYNXSQUAMOUSCELLCARCINOMA:headandneck%7CHigh-Grade_Serous_Ovarian_Cancer:ovaryfallopiantube%7CEsophageal_Adenocarcinoma:esophagusstomach%7CLUNGSQUAMOUSCELLCARCINOMA:lung%7CRECTALADENOCARCINOMA:bowel%7CGLIOBLASTOMAMULTIFORME:cnsbrain%7CBREASTINVASIVEDUCTALCARCINOMA:breast;cancerhotspots_ac=10;cancerhotspots_af=0.00041259231753104755;tp53db_class=noFH%26Other%26LFL;task_force_protein_domain=NLS_;task_force_protein_domain_source=https://pubmed.ncbi.nlm.nih.gov/10321742/;hexplorer=-2.02;hexplorer_mut=-3.80;hexplorer_wt=-1.79;hexplorer_rev=3.72;hexplorer_rev_mut=4.20;hexplorer_rev_wt=0.48;max_hbond_rev=-17.30;max_hbond_rev_wt=17.30;bayesdel=0.66;rsid=1131691039;clinvar=633606;heredicare_vid=6882896;variation_id=633606;clinvar_summary=reviewed_by_expert_panel:Likely_pathogenic;clinvar_submissions=Pathogenic|2021-12-11|criteria_provided,_single_submitter|C0085390:Li-Fraumeni_syndrome|Invitae|description:_This_sequence_change_affects_a_donor_splice_site_in_intron_8_of_the_TP53_gene._It_is_expected_to_disrupt_RNA_splicing._Variants_that_disrupt_the_donor_or_acceptor_splice_site_typically_lead_to_a_loss_of_protein_function_(PMID:_16199547),_and_loss-of-function_variants_in_TP53_are_known_to_be_pathogenic_(PMID:_20522432)._This_variant_is_not_present_in_population_databases_(gnomAD_no_frequency)._Disruption_of_this_splice_site_has_been_observed_in_individual(s)_with_Li-Fraumeni_syndrome_(PMID:_20805372,_29070607,_29324801)._In_at_least_one_individual_the_variant_was_observed_to_be_de_novo._ClinVar_contains_an_entry_for_this_variant_(Variation_ID:_633606)._Algorithms_developed_to_predict_the_effect_of_sequence_changes_on_RNA_splicing_suggest_that_this_variant_may_disrupt_the_consensus_splice_site._For_these_reasons,_this_variant_has_been_classified_as_Pathogenic.&not_provided|None|no_assertion_provided|C3661900:not_provided|MutSpliceDB:_a_database_of_splice_sites_variants_effects_on_splicing,_NIH|None&Pathogenic|2019-05-21|no_assertion_criteria_provided|C1835398:Li-Fraumeni_syndrome_1|Academic_Center_for_Education,_Culture_and_Research,_Motamed_Cancer_Institute|None&Likely_pathogenic|2019-08-28|reviewed_by_expert_panel|C0085390:Li-Fraumeni_syndrome|ClinGen_TP53_Variant_Curation_Expert_Panel,_ClinGen|description:_The_c.919%2B1G>A_is_canonical_splice_variant_predicted_to_result_in_a_truncated_or_absent_protein_(PVS1_Strong)._This_variant_is_absent_in_the_gnomAD_cohort_(PM2_Supporting%3B_http://gnomad.broadinstitute.org)._There_is_a_proband_with_a_de_novo_observation_with_bilateral,_metachronous_breast_cancer_without_mention_of_parental_confirmation_(PM6_Supporting%3B_PMID:_28509937)._In_summary,_TP53_c.919%2B1G>A_meets_criteria_to_be_classified_as_likely_pathogenic_for_Li-Fraumeni_syndrome._ACMG/AMP_criteria_applied,_as_specified_by_the_TP53_Variant_Curation_Expert_Panel:_PVS1_Strong,_PM2_Supporting,_PM6_Supporting.&Pathogenic|2023-05-11|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_The_c.919%2B1G>A_intronic_pathogenic_mutation_results_from_a_G_to_A_substitution_one_nucleotide_after_coding_exon_7_of_the_TP53_gene._This_alteration_has_been_reported_in_families_meeting_classic_Li_Fraumeni_syndrome_criteria_and/or_Chompret_criteria_for_LFS_(Marcel_V_et_al._J_Med_Genet,_2009_Nov%3B46:766-72%3B_Wilson_JR_et_al._J_Med_Genet,_2010_Nov%3B47:771-4%3B_Wong_ESY_et_al._NPJ_Genom_Med,_2016_Jan%3B1:15003%3B_Aceto_GM_et_al._Breast_Cancer_Res_Treat,_2019_Jun%3B175:479-485%3B_Haque_MM_et_al._Sci_Rep,_2018_Aug%3B8:11705%3B_Stoltze_U_et_al._PLoS_One,_2018_Jan%3B13:e0190050)._This_alteration_has_also_been_reported_as_a_de_novo_observation_with_bilateral,_metachronous_breast_cancer_without_mention_of_parental_confirmation_(O'Shea_R_et_al._Fam_Cancer,_2018_Jan%3B17:123-128)._This_nucleotide_position_is_highly_conserved_in_available_vertebrate_species._In_silico_splice_site_analysis_predicts_that_this_alteration_will_weaken_the_native_splice_donor_site._Alterations_that_disrupt_the_canonical_splice_site_are_expected_to_cause_aberrant_splicing,_resulting_in_an_abnormal_protein_or_a_transcript_that_is_subject_to_nonsense-mediated_mRNA_decay._Based_on_the_supporting_evidence,_this_alteration_is_interpreted_as_a_disease-causing_mutation.;heredicare_annotation=6882896|1|1|14|cDNA-Analyse_(47707):_Intron_Retention_von_Intron_8,_r.919_920ins919%2B1_920-1,_p.(Ala307Aspfs*31),_92_bp,_frameshift|2018-05-08;consequences=ENST00000269305|c.919%2B1G>A|None|splice_donor_variant|high|None|8|TP53|None|True|True|False|True|protein_coding|1172&ENST00000359597|c.919%2B1G>A|None|splice_donor_variant|high|None|7|TP53|None|True|False|False|False|protein_coding|1023&ENST00000413465|c.782%2B481G>A|None|intron_variant|modifier|None|6|TP53|None|True|False|False|False|protein_coding|851&ENST00000420246|c.919%2B1G>A|None|splice_donor_variant|high|None|8|TP53|None|True|False|False|False|protein_coding|1017&ENST00000445888|c.919%2B1G>A|None|splice_donor_variant|high|None|8|TP53|None|True|False|False|False|protein_coding|1172&ENST00000455263|c.919%2B1G>A|None|splice_donor_variant|high|None|8|TP53|None|True|False|False|False|protein_coding|1032&ENST00000503591|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding|1172&ENST00000504290|c.523%2B1G>A|None|splice_donor_variant|high|None|4|TP53|None|True|False|False|False|protein_coding|639&ENST00000504937|c.523%2B1G>A|None|splice_donor_variant|high|None|4|TP53|None|True|False|False|False|protein_coding|779&ENST00000505014|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|retained_intron|1256&ENST00000508793|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding|1172&ENST00000509690|c.523%2B1G>A|None|splice_donor_variant|high|None|5|TP53|None|False|False|False|False|protein_coding|779&ENST00000510385|c.523%2B1G>A|None|splice_donor_variant|high|None|4|TP53|None|True|False|False|False|protein_coding|624&ENST00000514944|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding|894&ENST00000574684|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding_CDS_not_defined|102&ENST00000576024|None|None|upstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding|93&ENST00000604348|None|None|downstream_gene_variant|modifier|None|None|TP53|None|True|False|False|False|protein_coding|1151&ENST00000610292|c.802%2B1G>A|None|splice_donor_variant|high|None|7|TP53|None|True|False|False|False|protein_coding|1057&ENST00000610538|c.802%2B1G>A|None|splice_donor_variant|high|None|8|TP53|None|True|False|False|False|protein_coding|917&ENST00000610623|c.442%2B1G>A|None|splice_donor_variant|high|None|4|TP53|None|True|False|False|False|protein_coding|558&ENST00000618944|c.442%2B1G>A|None|splice_donor_variant|high|None|4|TP53|None|True|False|False|False|protein_coding|543&ENST00000619186|c.442%2B1G>A|None|splice_donor_variant|high|None|4|TP53|None|True|False|False|False|protein_coding|698&ENST00000619485|c.802%2B1G>A|None|splice_donor_variant|high|None|8|TP53|None|True|False|False|False|protein_coding|1057&ENST00000620739|c.802%2B1G>A|None|splice_donor_variant|high|None|8|TP53|None|True|False|False|False|protein_coding|1057&ENST00000622645|c.802%2B1G>A|None|splice_donor_variant|high|None|8|TP53|None|True|False|False|False|protein_coding|902&ENST00000635293|c.802%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|8|TP53|None|False|False|False|False|nonsense_mediated_decay|1225&ENSR00000548580|None|None|regulatory_region_variant|modifier|None|None|None|None|False|False|False|False|None|None&NM_000546|c.919%2B1G>A|None|splice_donor_variant|high|None|8|TP53|None|True|True|False|True|mRNA|1172&NM_001126112|c.919%2B1G>A|None|splice_donor_variant|high|None|8|TP53|None|True|True|False|True|mRNA|1172&NM_001126113|c.919%2B1G>A|None|splice_donor_variant|high|None|8|TP53|None|True|False|False|False|mRNA|1032&NM_001126114|c.919%2B1G>A|None|splice_donor_variant|high|None|8|TP53|None|True|False|False|False|mRNA|1017&NM_001126115|c.523%2B1G>A|None|splice_donor_variant|high|None|4|TP53|None|True|False|False|False|mRNA|779&NM_001126116|c.523%2B1G>A|None|splice_donor_variant|high|None|4|TP53|None|True|False|False|False|mRNA|624&NM_001126117|c.523%2B1G>A|None|splice_donor_variant|high|None|4|TP53|None|True|False|False|False|mRNA|639&NM_001126118|c.802%2B1G>A|None|splice_donor_variant|high|None|7|TP53|None|True|False|False|False|mRNA|1057&NM_001276695|c.802%2B1G>A|None|splice_donor_variant|high|None|8|TP53|None|True|False|False|False|mRNA|917&NM_001276696|c.802%2B1G>A|None|splice_donor_variant|high|None|8|TP53|None|True|False|False|False|mRNA|902&NM_001276697|c.442%2B1G>A|None|splice_donor_variant|high|None|4|TP53|None|True|False|False|False|mRNA|698&NM_001276698|c.442%2B1G>A|None|splice_donor_variant|high|None|4|TP53|None|True|False|False|False|mRNA|543&NM_001276699|c.442%2B1G>A|None|splice_donor_variant|high|None|4|TP53|None|True|False|False|False|mRNA|558&NM_001276760|c.802%2B1G>A|None|splice_donor_variant|high|None|8|TP53|None|True|False|False|False|mRNA|1057&NM_001276761|c.802%2B1G>A|None|splice_donor_variant|high|None|8|TP53|None|True|False|False|False|mRNA|1057;literature=20522432&16199547&29324801&20805372&29070607&17066464&19542078&25896519&28509937&29263802&30796655&30076369&17118779&31700061&30886117
chr17	7670655	26458	C	T	.	.	phylop_100way=2.77;cadd_scaled=27.1;revel=ENST00000269305$0.536|ENST00000396473$0.536|ENST00000445888$0.536;spliceai_details=TP53%7C0.00%7C0.00%7C0.00%7C0.00%7C36%7C0%7C-8%7C-46;spliceai_max_delta=0.0;maxentscan_swa=ENST00000269305$-2.27%7C-2.81%7C-2.27%7C-0.66%7C-3.04%7C-0.66|ENST00000359597$-2.27%7C-2.81%7C-2.27%7C-0.66%7C-3.04%7C-0.66|ENST00000413465$-2.27%7C-2.81%7C-2.27%7C-0.66%7C-3.04%7C-0.66|ENST00000420246$-2.27%7C-2.81%7C-2.27%7C-0.66%7C-3.04%7C-0.66|ENST00000445888$-2.27%7C-2.81%7C-2.27%7C-0.66%7C-3.04%7C-0.66|ENST00000455263$-2.27%7C-2.81%7C-2.27%7C-0.66%7C-3.04%7C-0.66|ENST00000504290$-2.27%7C-2.81%7C-2.27%7C-0.66%7C-3.04%7C-0.66|ENST00000504937$-2.27%7C-2.81%7C-2.27%7C-0.66%7C-3.04%7C-0.66|ENST00000510385$-2.27%7C-2.81%7C-2.27%7C-0.66%7C-3.04%7C-0.66|ENST00000604348$-2.27%7C-2.81%7C-2.27%7C-0.66%7C-3.04%7C-0.66|ENST00000610292$-2.27%7C-2.81%7C-2.27%7C-0.66%7C-3.04%7C-0.66|ENST00000610538$-2.27%7C-2.81%7C-2.27%7C-0.66%7C-3.04%7C-0.66|ENST00000610623$-2.27%7C-2.81%7C-2.27%7C-0.66%7C-3.04%7C-0.66|ENST00000618944$-2.27%7C-2.81%7C-2.27%7C-0.66%7C-3.04%7C-0.66|ENST00000619186$-2.27%7C-2.81%7C-2.27%7C-0.66%7C-3.04%7C-0.66|ENST00000619485$-2.27%7C-2.81%7C-2.27%7C-0.66%7C-3.04%7C-0.66|ENST00000620739$-2.27%7C-2.81%7C-2.27%7C-0.66%7C-3.04%7C-0.66|ENST00000622645$-2.27%7C-2.81%7C-2.27%7C-0.66%7C-3.04%7C-0.66;tp53db_DNE_LOF_class=notDNE_notLOF;tp53db_bayes_del=-0.2009;tp53db_domain_function=Tetramerisation;tp53db_transactivation_class=functional;task_force_protein_domain=Oligomerization_region;task_force_protein_domain_source=BWRL;hexplorer=-4.78;hexplorer_mut=-7.03;hexplorer_wt=-2.25;hexplorer_rev=-0.60;hexplorer_rev_mut=7.18;hexplorer_rev_wt=7.78;bayesdel=-0.200945;heredicare_vid=9658718;cosmic=COSV53341854;heredicare_annotation=9658718|1|1|12|PHenotypic_ANnotation_of_TP53_Mutations:_nicht_in_IARC_Datenbank_Giacomelli_et_al._Combined_phenotype_score:_-0,363_±_0,017Kato_et_al.TA_Aktivität_Mittelwert:_105.91_Prozent_Kotler_et_al._Score:|2020-09-16;consequences=ENST00000269305|c.1054G>A|p.Asp352Asn|missense_variant|moderate|10|None|TP53|PF07710|True|True|False|True|protein_coding|1172&ENST00000359597|c.993%2B2880G>A|None|intron_variant|modifier|None|8|TP53|None|True|False|False|False|protein_coding|1023&ENST00000413465|c.782%2B3526G>A|None|intron_variant|modifier|None|6|TP53|None|True|False|False|False|protein_coding|851&ENST00000420246|c.*161G>A|None|3_prime_UTR_variant|modifier|11|None|TP53|None|True|False|False|False|protein_coding|1017&ENST00000445888|c.1054G>A|p.Asp352Asn|missense_variant|moderate|10|None|TP53|PF07710|True|False|False|False|protein_coding|1172&ENST00000455263|c.*73G>A|None|3_prime_UTR_variant|modifier|11|None|TP53|None|True|False|False|False|protein_coding|1032&ENST00000503591|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding|1172&ENST00000504290|c.*73G>A|None|3_prime_UTR_variant|modifier|7|None|TP53|None|True|False|False|False|protein_coding|639&ENST00000504937|c.658G>A|p.Asp220Asn|missense_variant|moderate|6|None|TP53|PF07710|True|False|False|False|protein_coding|779&ENST00000505014|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|retained_intron|1256&ENST00000508793|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding|1172&ENST00000509690|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding|779&ENST00000510385|c.*161G>A|None|3_prime_UTR_variant|modifier|7|None|TP53|None|True|False|False|False|protein_coding|624&ENST00000514944|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding|894&ENST00000574684|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding_CDS_not_defined|102&ENST00000576024|c.54-965G>A|None|intron_variant|modifier|None|1|TP53|None|False|False|False|False|protein_coding|93&ENST00000604348|None|None|downstream_gene_variant|modifier|None|None|TP53|None|True|False|False|False|protein_coding|1151&ENST00000610292|c.937G>A|p.Asp313Asn|missense_variant|moderate|9|None|TP53|PF07710|True|False|False|False|protein_coding|1057&ENST00000610538|c.*73G>A|None|3_prime_UTR_variant|modifier|11|None|TP53|None|True|False|False|False|protein_coding|917&ENST00000610623|c.*73G>A|None|3_prime_UTR_variant|modifier|7|None|TP53|None|True|False|False|False|protein_coding|558&ENST00000618944|c.*161G>A|None|3_prime_UTR_variant|modifier|7|None|TP53|None|True|False|False|False|protein_coding|543&ENST00000619186|c.577G>A|p.Asp193Asn|missense_variant|moderate|6|None|TP53|PF07710|True|False|False|False|protein_coding|698&ENST00000619485|c.937G>A|p.Asp313Asn|missense_variant|moderate|10|None|TP53|PF07710|True|False|False|False|protein_coding|1057&ENST00000620739|c.937G>A|p.Asp313Asn|missense_variant|moderate|10|None|TP53|PF07710|True|False|False|False|protein_coding|1057&ENST00000622645|c.*161G>A|None|3_prime_UTR_variant|modifier|11|None|TP53|None|True|False|False|False|protein_coding|902&ENST00000635293|c.937G>A|p.Asp313Asn|missense_variant_%26_NMD_transcript_variant|moderate|10|None|TP53|None|False|False|False|False|nonsense_mediated_decay|1225&NM_000546|c.1054G>A|p.Asp352Asn|missense_variant|moderate|10|None|TP53|None|True|True|False|True|mRNA|1172&NM_001126112|c.1054G>A|p.Asp352Asn|missense_variant|moderate|10|None|TP53|None|True|True|False|True|mRNA|1172&NM_001126113|c.*73G>A|None|3_prime_UTR_variant|modifier|11|None|TP53|None|True|False|False|False|mRNA|1032&NM_001126114|c.*161G>A|None|3_prime_UTR_variant|modifier|11|None|TP53|None|True|False|False|False|mRNA|1017&NM_001126115|c.658G>A|p.Asp220Asn|missense_variant|moderate|6|None|TP53|None|True|False|False|False|mRNA|779&NM_001126116|c.*161G>A|None|3_prime_UTR_variant|modifier|7|None|TP53|None|True|False|False|False|mRNA|624&NM_001126117|c.*73G>A|None|3_prime_UTR_variant|modifier|7|None|TP53|None|True|False|False|False|mRNA|639&NM_001126118|c.937G>A|p.Asp313Asn|missense_variant|moderate|9|None|TP53|None|True|False|False|False|mRNA|1057&NM_001276695|c.*73G>A|None|3_prime_UTR_variant|modifier|11|None|TP53|None|True|False|False|False|mRNA|917&NM_001276696|c.*161G>A|None|3_prime_UTR_variant|modifier|11|None|TP53|None|True|False|False|False|mRNA|902&NM_001276697|c.577G>A|p.Asp193Asn|missense_variant|moderate|6|None|TP53|None|True|False|False|False|mRNA|698&NM_001276698|c.*161G>A|None|3_prime_UTR_variant|modifier|7|None|TP53|None|True|False|False|False|mRNA|543&NM_001276699|c.*73G>A|None|3_prime_UTR_variant|modifier|7|None|TP53|None|True|False|False|False|mRNA|558&NM_001276760|c.937G>A|p.Asp313Asn|missense_variant|moderate|10|None|TP53|None|True|False|False|False|mRNA|1057&NM_001276761|c.937G>A|p.Asp313Asn|missense_variant|moderate|10|None|TP53|None|True|False|False|False|mRNA|1057;literature=28724667
chr17	7669623	1304	GC	G	.	.	phylop_100way=-3.579;spliceai_details=TP53%7C0.00%7C0.00%7C0.00%7C0.00%7C-45%7C48%7C3%7C48;spliceai_max_delta=0.0;maxentscan_swa=ENST00000269305$-7.62%7C-3.35%7C-7.62%7C-5.96%7C-10.11%7C-5.96|ENST00000359597$-7.62%7C-3.35%7C-7.62%7C-5.96%7C-10.11%7C-5.96|ENST00000413465$-7.62%7C-3.35%7C-7.62%7C-5.96%7C-10.11%7C-5.96|ENST00000420246$-7.62%7C-3.35%7C-7.62%7C-5.96%7C-10.11%7C-5.96|ENST00000445888$-7.62%7C-3.35%7C-7.62%7C-5.96%7C-10.11%7C-5.96|ENST00000455263$-7.62%7C-3.35%7C-7.62%7C-5.96%7C-10.11%7C-5.96|ENST00000504290$-7.62%7C-3.35%7C-7.62%7C-5.96%7C-10.11%7C-5.96|ENST00000504937$-7.62%7C-3.35%7C-7.62%7C-5.96%7C-10.11%7C-5.96|ENST00000510385$-7.62%7C-3.35%7C-7.62%7C-5.96%7C-10.11%7C-5.96|ENST00000604348$-7.62%7C-3.35%7C-7.62%7C-5.96%7C-10.11%7C-5.96|ENST00000610292$-7.62%7C-3.35%7C-7.62%7C-5.96%7C-10.11%7C-5.96|ENST00000610538$-7.62%7C-3.35%7C-7.62%7C-5.96%7C-10.11%7C-5.96|ENST00000610623$-7.62%7C-3.35%7C-7.62%7C-5.96%7C-10.11%7C-5.96|ENST00000618944$-7.62%7C-3.35%7C-7.62%7C-5.96%7C-10.11%7C-5.96|ENST00000619186$-7.62%7C-3.35%7C-7.62%7C-5.96%7C-10.11%7C-5.96|ENST00000619485$-7.62%7C-3.35%7C-7.62%7C-5.96%7C-10.11%7C-5.96|ENST00000620739$-7.62%7C-3.35%7C-7.62%7C-5.96%7C-10.11%7C-5.96|ENST00000622645$-7.62%7C-3.35%7C-7.62%7C-5.96%7C-10.11%7C-5.96;task_force_protein_domain=CTD_(repression_of_DNA-binding_region);task_force_protein_domain_source=https://pubmed.ncbi.nlm.nih.gov/27145840/;hexplorer=0.43;hexplorer_mut=-3.32;hexplorer_wt=-3.76;hexplorer_rev=-0.72;hexplorer_rev_mut=0.76;hexplorer_rev_wt=1.48;max_hbond=0.00;max_hbond_mut=4.90;max_hbond_wt=4.90;heredicare_vid=13959016;rsid=749817236;cosmic=COSV53596275;heredicare_annotation=13959016|1|1|13|Diese_Proteindomäne_wird_als_negative_regulatorische_Domäne_betrachtet._Insbesondere_Austäusche/STOP_in_>%1Yaa390_induzieren_bei_Giacomelli_nicht_Mutanten-Funktion:_class_3_ohne_Tendenz.|2022-06-14;consequences=ENST00000269305|c.1167del|p.Pro390LeufsTer32|frameshift_variant|high|11|None|TP53|None|True|True|False|True|protein_coding|1172&ENST00000359597|c.994-3380del|None|intron_variant|modifier|None|8|TP53|None|True|False|False|False|protein_coding|1023&ENST00000413465|c.782%2B4557del|None|intron_variant|modifier|None|6|TP53|None|True|False|False|False|protein_coding|851&ENST00000420246|c.*274del|None|3_prime_UTR_variant|modifier|12|None|TP53|None|True|False|False|False|protein_coding|1017&ENST00000445888|c.1167del|p.Pro390LeufsTer32|frameshift_variant|high|11|None|TP53|None|True|False|False|False|protein_coding|1172&ENST00000455263|c.*186del|None|3_prime_UTR_variant|modifier|12|None|TP53|None|True|False|False|False|protein_coding|1032&ENST00000504290|c.*186del|None|3_prime_UTR_variant|modifier|8|None|TP53|None|True|False|False|False|protein_coding|639&ENST00000504937|c.771del|p.Pro258LeufsTer32|frameshift_variant|high|7|None|TP53|None|True|False|False|False|protein_coding|779&ENST00000505014|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|retained_intron|1256&ENST00000509690|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding|779&ENST00000510385|c.*274del|None|3_prime_UTR_variant|modifier|8|None|TP53|None|True|False|False|False|protein_coding|624&ENST00000514944|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding|894&ENST00000574684|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding_CDS_not_defined|102&ENST00000576024|c.*25del|None|3_prime_UTR_variant|modifier|2|None|TP53|None|False|False|False|False|protein_coding|93&ENST00000610292|c.1050del|p.Pro351LeufsTer32|frameshift_variant|high|10|None|TP53|None|True|False|False|False|protein_coding|1057&ENST00000610538|c.*186del|None|3_prime_UTR_variant|modifier|12|None|TP53|None|True|False|False|False|protein_coding|917&ENST00000610623|c.*186del|None|3_prime_UTR_variant|modifier|8|None|TP53|None|True|False|False|False|protein_coding|558&ENST00000618944|c.*274del|None|3_prime_UTR_variant|modifier|8|None|TP53|None|True|False|False|False|protein_coding|543&ENST00000619186|c.690del|p.Pro231LeufsTer32|frameshift_variant|high|7|None|TP53|None|True|False|False|False|protein_coding|698&ENST00000619485|c.1050del|p.Pro351LeufsTer32|frameshift_variant|high|11|None|TP53|None|True|False|False|False|protein_coding|1057&ENST00000620739|c.1050del|p.Pro351LeufsTer32|frameshift_variant|high|11|None|TP53|None|True|False|False|False|protein_coding|1057&ENST00000622645|c.*274del|None|3_prime_UTR_variant|modifier|12|None|TP53|None|True|False|False|False|protein_coding|902&ENST00000635293|c.983%2B985del|None|intron_variant_%26_NMD_transcript_variant|modifier|None|10|TP53|None|False|False|False|False|nonsense_mediated_decay|1225&NM_000546|c.1167del|p.Pro390LeufsTer32|frameshift_variant|high|11|None|TP53|None|True|True|False|True|mRNA|1172&NM_001126112|c.1167del|p.Pro390LeufsTer32|frameshift_variant|high|11|None|TP53|None|True|True|False|True|mRNA|1172&NM_001126113|c.*186del|None|3_prime_UTR_variant|modifier|12|None|TP53|None|True|False|False|False|mRNA|1032&NM_001126114|c.*274del|None|3_prime_UTR_variant|modifier|12|None|TP53|None|True|False|False|False|mRNA|1017&NM_001126115|c.771del|p.Pro258LeufsTer32|frameshift_variant|high|7|None|TP53|None|True|False|False|False|mRNA|779&NM_001126116|c.*274del|None|3_prime_UTR_variant|modifier|8|None|TP53|None|True|False|False|False|mRNA|624&NM_001126117|c.*186del|None|3_prime_UTR_variant|modifier|8|None|TP53|None|True|False|False|False|mRNA|639&NM_001126118|c.1050del|p.Pro351LeufsTer32|frameshift_variant|high|10|None|TP53|None|True|False|False|False|mRNA|1057&NM_001276695|c.*186del|None|3_prime_UTR_variant|modifier|12|None|TP53|None|True|False|False|False|mRNA|917&NM_001276696|c.*274del|None|3_prime_UTR_variant|modifier|12|None|TP53|None|True|False|False|False|mRNA|902&NM_001276697|c.690del|p.Pro231LeufsTer32|frameshift_variant|high|7|None|TP53|None|True|False|False|False|mRNA|698&NM_001276698|c.*274del|None|3_prime_UTR_variant|modifier|8|None|TP53|None|True|False|False|False|mRNA|543&NM_001276699|c.*186del|None|3_prime_UTR_variant|modifier|8|None|TP53|None|True|False|False|False|mRNA|558&NM_001276760|c.1050del|p.Pro351LeufsTer32|frameshift_variant|high|11|None|TP53|None|True|False|False|False|mRNA|1057&NM_001276761|c.1050del|p.Pro351LeufsTer32|frameshift_variant|high|11|None|TP53|None|True|False|False|False|mRNA|1057;literature=28369373
chr17	7670669	242	GC	G	.	.	phylop_100way=0.368;spliceai_details=TP53%7C0.00%7C0.00%7C0.00%7C0.00%7C49%7C46%7C37%7C30;spliceai_max_delta=0.0;maxentscan_swa=ENST00000269305$-6.29%7C-4.22%7C-6.29%7C-0.66%7C-2.97%7C-0.66|ENST00000359597$-6.29%7C-4.22%7C-6.29%7C-0.66%7C-2.97%7C-0.66|ENST00000413465$-6.29%7C-4.22%7C-6.29%7C-0.66%7C-2.97%7C-0.66|ENST00000420246$-6.29%7C-4.22%7C-6.29%7C-0.66%7C-2.97%7C-0.66|ENST00000445888$-6.29%7C-4.22%7C-6.29%7C-0.66%7C-2.97%7C-0.66|ENST00000455263$-6.29%7C-4.22%7C-6.29%7C-0.66%7C-2.97%7C-0.66|ENST00000504290$-6.29%7C-4.22%7C-6.29%7C-0.66%7C-2.97%7C-0.66|ENST00000504937$-6.29%7C-4.22%7C-6.29%7C-0.66%7C-2.97%7C-0.66|ENST00000510385$-6.29%7C-4.22%7C-6.29%7C-0.66%7C-2.97%7C-0.66|ENST00000604348$-6.29%7C-4.22%7C-6.29%7C-0.66%7C-2.97%7C-0.66|ENST00000610292$-6.29%7C-4.22%7C-6.29%7C-0.66%7C-2.97%7C-0.66|ENST00000610538$-6.29%7C-4.22%7C-6.29%7C-0.66%7C-2.97%7C-0.66|ENST00000610623$-6.29%7C-4.22%7C-6.29%7C-0.66%7C-2.97%7C-0.66|ENST00000618944$-6.29%7C-4.22%7C-6.29%7C-0.66%7C-2.97%7C-0.66|ENST00000619186$-6.29%7C-4.22%7C-6.29%7C-0.66%7C-2.97%7C-0.66|ENST00000619485$-6.29%7C-4.22%7C-6.29%7C-0.66%7C-2.97%7C-0.66|ENST00000620739$-6.29%7C-4.22%7C-6.29%7C-0.66%7C-2.97%7C-0.66|ENST00000622645$-6.29%7C-4.22%7C-6.29%7C-0.66%7C-2.97%7C-0.66;task_force_protein_domain=Oligomerization_region;task_force_protein_domain_source=BWRL;hexplorer=0.32;hexplorer_mut=3.06;hexplorer_wt=2.73;hexplorer_rev=-0.20;hexplorer_rev_mut=2.00;hexplorer_rev_wt=2.20;heredicare_vid=14026119;user_classification=5|More_c-terminal_variants_are_classified_pathogenic_in_Penkert_et_al._FS-variant_which_affects_oligomerization_domain_and_CTD|2023-09-11_14:19:16|ACMG_gene_specific:_TP53|5|PVS1+very_strong_pathogenic+Frameshift_variant_which_affects_oligomerziation_domain+1$PS1+medium_pathogenic+More_C-terminal_nonsense_variants_are_classified_pathogenic+1$PM2+supporting_pathogenic+Absent_from_controls+1|&3|UFriedrich_%2B_HRoth:_wir_finden_im_Scheme_keinen_Hinweis_darauf,_dass_man_auch_funktionelle_Assays_anderer_(dahinter)_liegender_Varianten_als_PS3_einsetzen_darf|2023-11-08_10:02:03|ACMG_gene_specific:_TP53|3|PM2+supporting_pathogenic+nicht_in_gnomAD+1|&5|PVS1,_PM1,_PM2|2023-11-13_10:06:55|ACMG_standard|5|PVS1+very_strong_pathogenic+Null_variant_(frame-shift)_in_gene_TP53,_predicted_to_cause_NMD%3B_+1$PM1+supporting_pathogenic+UniProt_protein_P53_HUMAN_region_of_interest_'Oligomerization'_and_UniProt_protein_P53_HUMAN_short_sequence_motif_'Nuclear_export_signal'._The_exon_contains_51_pathogenic_variants._The_truncated_region_contains_29_pathogenic_variants.+1$PM2+supporting_pathogenic+Nicht_in_Gnomad+1|&4|This_classification_does_not_yet_even_account_for_the_truncation_and_therefore_further_loss_of_amino_acids_in_the_functional_oligomerization_domain.|2023-11-13_14:10:06|ACMG_gene_specific:_TP53|4|PS3+strong_pathogenic+Kato_<20%%3B_Giacomelli_>0.568,_see_my_mail_with_thresholds_from_December_2022_+1$PM2+medium_pathogenic+absent_in_Gmomad+1|&4|truncating,_in_tetramerisation_domain|2023-11-14_10:20:34|ACMG_gene_specific:_TP53|4|PVS1+strong_pathogenic+truncating,_in_tetramerisation_domain+1$PM2+supporting_pathogenic+absent_in_ctrls,_not_in_gnomAD,_ESP,_etc+1$PS1+medium_pathogenic+TP53_VCEP+1|;consensus_classification=4|PVS1_strong,_PS3_sup,_PM2_sup__Frameshift-variant_which_affects_oligomerization_domain_and_CTD._More_c-terminal_variants_are_classified_pathogenic_in_Penkert_et_al.,_p.Ala347Pro_shows_only_11.3%_of_wild-type_Transcriptional_activity_in_yeast_(Kato_et_al.)|2023-10-12_08:02:31|ACMG_gene_specific:_TP53|4|PVS1+strong_pathogenic+Frameshift_variant_which_affects_oligomerziation_domain+1$PS3+supporting_pathogenic+p.Ala347Pro_shows_only_11.3%_of_wild-type_Transcriptional_activity_in_yeast_(Kato_et_al.)+1$PM2+supporting_pathogenic+Absent_from_controls+1|;heredicare_annotation=14026119|3|3|||;consequences=ENST00000269305|c.1039del|p.Ala347ProfsTer23|frameshift_variant|high|10|None|TP53|PF07710|True|True|False|True|protein_coding|1172&ENST00000359597|c.993%2B2865del|None|intron_variant|modifier|None|8|TP53|None|True|False|False|False|protein_coding|1023&ENST00000413465|c.782%2B3511del|None|intron_variant|modifier|None|6|TP53|None|True|False|False|False|protein_coding|851&ENST00000420246|c.*146del|None|3_prime_UTR_variant|modifier|11|None|TP53|None|True|False|False|False|protein_coding|1017&ENST00000445888|c.1039del|p.Ala347ProfsTer23|frameshift_variant|high|10|None|TP53|PF07710|True|False|False|False|protein_coding|1172&ENST00000455263|c.*58del|None|3_prime_UTR_variant|modifier|11|None|TP53|None|True|False|False|False|protein_coding|1032&ENST00000503591|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding|1172&ENST00000504290|c.*58del|None|3_prime_UTR_variant|modifier|7|None|TP53|None|True|False|False|False|protein_coding|639&ENST00000504937|c.643del|p.Ala215ProfsTer23|frameshift_variant|high|6|None|TP53|PF07710|True|False|False|False|protein_coding|779&ENST00000505014|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|retained_intron|1256&ENST00000508793|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding|1172&ENST00000509690|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding|779&ENST00000510385|c.*146del|None|3_prime_UTR_variant|modifier|7|None|TP53|None|True|False|False|False|protein_coding|624&ENST00000514944|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding|894&ENST00000574684|None|None|downstream_gene_variant|modifier|None|None|TP53|None|False|False|False|False|protein_coding_CDS_not_defined|102&ENST00000576024|c.54-980del|None|intron_variant|modifier|None|1|TP53|None|False|False|False|False|protein_coding|93&ENST00000604348|None|None|downstream_gene_variant|modifier|None|None|TP53|None|True|False|False|False|protein_coding|1151&ENST00000610292|c.922del|p.Ala308ProfsTer23|frameshift_variant|high|9|None|TP53|PF07710|True|False|False|False|protein_coding|1057&ENST00000610538|c.*58del|None|3_prime_UTR_variant|modifier|11|None|TP53|None|True|False|False|False|protein_coding|917&ENST00000610623|c.*58del|None|3_prime_UTR_variant|modifier|7|None|TP53|None|True|False|False|False|protein_coding|558&ENST00000618944|c.*146del|None|3_prime_UTR_variant|modifier|7|None|TP53|None|True|False|False|False|protein_coding|543&ENST00000619186|c.562del|p.Ala188ProfsTer23|frameshift_variant|high|6|None|TP53|PF07710|True|False|False|False|protein_coding|698&ENST00000619485|c.922del|p.Ala308ProfsTer23|frameshift_variant|high|10|None|TP53|PF07710|True|False|False|False|protein_coding|1057&ENST00000620739|c.922del|p.Ala308ProfsTer23|frameshift_variant|high|10|None|TP53|PF07710|True|False|False|False|protein_coding|1057&ENST00000622645|c.*146del|None|3_prime_UTR_variant|modifier|11|None|TP53|None|True|False|False|False|protein_coding|902&ENST00000635293|c.922del|p.Ala308ProfsTer41|frameshift_variant_%26_NMD_transcript_variant|high|10|None|TP53|None|False|False|False|False|nonsense_mediated_decay|1225&NM_000546|c.1039del|p.Ala347ProfsTer23|frameshift_variant|high|10|None|TP53|None|True|True|False|True|mRNA|1172&NM_001126112|c.1039del|p.Ala347ProfsTer23|frameshift_variant|high|10|None|TP53|None|True|True|False|True|mRNA|1172&NM_001126113|c.*58del|None|3_prime_UTR_variant|modifier|11|None|TP53|None|True|False|False|False|mRNA|1032&NM_001126114|c.*146del|None|3_prime_UTR_variant|modifier|11|None|TP53|None|True|False|False|False|mRNA|1017&NM_001126115|c.643del|p.Ala215ProfsTer23|frameshift_variant|high|6|None|TP53|None|True|False|False|False|mRNA|779&NM_001126116|c.*146del|None|3_prime_UTR_variant|modifier|7|None|TP53|None|True|False|False|False|mRNA|624&NM_001126117|c.*58del|None|3_prime_UTR_variant|modifier|7|None|TP53|None|True|False|False|False|mRNA|639&NM_001126118|c.922del|p.Ala308ProfsTer23|frameshift_variant|high|9|None|TP53|None|True|False|False|False|mRNA|1057&NM_001276695|c.*58del|None|3_prime_UTR_variant|modifier|11|None|TP53|None|True|False|False|False|mRNA|917&NM_001276696|c.*146del|None|3_prime_UTR_variant|modifier|11|None|TP53|None|True|False|False|False|mRNA|902&NM_001276697|c.562del|p.Ala188ProfsTer23|frameshift_variant|high|6|None|TP53|None|True|False|False|False|mRNA|698&NM_001276698|c.*146del|None|3_prime_UTR_variant|modifier|7|None|TP53|None|True|False|False|False|mRNA|543&NM_001276699|c.*58del|None|3_prime_UTR_variant|modifier|7|None|TP53|None|True|False|False|False|mRNA|558&NM_001276760|c.922del|p.Ala308ProfsTer23|frameshift_variant|high|10|None|TP53|None|True|False|False|False|mRNA|1057&NM_001276761|c.922del|p.Ala308ProfsTer23|frameshift_variant|high|10|None|TP53|None|True|False|False|False|mRNA|1057
chr11	108304673	18844	A	G	.	.	phylop_100way=7.165;cadd_scaled=33;spliceai_details=ATM%7C0.13%7C0.98%7C0.00%7C0.00%7C23%7C2%7C-14%7C1;spliceai_max_delta=0.98;maxentscan_ref=10.047;maxentscan_alt=2.092;maxentscan=ENST00000452508$10.05%7C2.09|ENST00000675843$10.05%7C2.09;maxentscan_swa=ENST00000452508$1.84%7C-1.58%7C1.84%7C10.05%7C2.09%7C10.05|ENST00000675843$1.84%7C-1.58%7C1.84%7C10.05%7C2.09%7C10.05;gnomad_ac=1;gnomad_af=6.57186e-06;gnomad_hom=0;gnomad_het=1;gnomad_popmax=NFE;gnomad_popmax_AF=1.47037e-05;gnomad_popmax_AC=1;flossies_num_afr=0;flossies_num_eur=1;hexplorer=0.34;hexplorer_mut=-6.37;hexplorer_wt=-6.71;hexplorer_rev=4.82;hexplorer_rev_mut=-0.45;hexplorer_rev_wt=-5.26;max_hbond=-2.10;max_hbond_mut=8.60;max_hbond_wt=10.70;bayesdel=0.209351;clinvar=187521;heredicare_vid=6638513;rsid=786203796;variation_id=187521;clinvar_summary=criteria_provided,_multiple_submitters,_no_conflicts:Pathogenic/Likely_pathogenic;clinvar_submissions=Pathogenic|2022-09-27|criteria_provided,_single_submitter|C0004135:Ataxia-telangiectasia_syndrome|Invitae|description:_This_sequence_change_affects_an_acceptor_splice_site_in_intron_36_of_the_ATM_gene._RNA_analysis_indicates_that_disruption_of_this_splice_site_induces_altered_splicing_and_may_result_in_an_absent_or_disrupted_protein_product._This_variant_is_not_present_in_population_databases_(gnomAD_no_frequency)._Disruption_of_this_splice_site_has_been_observed_in_individual(s)_with_ataxia-telangiectasia_(PMID:_10330348)._ClinVar_contains_an_entry_for_this_variant_(Variation_ID:_187521)._Studies_have_shown_that_disruption_of_this_splice_site_results_in_activation_of_a_cryptic_splice_site_and_introduces_a_premature_termination_codon_(Invitae)._The_resulting_mRNA_is_expected_to_undergo_nonsense-mediated_decay._For_these_reasons,_this_variant_has_been_classified_as_Pathogenic.&Likely_pathogenic|2021-05-25|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Color_Diagnostics,_LLC_DBA_Color_Health|description:_This_variant_causes_an_A_to_G_nucleotide_substitution_at_the_-2_position_of_intron_36_of_the_ATM_gene._Splice_site_prediction_tools_predict_that_this_variant_may_have_a_significant_impact_on_RNA_splicing._Although_this_prediction_has_not_been_confirmed_in_published_RNA_studies,_this_variant_is_expected_to_result_in_an_absent_or_disrupted_protein_product._To_our_knowledge,_this_variant_has_not_been_reported_in_individuals_affected_with_hereditary_cancer_in_the_literature._This_variant_has_not_been_identified_in_the_general_population_by_the_Genome_Aggregation_Database_(gnomAD)._Loss_of_ATM_function_is_a_known_mechanism_of_disease_(clinicalgenome.org)._Based_on_the_available_evidence,_this_variant_is_classified_as_Likely_Pathogenic.&Pathogenic|2023-04-05|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_The_c.5497-2A>G_pathogenic_mutation_results_from_an_A_to_G_substitution_two_nucleotides_before_coding_exon_36_of_the_ATM_gene._An_alteration_impacting_the_same_nucleotide_position_has_been_reported_in_a_patient_with_ataxia-telangiectasia_(AT)_(Teraoka_et_al._Am._J._Hum._Genet._1999_Jun%3B64(6):1617-31)._This_variant_is_considered_to_be_rare_based_on_population_cohorts_in_the_Genome_Aggregation_Database_(gnomAD)._This_nucleotide_position_is_highly_conserved_in_available_vertebrate_species._In_silico_splice_site_analysis_predicts_that_this_alteration_will_weaken_the_native_splice_acceptor_site._RNA_studies_have_demonstrated_that_this_alteration_results_in_abnormal_splicing_in_the_set_of_samples_tested_(Ambry_internal_data)._In_addition_to_the_clinical_data_presented_in_the_literature,_alterations_that_disrupt_the_canonical_splice_site_are_expected_to_cause_aberrant_splicing,_resulting_in_an_abnormal_protein_or_a_transcript_that_is_subject_to_nonsense-mediated_mRNA_decay._As_such,_this_alteration_is_classified_as_a_disease-causing_mutation.;heredicare_annotation=6638513|4|5|15|class_5%3B_bei_AT_Patienten_(PVS1,_PM2_supp,_PS1_mod)|2023-06-13;consequences=ENST00000278616|c.5497-2A>G|None|splice_acceptor_variant_%26_NMD_transcript_variant|high|None|36|ATM|None|False|False|False|False|nonsense_mediated_decay|9109&ENST00000452508|c.5497-2A>G|None|splice_acceptor_variant|high|None|37|ATM|None|True|False|False|False|protein_coding|9109&ENST00000524792|n.1712-2A>G|None|splice_acceptor_variant_%26_non_coding_transcript_variant|high|None|10|ATM|None|False|False|False|False|retained_intron|5875&ENST00000525056|None|None|upstream_gene_variant|modifier|None|None|ATM|None|False|False|False|False|retained_intron|3589&ENST00000525729|None|None|downstream_gene_variant|modifier|None|None|C11orf65|None|True|False|False|False|protein_coding|735&ENST00000527805|c.*561-2A>G|None|splice_acceptor_variant_%26_NMD_transcript_variant|high|None|34|ATM|None|False|False|False|False|nonsense_mediated_decay|4608&ENST00000529588|c.9-2A>G|None|splice_acceptor_variant_%26_NMD_transcript_variant|high|None|1|ATM|None|False|False|False|False|nonsense_mediated_decay|230&ENST00000532765|None|None|upstream_gene_variant|modifier|None|None|ATM|None|False|False|False|False|protein_coding_CDS_not_defined|604&ENST00000533690|n.901-2A>G|None|splice_acceptor_variant_%26_non_coding_transcript_variant|high|None|4|ATM|None|False|False|False|False|retained_intron|3332&ENST00000675595|c.*561-2A>G|None|splice_acceptor_variant_%26_NMD_transcript_variant|high|None|34|ATM|None|False|False|False|False|nonsense_mediated_decay|4608&ENST00000675843|c.5497-2A>G|None|splice_acceptor_variant|high|None|36|ATM|None|True|True|False|True|protein_coding|9109&ENST00000682286|None|None|upstream_gene_variant|modifier|None|None|ATM|None|False|False|False|False|protein_coding_CDS_not_defined|6376&ENST00000682302|None|None|upstream_gene_variant|modifier|None|None|ATM|None|False|False|False|False|retained_intron|6038&ENST00000683174|n.6981-2A>G|None|splice_acceptor_variant_%26_non_coding_transcript_variant|high|None|36|ATM|None|False|False|False|False|retained_intron|13067&ENST00000683524|n.721-2A>G|None|splice_acceptor_variant_%26_non_coding_transcript_variant|high|None|5|ATM|None|False|False|False|False|protein_coding_CDS_not_defined|6838&ENST00000684152|n.1211-2A>G|None|splice_acceptor_variant_%26_non_coding_transcript_variant|high|None|4|ATM|None|False|False|False|False|retained_intron|7033&NM_000051|c.5497-2A>G|None|splice_acceptor_variant|high|None|36|ATM|None|True|True|False|True|mRNA|9109&NM_001330368|None|None|downstream_gene_variant|modifier|None|None|C11orf65|None|True|False|False|False|mRNA|735&NM_001351110|None|None|downstream_gene_variant|modifier|None|None|C11orf65|None|False|False|False|False|mRNA|722&NM_001351834|c.5497-2A>G|None|splice_acceptor_variant|high|None|37|ATM|None|True|True|False|True|mRNA|9109&XM_005271562|c.5497-2A>G|None|splice_acceptor_variant|high|None|36|ATM|None|False|False|False|False|mRNA|9109&XM_006718843|c.5497-2A>G|None|splice_acceptor_variant|high|None|36|ATM|None|False|False|False|False|mRNA|9109&XM_006718845|c.1453-2A>G|None|splice_acceptor_variant|high|None|11|ATM|None|False|False|False|False|mRNA|5090&XM_011542840|c.5497-2A>G|None|splice_acceptor_variant|high|None|37|ATM|None|False|False|False|False|mRNA|9109&XM_011542842|c.5332-2A>G|None|splice_acceptor_variant|high|None|35|ATM|None|False|False|False|False|mRNA|8945&XM_011542843|c.5497-2A>G|None|splice_acceptor_variant|high|None|36|ATM|None|False|False|False|False|mRNA|8680&XM_011542844|c.4453-2A>G|None|splice_acceptor_variant|high|None|36|ATM|None|False|False|False|False|mRNA|8071&XM_011542845|c.4189-2A>G|None|splice_acceptor_variant|high|None|28|ATM|None|False|False|False|False|None|None&XM_017017789|c.5497-2A>G|None|splice_acceptor_variant|high|None|37|ATM|None|False|False|False|False|None|None&XM_017017790|c.5497-2A>G|None|splice_acceptor_variant|high|None|36|ATM|None|False|False|False|False|mRNA|9109&XM_017017791|c.5497-2A>G|None|splice_acceptor_variant|high|None|36|ATM|None|False|False|False|False|None|None&XM_017017792|None|None|downstream_gene_variant|modifier|None|None|ATM|None|False|False|False|False|None|None&XR_002957150|n.6097-2A>G|None|splice_acceptor_variant_%26_non_coding_transcript_variant|high|None|35|ATM|None|False|False|False|False|None|None;literature=25614872&10330348&23807571&16199547&31843900
chr11	108289753	29153	T	G	.	.	phylop_100way=7.709;cadd_scaled=28.8;revel=ENST00000278616$0.758|ENST00000389511$0.758|ENST00000452508$0.758|ENST00000531525$0.511;spliceai_details=ATM%7C0.00%7C0.00%7C0.00%7C0.00%7C-47%7C49%7C1%7C48;spliceai_max_delta=0.0;maxentscan_swa=ENST00000452508$-13.14%7C-6.92%7C-13.14%7C3.04%7C3.00%7C3.04|ENST00000675843$-13.14%7C-6.92%7C-13.14%7C3.04%7C3.00%7C3.04;gnomad_ac=160;gnomad_af=0.00105107;gnomad_hom=0;gnomad_het=160;gnomad_popmax=AMR;gnomad_popmax_AF=0.000850451;gnomad_popmax_AC=13;flossies_num_afr=2;flossies_num_eur=28;hexplorer=2.59;hexplorer_mut=-5.81;hexplorer_wt=-8.40;hexplorer_rev=-3.57;hexplorer_rev_mut=5.73;hexplorer_rev_wt=9.29;max_hbond=2.50;max_hbond_mut=4.50;max_hbond_wt=2.00;bayesdel=0.29777;heredicare_vid=10220809;clinvar=127388;rsid=138327406;cosmic=COSV105845602;variation_id=127388;clinvar_summary=criteria_provided,_conflicting_interpretations:Conflicting_interpretations_of_pathogenicity%7CUncertain_significance(4)%7CBenign(8)%7CLikely_benign(6);clinvar_submissions=Likely_benign|2019-11-26|criteria_provided,_single_submitter|CN169374:not_specified|Genetic_Services_Laboratory,_University_of_Chicago|None&Benign|2017-05-30|criteria_provided,_single_submitter|CN169374:not_specified|PreventionGenetics,_PreventionGenetics|None&Benign|2017-11-22|criteria_provided,_single_submitter|C3661900:not_provided|Athena_Diagnostics_Inc|None&Likely_benign|None|no_assertion_criteria_provided|C0006142:Malignant_tumor_of_breast|Department_of_Pathology_and_Laboratory_Medicine,_Sinai_Health_System|description:_The_ATM_p.Phe1463Cys_variant_was_identified_in_12_of_4036_proband_chromosomes_(frequency:_0.00297)_from_individuals_or_families_with_breast_cancer,_ovarian_cancer,_Non-Hodgkin's_lymphoma_and_Lynch_syndrome_(Liberzon_2004,_Maillet_2002,_Stafford_2017,_Tung_2016,_Yorczyk_2015,_Yurgelun_2015)._The_variant_was_also_identified_in_dbSBP_(ID:_rs138327406)_as_â€šÃ„ÃºWith_other_alleleâ€šÃ„Ã¹,_ClinVar_6x_with_conflicting_interpretations_of_pathogenicity_(as_uncertain_significance_by_EGL_Genetic_and_Vantari_Genetics,_as_likely_benign_by_GeneDx,_and_as_benign_by_Invitae_and_Ambry_Genetics),_Clinvitae_(4x),_and_Cosmic_databases._The_variant_was_not_identified_in_MutDB,_LOVD_3.0,_and_ATM-LOVD_databases._The_variant_was_identified_in_control_databases_in_405_of_276966_chromosomes_at_a_frequency_of_0.001462_in_the_following_populations:_Ashkenazi_Jewish_in_274_(7_homozygous)_of_10144_chromosomes_(freq._0.027),_Other_in_21_of_6456_chromosomes_(freq._0.0033),_Latino_in_35_of_34392_chromosomes_(freq._0.001),_European_(Non-Finnish)_in_67_of_126564_chromosomes_(freq._0.0005)_and_African_in_8_of_24014_(freq._0.0003),_increasing_the_likelihood_this_could_be_a_low_frequency_benign_variant_(Genome_Aggregation_Consortium_Feb_27,_2017)._The_p.Phe1463Cys_variant_was_found_to_co-occur_with_p.Pro604Ser_in_2_individuals_with_Non-Hodgkinâ€šÃ„Ã´s_lymphoma_(Liberzon_2004)._One_study_concluded_that_the_p.Phe1463Cys_variant_is_pathogenic_in_breast_cancer_because_the_amino_acid_substitution_is_known_to_be_deleterious_to_ATM_function_in_patients_with_B_cell_non-Hodgkinâ€šÃ„Ã´s_lymphomas,_as_well_as_based_on_conservation_data_(Maillet_2002)._The_p.Phe1463_residue_is_conserved_in_mammals_but_not_in_more_distantly_related_organisms,_and_computational_analyses_(PolyPhen-2,_SIFT,_AlignGVGD,_BLOSUM,_MutationTaster)_suggest_that_the_variant_may_impact_the_protein%3B_however,_this_information_is_not_predictive_enough_to_assume_pathogenicity._The_variant_occurs_outside_of_the_splicing_consensus_sequence_and_in_silico_or_computational_prediction_software_programs_(SpliceSiteFinder,_MaxEntScan,_NNSPLICE,_GeneSplicer,_HumanSpliceFinder)_do_not_predict_a_difference_in_splicing._In_summary,_based_on_the_above_information_the_clinical_significance_of_this_variant_cannot_be_determined_with_certainty_at_this_time_although_we_would_lean_towards_a_more_benign_role_for_this_variant._This_variant_is_classified_as_likely_benign.&Likely_benign|2018-07-02|criteria_provided,_single_submitter|C0004135:Ataxia-telangiectasia_syndrome|Mendelics|None&Benign|2022-11-03|criteria_provided,_single_submitter|C0004135:Ataxia-telangiectasia_syndrome|Invitae|None&Benign|2014-12-04|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Color_Diagnostics,_LLC_DBA_Color_Health|None&Uncertain_significance|2015-02-05|criteria_provided,_single_submitter|C3661900:not_provided|Eurofins_Ntd_Llc_(ga)|None&Uncertain_significance|2021-09-15|no_assertion_criteria_provided|C0027672:Hereditary_cancer-predisposing_syndrome|Institute_for_Biomarker_Research,_Medical_Diagnostic_Laboratories,_L.L.C.|None&Uncertain_significance|2015-10-26|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Vantari_Genetics|None&Likely_benign|2016-05-09|criteria_provided,_single_submitter|C3661900:not_provided|Women's_Health_and_Genetics/Laboratory_Corporation_of_America,_LabCorp|description:_Variant_summary:_The_ATM_c.4388T>G_(p.Phe1463Cys)_variant_involves_the_alteration_of_a_conserved_nucleotide._4/4_in_silico_tools_predict_a_damaging_outcome_for_this_variant_(SNPs%26GO_not_captured_due_to_low_reliability_index)._However,_these_predictions_have_not_been_validated_by_any_in_vitro/vivo_functional_studies._This_variant_was_found_in_172/120622_control_chromosomes_(3_homozygotes)_at_a_frequency_of_0.0014259,_which_is_approximately_3_times_the_estimated_maximal_expected_allele_frequency_of_a_pathogenic_ATM_variant_for_breast_cancer_(0.0005001),_suggesting_this_variant_does_not_cause_breast_cancer._The_variant_was_found_in_149/65460_European_non-Finnish_chromosomes_(0.002276)_with_3_homozygotes%3B_while_this_frequency_does_not_exceed_the_estimated_maximal_expected_allele_frequency_of_a_pathogenic_ATM_variant_for_Ataxia-telangiectasia_(AT%3B_0.0039528),_AT_is_a_childhood_disorder,_and_thus_it_would_be_unlikely_for_there_to_be_3_homozygous_unaffected_individuals_in_the_ExAC_database._Furthermore,_it_has_been_shown_that_while_heterozygotes_are_not_at_increased_risk_of_developing_A-T_neurologic_manifestations,_they_have_a_fourfold_increased_risk_of_developing_breast_cancer_through_mechanisms_that_are_not_understood._Thus,_if_this_were_a_pathogenic_AT-causing_variant,_it_would_increase_the_risk_of_breast_cancer._However,_population_control_data_strongly_indicate_that_this_variant_does_not_cause_breast_cancer.This_variant_has_been_reported_in_patients_with_a_variety_types_of_cancers_such_as_BrC,_HD,_HBOC,_B-CLL,_OvC,_Pancreatic_Cancer,_and_hemangioblastomas,_however,_there_was_no_strong_evidence_to_support_the_causative_correlation_of_this_variant_with_the_diseases._Additionally,_the_variant_was_found_to_co-occur_with_likely_pathogenic_variants_(BRIP1_c.440dupA_and_ATM_c.1027_1030delGAAA)_in_internal_specimens_tested_for_cancer_risk.Two_clinical_laboratories_(via_ClinVar)_classified_this_variant_as_benign,_one_classified_this_variant_as_likely_benign,_and_two_labs_classified_it_as_VUS,_without_evidence_to_independently_evaluate._Considering_all,_the_variant_was_classified_as_Likely_Benign_until_additional_information_becomes_available.&Likely_benign|2019-12-01|criteria_provided,_single_submitter|C3661900:not_provided|CeGaT_Center_for_Human_Genetics_Tuebingen|None&Benign|2022-02-16|criteria_provided,_single_submitter|CN169374:not_specified|Quest_Diagnostics_Nichols_Institute_San_Juan_Capistrano|None&Likely_benign|2017-08-24|criteria_provided,_single_submitter|C3661900:not_provided|ARUP_Laboratories,_Molecular_Genetics_and_Genomics,_ARUP_Laboratories|description:_The_ATM_c.4388T>G%3Bp.Phe1463Cys_variant_(rs138327406)_has_been_previously_reported_in_cohorts_of_early_onset_breast_cancer_(Maillet_2002),_Hodgkinâ€™s_lymphoma_(Liberzon_2004)_and_both_(Offit_2002)._However,_as_listed_in_the_ExAC_browser,_this_variant_has_a_high_frequency_in_the_general_population_(0.14%%3B_identified_in_164_out_of_118,972_chromosomes,_including_3_homozygotes),_and_in_one_study_(Offit_2002),_this_variant_was_found_at_equal_frequencies_in_cases_and_controls_(1.56%)._This_variant_is_also_listed_in_the_ClinVar_database_as_likely_benign_or_benign_(Variation_ID:_127388),_and_has_been_classified_as_likely_benign_by_a_consortium_of_clinical_labs_examining_variants_associated_with_breast_cancer_(Maxwell_2016)._Thus,_the_p.Phe1463Cys_variant_is_likely_to_be_benign._References:_ClinVar_link_to_ATM_variant:_https://www.ncbi.nlm.nih.gov/clinvar/variation/127388/_Liberzon_et_al._Molecular_variants_of_the_ATM_gene_in_Hodgkin's_disease_in_children._Br_J_Cancer._2004%3B_90(2):_522-525._Maxwell_et_al._Evaluation_of_ACMG-Guideline-Based_Variant_Classification_of_Cancer_Susceptibility_and_Non-Cancer-Associated_Genes_in_Families_Affected_by_Breast_Cancer._Am_J_Hum_Genet._2016%3B_98(5):_801-817._Maillet_et_al._Constitutional_alterations_of_the_ATM_gene_in_early_onset_sporadic_breast_cancer._J_Med_Genet._2002%3B_39(10):_751-753._Offit_et_al._Rare_variants_of_ATM_and_risk_for_Hodgkin's_disease_and_radiation-associated_breast_cancers._Clin_Cancer_Res._2002%3B_8(12):_3813-3819.&Benign|2020-04-17|no_assertion_criteria_provided|C0004135:Ataxia-telangiectasia_syndrome|Natera,_Inc.|None&Benign|2017-05-26|criteria_provided,_single_submitter|CN169374:not_specified|GeneDx|description:_This_variant_is_considered_likely_benign_or_benign_based_on_one_or_more_of_the_following_criteria:_it_is_a_conservative_change,_it_occurs_at_a_poorly_conserved_position_in_the_protein,_it_is_predicted_to_be_benign_by_multiple_in_silico_algorithms,_and/or_has_population_frequency_not_consistent_with_disease.&Uncertain_significance|2017-04-27|criteria_provided,_single_submitter|C0004135:Ataxia-telangiectasia_syndrome|Illumina_Laboratory_Services,_Illumina|description:_This_variant_was_observed_as_part_of_a_predisposition_screen_in_an_ostensibly_healthy_population._A_literature_search_was_performed_for_the_gene,_cDNA_change,_and_amino_acid_change_(where_applicable)._Publications_were_found_based_on_this_search._However,_the_evidence_from_the_literature,_in_combination_with_allele_frequency_data_from_public_databases_where_available,_was_not_sufficient_to_rule_this_variant_in_or_out_of_causing_disease._Therefore,_this_variant_is_classified_as_a_variant_of_unknown_significance.&Benign|2014-06-19|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_This_alteration_is_classified_as_benign_based_on_a_combination_of_the_following:_population_frequency,_intact_protein_function,_lack_of_segregation_with_disease,_co-occurrence,_RNA_analysis,_in_silico_models,_amino_acid_conservation,_lack_of_disease_association_in_case-control_studies,_and/or_the_mechanism_of_disease_or_impacted_region_is_inconsistent_with_a_known_cause_of_pathogenicity.&not_provided|2013-09-19|no_assertion_provided|CN169374:not_specified|ITMI|None&Uncertain_significance|2023-08-15|criteria_provided,_single_submitter|CN169374:not_specified|Center_for_Genomic_Medicine,_Rigshospitalet,_Copenhagen_University_Hospital|None&Likely_benign|2018-02-22|criteria_provided,_single_submitter|C0004135:Ataxia-telangiectasia_syndrome|Counsyl|None&Benign|2020-06-10|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Sema4,_Sema4|None;heredicare_annotation=10220809|40|42|11|30X_in_Flossies|2019-11-12;consequences=ENST00000278616|c.4388T>G|p.Phe1463Cys|missense_variant_%26_NMD_transcript_variant|moderate|29|None|ATM|None|False|False|False|False|nonsense_mediated_decay|9109&ENST00000452508|c.4388T>G|p.Phe1463Cys|missense_variant|moderate|30|None|ATM|None|True|False|False|False|protein_coding|9109&ENST00000524792|n.603T>G|None|non_coding_transcript_exon_variant|modifier|3|None|ATM|None|False|False|False|False|retained_intron|5875&ENST00000527805|c.4388T>G|p.Phe1463Cys|missense_variant_%26_NMD_transcript_variant|moderate|29|None|ATM|None|False|False|False|False|nonsense_mediated_decay|4608&ENST00000531525|c.395T>G|p.Phe132Cys|missense_variant|moderate|3|None|ATM|None|False|False|False|False|protein_coding|464&ENST00000533733|n.1651T>G|None|non_coding_transcript_exon_variant|modifier|3|None|ATM|None|False|False|False|False|retained_intron|2562&ENST00000675595|c.4223T>G|p.Phe1408Cys|missense_variant_%26_NMD_transcript_variant|moderate|28|None|ATM|None|False|False|False|False|nonsense_mediated_decay|4608&ENST00000675843|c.4388T>G|p.Phe1463Cys|missense_variant|moderate|29|None|ATM|None|True|True|False|True|protein_coding|9109&ENST00000682289|None|None|downstream_gene_variant|modifier|None|None|ATM|None|False|False|False|False|retained_intron|1335&ENST00000683174|n.4538T>G|None|non_coding_transcript_exon_variant|modifier|29|None|ATM|None|False|False|False|False|retained_intron|13067&ENST00000683524|None|None|upstream_gene_variant|modifier|None|None|ATM|None|False|False|False|False|protein_coding_CDS_not_defined|6838&NM_000051|c.4388T>G|p.Phe1463Cys|missense_variant|moderate|29|None|ATM|None|True|True|False|True|mRNA|9109&NM_001351834|c.4388T>G|p.Phe1463Cys|missense_variant|moderate|30|None|ATM|None|True|True|False|True|mRNA|9109&XM_005271562|c.4388T>G|p.Phe1463Cys|missense_variant|moderate|29|None|ATM|None|False|False|False|False|mRNA|9109&XM_006718843|c.4388T>G|p.Phe1463Cys|missense_variant|moderate|29|None|ATM|None|False|False|False|False|mRNA|9109&XM_006718845|c.344T>G|p.Phe115Cys|missense_variant|moderate|4|None|ATM|None|False|False|False|False|mRNA|5090&XM_011542840|c.4388T>G|p.Phe1463Cys|missense_variant|moderate|30|None|ATM|None|False|False|False|False|mRNA|9109&XM_011542842|c.4223T>G|p.Phe1408Cys|missense_variant|moderate|28|None|ATM|None|False|False|False|False|mRNA|8945&XM_011542843|c.4388T>G|p.Phe1463Cys|missense_variant|moderate|29|None|ATM|None|False|False|False|False|mRNA|8680&XM_011542844|c.3344T>G|p.Phe1115Cys|missense_variant|moderate|29|None|ATM|None|False|False|False|False|mRNA|8071&XM_011542845|c.3080T>G|p.Phe1027Cys|missense_variant|moderate|21|None|ATM|None|False|False|False|False|None|None&XM_017017789|c.4388T>G|p.Phe1463Cys|missense_variant|moderate|30|None|ATM|None|False|False|False|False|None|None&XM_017017790|c.4388T>G|p.Phe1463Cys|missense_variant|moderate|29|None|ATM|None|False|False|False|False|mRNA|9109&XM_017017791|c.4388T>G|p.Phe1463Cys|missense_variant|moderate|29|None|ATM|None|False|False|False|False|None|None&XM_017017792|c.4388T>G|p.Phe1463Cys|missense_variant|moderate|29|None|ATM|None|False|False|False|False|None|None&XR_002957150|n.5121T>G|None|non_coding_transcript_exon_variant|modifier|29|None|ATM|None|False|False|False|False|None|None;literature=25741868&24728327&27153395&31780696&25318351&23555315&25479140&24549055&24448499&25589003&26976419&12362033&19781682&26787654&14735203&23376243&28652578&28591191&27621404&25587027&29356034&12697903&12473594&26917275&14695997&11996792&27878467&28492530&25257991&28569743&31382929&32756499&26934580&31920950&29641532&30385747&29522266&26053094&28779002
chr11	108227625	17236	A	G	.	.	phylop_100way=8.343;cadd_scaled=24.1;revel=ENST00000278616$0.510|ENST00000452508$0.510|ENST00000527805$0.510|ENST00000527891$0.510|ENST00000532931$0.510;spliceai_details=ATM%7C0.00%7C0.00%7C0.01%7C0.00%7C-30%7C5%7C-1%7C-30;spliceai_max_delta=0.01;maxentscan_swa=ENST00000452508$1.22%7C9.40%7C1.22%7C-2.98%7C-3.31%7C-2.98|ENST00000526567$1.22%7C9.40%7C1.22%7C-2.98%7C-3.31%7C-2.98|ENST00000530958$1.22%7C9.40%7C1.22%7C-2.98%7C-3.31%7C-2.98|ENST00000639240$1.22%7C9.40%7C1.22%7C-2.98%7C-3.31%7C-2.98|ENST00000639953$1.22%7C9.40%7C1.22%7C-2.98%7C-3.31%7C-2.98|ENST00000640388$1.22%7C9.40%7C1.22%7C-2.98%7C-3.31%7C-2.98|ENST00000675843$1.22%7C9.40%7C1.22%7C-2.98%7C-3.31%7C-2.98|ENST00000682465$1.22%7C9.40%7C1.22%7C-2.98%7C-3.31%7C-2.98|ENST00000683150$1.22%7C9.40%7C1.22%7C-2.98%7C-3.31%7C-2.98|ENST00000683468$1.22%7C9.40%7C1.22%7C-2.98%7C-3.31%7C-2.98|ENST00000683914$1.22%7C9.40%7C1.22%7C-2.98%7C-3.31%7C-2.98|ENST00000684029$1.22%7C9.40%7C1.22%7C-2.98%7C-3.31%7C-2.98;hexplorer=-0.27;hexplorer_mut=3.03;hexplorer_wt=3.29;hexplorer_rev=2.22;hexplorer_rev_mut=1.60;hexplorer_rev_wt=-0.63;max_hbond=0.00;max_hbond_mut=5.10;max_hbond_wt=5.10;max_hbond_rev=0.00;max_hbond_rev_mut=8.00;max_hbond_rev_wt=8.00;bayesdel=0.200753;clinvar=181942;rsid=730881359;heredicare_vid=7625403;cosmic=COSV53722505;variation_id=181942;clinvar_summary=criteria_provided,_multiple_submitters,_no_conflicts:Pathogenic/Likely_pathogenic;clinvar_submissions=Likely_pathogenic|2016-11-29|criteria_provided,_single_submitter|C0004135:Ataxia-telangiectasia_syndrome|Counsyl|None&Pathogenic|2020-09-01|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Color_Diagnostics,_LLC_DBA_Color_Health|description:_This_variant_results_in_the_loss_of_the_translation_start_codon_(methionine_at_codon_1)_of_the_ATM_gene._This_variant_is_expected_to_disrupt_the_expression_of_the_full-length_ATM_protein._The_next_in-frame_methionine_occurs_at_codon_94,_but_it_has_not_been_shown_if_a_functional_ATM_protein_product_can_be_produced_using_p.Met94_as_an_alternative_translation_start_site._This_variant_has_been_reported_in_trans_with_p.Gly2891Asp_variant_in_an_individual_affected_with_breast_cancer_and_mild_ataxia-telangiectasia_(PMID:_22146522)._Cells_derived_from_this_patient_showed_10-20%_of_kinase_activity_compared_to_normal_cells._A_functional_study_has_shown_that_the_cells_transfected_with_this_variant_construct_show_a_very_low_level_expression_of_a_truncated_protein,_probably_due_to_the_use_of_a_downstream_methionine_for_translation_initiation_(PMID:_22146522)._This_variant_has_not_been_identified_in_the_general_population_by_the_Genome_Aggregation_Database_(gnomAD)._Based_on_the_available_evidence,_this_variant_is_classified_as_Pathogenic.&Likely_pathogenic|2019-10-01|criteria_provided,_single_submitter|C3661900:not_provided|CeGaT_Center_for_Human_Genetics_Tuebingen|None&Pathogenic|None|no_assertion_criteria_provided|C2931038:Familial_pancreatic_carcinoma|Department_of_Pathology_and_Laboratory_Medicine,_Sinai_Health_System|description:_The_ATM_c.1A>G_variant_was_identified_in_the_literature_however_the_frequency_of_this_variant_in_an_affected_population_was_not_provided._The_variant_was_also_identified_in_dbSNP_(ID:_rs730881359)_as_â€šÃ„ÃºWith_Pathogenic,_otherâ€šÃ„Ã¹_allele_,ClinVar_(classified_as_pathogenic_by_GeneReviews_and_as_likely_pathogenic_by_Counsyl).The_variant_was_not_identified_in_the_LOVD_3.0_database._The_variant_was_not_identified_in_the_following_control_databases:_the_Exome_Aggregation_Consortium_(August_8th_2016),_or_the_Genome_Aggregation_Database_(Feb_27,_2017)._The_c.1A>G_variant_occurs_in_the_first_base_of_the_translation_initiation_site_(the_methionine_amino_acid_start_site),_increasing_the_likelihood_this_variant_may_disrupt_translation_or_lead_to_an_abnormal_protein_product._The_variant_was_observed_in_a_breast_cancer_patient_with_severe_reaction_to_radiotherapy_who_was_found_to_have_2_ATM_mutations:_c.1A>G_and_c.8672G>A_(Byrd,_2012)._The_mutations_were_found_to_be_on_different_alleles,_and_the_c.8762G>A_allele's_resulting_mutant_protein_was_expressed_and_shown_to_have_some_residual_ATM_kinase_activity_in_lymphoblastoid_and_skin_fibroblast_cell_lines._The_c.1A>G_variant_was_hypothesized_to_ablate_the_initiation_of_ATM_protein_translation_entirely_but_the_possibility_of_the_expression_of_ATM_protein_if_the_GUG_of_the_RNA_were_able_to_allow_translation_could_not_be_ruled_out._The_possibility_that_initiation_from_a_downstream_methionine_resulting_in_a_truncated_protein_was_also_considered._The_c.1A>G_mutation_was_modelled_individually_by_site-directed_mutagenesis_of_full-length_normal_ATM_cDNA._Very_low_protein_levels_were_observed_and_the_molecular_weight_was_lower_that_wild_type_protein,_and_the_kinase_level_or_the_resulting_protein_was_too_low_to_be_measured_in_this_assay._These_observations_were_consistent_with_a_second_patient_with_a_different_mutation_of_the_initiation_codon._In_summary,_based_on_the_above_information_this_variant_meets_our_laboratoryâ€šÃ„Ã´s_criteria_to_be_classified_as_pathogenic.&Pathogenic|2022-10-31|criteria_provided,_single_submitter|C0004135:Ataxia-telangiectasia_syndrome|Invitae|description:_This_sequence_change_affects_the_initiator_methionine_of_the_ATM_mRNA._The_next_in-frame_methionine_is_located_at_codon_94._This_variant_is_not_present_in_population_databases_(gnomAD_no_frequency)._Disruption_of_the_initiator_codon_has_been_observed_in_individuals_with_ataxia-telangiectasia_(PMID:_9463314,_12552559,_21665257,_21792198,_22146522,_22649200)._ClinVar_contains_an_entry_for_this_variant_(Variation_ID:_181942)._For_these_reasons,_this_variant_has_been_classified_as_Pathogenic.&Pathogenic|2023-02-03|criteria_provided,_single_submitter|C0346153:Familial_cancer_of_breast|Myriad_Genetics,_Inc.|description:_This_variant_is_considered_pathogenic._This_variant_is_located_within_the_gene_translation_start_codon_(p.Met1?)_and_is_predicted_to_result_in_abnormal_protein_translation._This_variant_has_been_reported_in_multiple_individuals_with_clinical_features_of_gene-specific_disease_[PMID:_21665257,_9463314,_21792198,_12552559,_22649200,_22146522,_30549301].&not_provided|None|no_assertion_provided|C0004135:Ataxia-telangiectasia_syndrome|GeneReviews|None&Pathogenic|2021-12-09|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_The_p.M1?_pathogenic_mutation_(also_known_as_c.1A>G),_located_in_coding_exon_1_of_the_ATM_gene,_results_from_a_A_to_G_substitution_at_nucleotide_position_1._This_alters_the_methionine_residue_at_the_initiation_codon_(ATG)._This_alteration_and_several_others_affecting_the_initiation_codon_in_ATM_have_been_reported_in_individuals_with_ovarian_cancer,_breast_cancer,_and_prostate_cancer_(Crawford_B_et_al._Breast_Cancer_Res._Treat.,_2017_Jun%3B163:383-390%3B_Carter_NJ_et_al._Gynecol._Oncol.,_2018_12%3B151(3):481-488%3B_Zafeiriou_Z_et_al._Eur._Urol.,_2019_01%3B75(1):184-192%3B_Decker_B_at_al._J._Med._Genet.,_2017_11%3B54(11):732-741)._Initiation_codon_alterations,_including_this_alteration._have_also_been_reported_in_a_compound_heterozygous_state_in_multiple_patients_with_ataxia_telangiectasia_(Gilad_S_et_al._Hum._Mol._Genet.,_1996_Apr%3B5:433-9%3B_Stankovic_T_et_al._Am._J._Hum._Genet.,_1998_Feb%3B62(2):334-45%3B_Buzin_CH_et_al._Hum._Mutat.,_2003_Feb%3B21:123-31%3B_Reiman_A_et_al._Br._J._Cancer,_2011_Aug%3B105(4):586-91%3B_Byrd_PJ_et_al._Br._J._Cancer,_2012_Jan%3B106:262-8%3B_Schon_et_al._Ann._Neurol.,_2019_02%3B85(2):170-180)._In_addition_to_the_clinical_data_presented_in_the_literature,_sequence_variations_that_modify_the_initiation_codon_are_expected_to_result_in_either_loss_of_translation_initiation,_N-terminal_truncation,_or_cause_a_shift_in_the_mRNA_reading_frame._Based_on_the_supporting_evidence,_this_alteration_is_interpreted_as_a_disease-causing_mutation.;heredicare_annotation=7625403|1|1|14|Variant_frequently_found_in_AT_patients._ClinVar_Submissions_and_PMID:_20301790,_22146522,_21665257|2022-07-12;consequences=ENST00000278612|None|None|upstream_gene_variant|modifier|None|None|NPAT|None|True|True|False|True|protein_coding|4266&ENST00000278616|c.1A>G|p.Met1?|start_lost_%26_NMD_transcript_variant|high|2|None|ATM|None|False|False|False|False|nonsense_mediated_decay|9109&ENST00000384240|None|None|downstream_gene_variant|modifier|None|None|None|None|False|False|False|False|None|None&ENST00000452508|c.1A>G|p.Met1?|start_lost|high|3|None|ATM|None|True|False|False|False|protein_coding|9109&ENST00000526567|c.1A>G|p.Met1?|start_lost|high|2|None|ATM|None|True|False|False|False|protein_coding|336&ENST00000527805|c.1A>G|p.Met1?|start_lost_%26_NMD_transcript_variant|high|2|None|ATM|None|False|False|False|False|nonsense_mediated_decay|4608&ENST00000530958|c.1A>G|p.Met1?|start_lost|high|1|None|ATM|None|True|False|False|False|protein_coding|503&ENST00000532931|c.1A>G|p.Met1?|start_lost|high|3|None|ATM|None|False|False|False|False|protein_coding|277&ENST00000601453|c.1A>G|p.Met1?|start_lost|high|3|None|ATM|None|False|False|False|False|protein_coding|401&ENST00000610253|None|None|upstream_gene_variant|modifier|None|None|NPAT|None|False|False|False|False|protein_coding_CDS_not_defined|3946&ENST00000638443|c.1A>G|p.Met1?|start_lost_%26_NMD_transcript_variant|high|2|None|ATM|None|False|False|False|False|nonsense_mediated_decay|336&ENST00000639240|c.1A>G|p.Met1?|start_lost|high|3|None|ATM|None|True|False|False|False|protein_coding|336&ENST00000639953|c.1A>G|p.Met1?|start_lost|high|4|None|ATM|None|True|False|False|False|protein_coding|336&ENST00000640388|c.1A>G|p.Met1?|start_lost|high|4|None|ATM|None|True|False|False|False|protein_coding|336&ENST00000675595|c.1A>G|p.Met1?|start_lost_%26_NMD_transcript_variant|high|2|None|ATM|None|False|False|False|False|nonsense_mediated_decay|4608&ENST00000675843|c.1A>G|p.Met1?|start_lost|high|2|None|ATM|None|True|True|False|True|protein_coding|9109&ENST00000682147|n.135A>G|None|non_coding_transcript_exon_variant|modifier|2|None|ATM|None|False|False|False|False|protein_coding_CDS_not_defined|1339&ENST00000682430|n.100A>G|None|non_coding_transcript_exon_variant|modifier|2|None|ATM|None|False|False|False|False|protein_coding_CDS_not_defined|986&ENST00000682465|c.1A>G|p.Met1?|start_lost|high|2|None|ATM|None|True|False|False|False|protein_coding|336&ENST00000682516|n.135A>G|None|non_coding_transcript_exon_variant|modifier|2|None|ATM|None|False|False|False|False|protein_coding_CDS_not_defined|2992&ENST00000682956|n.135A>G|None|non_coding_transcript_exon_variant|modifier|2|None|ATM|None|False|False|False|False|retained_intron|2343&ENST00000683150|c.1A>G|p.Met1?|start_lost|high|3|None|ATM|None|True|False|False|False|protein_coding|336&ENST00000683174|n.151A>G|None|non_coding_transcript_exon_variant|modifier|2|None|ATM|None|False|False|False|False|retained_intron|13067&ENST00000683468|c.1A>G|p.Met1?|start_lost|high|1|None|ATM|None|True|False|False|False|protein_coding|336&ENST00000683488|n.4582A>G|None|non_coding_transcript_exon_variant|modifier|1|None|ATM|None|False|False|False|False|retained_intron|5018&ENST00000683914|c.1A>G|p.Met1?|start_lost|high|2|None|ATM|None|True|False|False|False|protein_coding|336&ENST00000684029|c.1A>G|p.Met1?|start_lost|high|2|None|ATM|None|True|False|False|False|protein_coding|503&ENST00000684037|c.1A>G|p.Met1?|start_lost_%26_NMD_transcript_variant|high|2|None|ATM|None|False|False|False|False|nonsense_mediated_decay|1067&ENST00000684061|n.135A>G|None|non_coding_transcript_exon_variant|modifier|2|None|ATM|None|False|False|False|False|retained_intron|2515&ENST00000684179|n.135A>G|None|non_coding_transcript_exon_variant|modifier|2|None|ATM|None|False|False|False|False|retained_intron|2234&NM_000051|c.1A>G|p.Met1?|start_lost|high|2|None|ATM|None|True|True|False|True|mRNA|9109&NM_001321307|None|None|upstream_gene_variant|modifier|None|None|NPAT|None|False|False|False|False|mRNA|4287&NM_001351834|c.1A>G|p.Met1?|start_lost|high|3|None|ATM|None|True|True|False|True|mRNA|9109&NM_001351835|c.1A>G|p.Met1?|start_lost|high|2|None|ATM|None|True|False|False|False|mRNA|336&NM_001351836|c.1A>G|p.Met1?|start_lost|high|2|None|ATM|None|True|False|False|False|mRNA|336&NM_002519|None|None|upstream_gene_variant|modifier|None|None|NPAT|None|True|True|False|True|mRNA|4266&XM_005271562|c.1A>G|p.Met1?|start_lost|high|2|None|ATM|None|False|False|False|False|mRNA|9109&XM_006718843|c.1A>G|p.Met1?|start_lost|high|2|None|ATM|None|False|False|False|False|mRNA|9109&XM_011542840|c.1A>G|p.Met1?|start_lost|high|3|None|ATM|None|False|False|False|False|mRNA|9109&XM_011542842|c.1A>G|p.Met1?|start_lost|high|2|None|ATM|None|False|False|False|False|mRNA|8945&XM_011542843|c.1A>G|p.Met1?|start_lost|high|2|None|ATM|None|False|False|False|False|mRNA|8680&XM_011542844|c.-1022A>G|None|5_prime_UTR_variant|modifier|2|None|ATM|None|False|False|False|False|mRNA|8071&XM_011542854|None|None|upstream_gene_variant|modifier|None|None|NPAT|None|False|False|False|False|mRNA|4293&XM_017017789|c.1A>G|p.Met1?|start_lost|high|3|None|ATM|None|False|False|False|False|None|None&XM_017017790|c.1A>G|p.Met1?|start_lost|high|2|None|ATM|None|False|False|False|False|mRNA|9109&XM_017017791|c.1A>G|p.Met1?|start_lost|high|2|None|ATM|None|False|False|False|False|None|None&XM_017017792|c.1A>G|p.Met1?|start_lost|high|2|None|ATM|None|False|False|False|False|None|None&XR_002957150|n.734A>G|None|non_coding_transcript_exon_variant|modifier|2|None|ATM|None|False|False|False|False|None|None;literature=9463314&12552559&21665257&22649200&8845835&21792198&22146522&27397505&30886146&32015491&34638981&30279689&35200138&27304073&34262154&35886994&36016404&25060887&30832413&35596192&28676128&31745186&30355619&23056035&31730469&24278694&36804602&31623857&30797618&31134131&31387573&27079349&33302456&35454905&35171259&34825286&32745158&34247626&22751958&29449433&37076313&22110173&28304350&29945567&37732318&37664480&35078243&32793315&36901733&21709286&27184744&26901225&34007531&26351212&35464432&19581426&30634484&36269050&29719807
chr11	108365356	3701	G	GA	.	.	spliceai_details=ATM%7C0.00%7C0.02%7C0.00%7C0.00%7C-16%7C-31%7C36%7C48,C11orf65%7C0.00%7C0.00%7C0.00%7C0.00%7C-37%7C29%7C22%7C-21;spliceai_max_delta=0.02,0.0;maxentscan_swa=ENST00000452508$-2.50%7C-6.43%7C-2.50%7C-4.62%7C-4.62%7C-4.62|ENST00000525729$-0.10%7C-0.10%7C-0.10%7C-3.95%7C-2.49%7C-3.95|ENST00000615746$-0.10%7C-0.10%7C-0.10%7C-3.95%7C-2.49%7C-3.95|ENST00000675843$-2.50%7C-6.43%7C-2.50%7C-4.62%7C-4.62%7C-4.62;task_force_protein_domain=FATKIN;task_force_protein_domain_source=BWRL;hexplorer=-0.50;hexplorer_mut=3.94;hexplorer_wt=4.44;hexplorer_rev=-0.02;hexplorer_rev_mut=4.35;hexplorer_rev_wt=4.37;max_hbond=0.00;max_hbond_mut=7.60;max_hbond_wt=7.60;max_hbond_rev=0.00;max_hbond_rev_mut=3.90;max_hbond_rev_wt=3.90;heredicare_vid=10060149;clinvar=233164;rsid=876660235;variation_id=233164;clinvar_summary=criteria_provided,_multiple_submitters,_no_conflicts:Pathogenic/Likely_pathogenic;clinvar_submissions=Pathogenic|2022-05-05|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_The_c.9021dupA_pathogenic_mutation,_located_in_coding_exon_62_of_the_ATM_gene,_results_from_a_duplication_of_A_at_nucleotide_position_9021,_causing_a_translational_frameshift_with_a_predicted_alternate_stop_codon_(p.R3008Tfs*55)._Functional_analysis_of_a_lymphoblastoid_cell_line_derived_from_a_compound_heterozygous_patient_with_ataxia_telangiectasia_(AT)_suggests_this_alteration_results_in_deficient_ATM_protein_and_a_double-strand_break_repair_pattern_resembling_MRN-complex_dysfunction._Authors_note_that_the_individual_from_whom_this_cell_line_was_derived_was_older_than_60_years_with_an_attenuated_or_variant_form_of_AT_with_moderate_radiosensitivity,_chromosomal_instability,_and_cancer_proneness_(Keimling_M_et_al._FASEB_J._2011_Nov%3B_25(11):3849-60)._An_individual_with_classic_ataxia-telangiectasia_was_found_to_be_homozygous_for_this_mutation_(designated_9021_9022insA,_p.Arg3008ThrfsTer54)_with_the_diagnosis_confirmed_by_absence_of_ATM_protein_by_immunoblotting_in_lymphoblastoid_cell_lines_and_radiosensitivity_demonstrated_on_a_colony_survival_assay_(Podralska_MJ_et_al._Mol_Genet_Genomic_Med,_2014_Nov%3B2:504-11%3B_Mitui_M_et_al._Ann._Hum._Genet._2005_Nov%3B69:657-64)._In_addition_to_the_clinical_data_presented_in_the_literature,_this_frameshift_occurs_near_the_3'_terminus_of_ATM_and_results_in_the_elongation_of_the_protein_by_6_amino_acids._This_mutation_alters_the_sequence_of_the_FATC_domain_of_the_ATM_protein_which_has_been_shown_to_be_necessary_for_ATM_regulation_(Jiang_XJ_et_al._Biol._Chem._2006_Jun%3B281(23):15741-6)._As_such,_this_alteration_is_interpreted_as_a_disease-causing_mutation.&Pathogenic|2020-12-09|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Color_Diagnostics,_LLC_DBA_Color_Health|description:_This_variant_inserts_1_nucleotide_in_exon_63_of_the_ATM_gene,_creating_a_frameshift_in_the_last_exon._This_variant_is_also_known_as_c.9021_9022insA_in_the_literature._This_variant_alters_the_C-terminus_of_the_TP53_binding_domain_and_FATC_domain_sequence_and_is_expected_to_disrupt_ATP_protein_function._This_variant_has_been_reported_in_two_biallelic_individuals_affected_with_2_ataxia-telangiectasia_(PMID:_21778326,_25614872)._This_variant_has_not_been_identified_in_the_general_population_by_the_Genome_Aggregation_Database_(gnomAD)._Loss_of_ATM_function_is_a_known_mechanism_of_disease_(clinicalgenome.org)._Based_on_the_available_evidence,_this_variant_is_classified_as_Pathogenic.&Pathogenic|2017-04-21|criteria_provided,_single_submitter|C3661900:not_provided|GeneDx|description:_This_duplication_of_one_nucleotide_in_ATM_is_denoted_c.9021dupA_at_the_cDNA_level_and_p.Arg3008ThrfsX55_(R3008TfsX55)_at_the_protein_level._The_normal_sequence,_with_the_base_that_is_duplicated_in_brackets,_is_CTGA[dupA]CGTG._The_duplication_causes_a_frameshift,_which_changes_an_Arginine_to_a_Threonine_at_codon_3008,_and_creates_a_premature_stop_codon_at_position_55_of_the_new_reading_frame._Even_though_this_frameshift_occurs_in_the_last_exon_of_the_gene,_and_nonsense-mediated_decay_is_not_expected_to_occur,_it_is_significant_since_the_last_49_amino_acids_are_replaced_with_54_incorrect_amino_acids_and_impacts_the_FATC_domain_(Stracker_2013)._ATM_Arg3008ThrfsX55_has_been_observed_in_the_homozygous_state_in_a_patient_with_classic_Ataxia_Telangiectasia,_whose_lymphoblastoid_cell_line_exhibited_radiosensitivity_and_absence_of_ATM_protein_production_(Mitui_2005,_Podralska_2014)._We_consider_this_variant_to_be_pathogenic.&Likely_pathogenic|2021-10-25|criteria_provided,_single_submitter|C0346153:Familial_cancer_of_breast|Molecular_Diagnostics_Laboratory,_M_Health_Fairview:_University_of_Minnesota|None&Pathogenic|2021-09-26|criteria_provided,_single_submitter|C0004135:Ataxia-telangiectasia_syndrome|Invitae|description:_This_sequence_change_results_in_a_frameshift_in_the_ATM_gene_(p.Arg3008Thrfs*55)._While_this_is_not_anticipated_to_result_in_nonsense_mediated_decay,_it_is_expected_to_disrupt_the_last_49_amino_acid(s)_of_the_ATM_protein_and_extend_the_protein_by_5_additional_amino_acid_residues._This_variant_is_not_present_in_population_databases_(ExAC_no_frequency)._This_frameshift_has_been_observed_in_individual(s)_with_ataxia-telangiectasia_(PMID:_21778326)._Algorithms_developed_to_predict_the_effect_of_variants_on_protein_structure_and_function_are_not_available_or_were_not_evaluated_for_this_variant._Experimental_studies_have_shown_that_this_frameshift_affects_ATM_function_(PMID:_21778326)._This_variant_disrupts_the_p.Arg3008_amino_acid_residue_in_ATM._Other_variant(s)_that_disrupt_this_residue_have_been_determined_to_be_pathogenic_(PMID:_12552566,_15101044,_18573109,_22649200)._This_suggests_that_this_residue_is_clinically_significant,_and_that_variants_that_disrupt_this_residue_are_likely_to_be_disease-causing._For_these_reasons,_this_variant_has_been_classified_as_Pathogenic.;heredicare_annotation=10060149|4|4|15|Keimling_et_al.,_2011%3B_Mitui_et_al._2005_betrifft_noch_die_PI3K-Domäne._Kommt_homozygot_in_AT-Patient_vor.|2018-11-30;consequences=ENST00000278616|c.9021dup|p.Arg3008ThrfsTer55|frameshift_variant_%26_NMD_transcript_variant|high|63|None|ATM|None|False|False|False|False|nonsense_mediated_decay|9109&ENST00000452508|c.9021dup|p.Arg3008ThrfsTer55|frameshift_variant|high|64|None|ATM|None|True|False|False|False|protein_coding|9109&ENST00000524755|c.226%2B27851dup|None|intron_variant|modifier|None|2|C11orf65|None|False|False|False|False|protein_coding|313&ENST00000524792|n.5236dup|None|non_coding_transcript_exon_variant|modifier|37|None|ATM|None|False|False|False|False|retained_intron|5875&ENST00000525178|n.509dup|None|non_coding_transcript_exon_variant|modifier|6|None|ATM|None|False|False|False|False|protein_coding_CDS_not_defined|874&ENST00000525729|c.640%2B20563dup|None|intron_variant|modifier|None|6|C11orf65|None|True|False|False|False|protein_coding|735&ENST00000526725|n.272-24993dup|None|intron_variant_%26_non_coding_transcript_variant|modifier|None|2|C11orf65|None|False|False|False|False|protein_coding_CDS_not_defined|474&ENST00000527181|n.360dup|None|non_coding_transcript_exon_variant|modifier|4|None|ATM|None|False|False|False|False|retained_intron|736&ENST00000527531|c.*2-9248dup|None|intron_variant_%26_NMD_transcript_variant|modifier|None|9|C11orf65|None|False|False|False|False|nonsense_mediated_decay|934&ENST00000527805|c.*4085dup|None|3_prime_UTR_variant_%26_NMD_transcript_variant|modifier|61|None|ATM|None|False|False|False|False|nonsense_mediated_decay|4608&ENST00000615746|c.*2-9248dup|None|intron_variant|modifier|None|10|C11orf65|None|True|False|False|False|protein_coding|934&ENST00000638786|n.1719dup|None|non_coding_transcript_exon_variant|modifier|14|None|ATM|None|False|False|False|False|protein_coding_CDS_not_defined|4330&ENST00000675595|c.*4156dup|None|3_prime_UTR_variant_%26_NMD_transcript_variant|modifier|62|None|ATM|None|False|False|False|False|nonsense_mediated_decay|4608&ENST00000675843|c.9021dup|p.Arg3008ThrfsTer55|frameshift_variant|high|63|None|ATM|None|True|True|False|True|protein_coding|9109&ENST00000682286|n.3778dup|None|non_coding_transcript_exon_variant|modifier|27|None|ATM|None|False|False|False|False|protein_coding_CDS_not_defined|6376&ENST00000682302|n.3439dup|None|non_coding_transcript_exon_variant|modifier|26|None|ATM|None|False|False|False|False|retained_intron|6038&ENST00000682569|n.2368dup|None|non_coding_transcript_exon_variant|modifier|2|None|ATM|None|False|False|False|False|retained_intron|3011&ENST00000683174|n.10505dup|None|non_coding_transcript_exon_variant|modifier|63|None|ATM|None|False|False|False|False|retained_intron|13067&ENST00000683524|n.4245dup|None|non_coding_transcript_exon_variant|modifier|32|None|ATM|None|False|False|False|False|protein_coding_CDS_not_defined|6838&ENST00000684152|n.4437dup|None|non_coding_transcript_exon_variant|modifier|29|None|ATM|None|False|False|False|False|retained_intron|7033&ENST00000684180|n.1495dup|None|non_coding_transcript_exon_variant|modifier|11|None|ATM|None|False|False|False|False|retained_intron|4109&ENST00000684447|n.5514dup|None|non_coding_transcript_exon_variant|modifier|13|None|ATM|None|False|False|False|False|retained_intron|8126&NM_000051|c.9021dup|p.Arg3008ThrfsTer55|frameshift_variant|high|63|None|ATM|None|True|True|False|True|mRNA|9109&NM_001330368|c.640%2B20563dup|None|intron_variant|modifier|None|6|C11orf65|None|True|False|False|False|mRNA|735&NM_001351110|c.694%2B20563dup|None|intron_variant|modifier|None|7|C11orf65|None|False|False|False|False|mRNA|722&NM_001351834|c.9021dup|p.Arg3008ThrfsTer55|frameshift_variant|high|64|None|ATM|None|True|True|False|True|mRNA|9109&NR_147053|n.1105-9248dup|None|intron_variant_%26_non_coding_transcript_variant|modifier|None|10|C11orf65|None|False|False|False|False|misc_RNA|2728&XM_005271414|c.787%2B20563dup|None|intron_variant|modifier|None|8|C11orf65|None|False|False|False|False|None|None&XM_005271415|c.731%2B27851dup|None|intron_variant|modifier|None|7|C11orf65|None|False|False|False|False|None|None&XM_005271562|c.9021dup|p.Arg3008ThrfsTer55|frameshift_variant|high|63|None|ATM|None|False|False|False|False|mRNA|9109&XM_006718843|c.9021dup|p.Arg3008ThrfsTer55|frameshift_variant|high|63|None|ATM|None|False|False|False|False|mRNA|9109&XM_006718845|c.4977dup|p.Arg1660ThrfsTer55|frameshift_variant|high|38|None|ATM|None|False|False|False|False|mRNA|5090&XM_011542640|c.787%2B20563dup|None|intron_variant|modifier|None|8|C11orf65|None|False|False|False|False|None|None&XM_011542642|c.732-16284dup|None|intron_variant|modifier|None|7|C11orf65|None|False|False|False|False|None|None&XM_011542643|c.732-24993dup|None|intron_variant|modifier|None|7|C11orf65|None|False|False|False|False|mRNA|737&XM_011542840|c.9021dup|p.Arg3008ThrfsTer55|frameshift_variant|high|64|None|ATM|None|False|False|False|False|mRNA|9109&XM_011542842|c.8856dup|p.Arg2953ThrfsTer55|frameshift_variant|high|62|None|ATM|None|False|False|False|False|mRNA|8945&XM_011542844|c.7977dup|p.Arg2660ThrfsTer55|frameshift_variant|high|63|None|ATM|None|False|False|False|False|mRNA|8071&XM_011542845|c.7713dup|p.Arg2572ThrfsTer55|frameshift_variant|high|55|None|ATM|None|False|False|False|False|None|None&XM_017017247|c.903%2B17703dup|None|intron_variant|modifier|None|9|C11orf65|None|False|False|False|False|None|None&XM_017017789|c.9021dup|p.Arg3008ThrfsTer55|frameshift_variant|high|64|None|ATM|None|False|False|False|False|None|None&XM_017017790|c.9021dup|p.Arg3008ThrfsTer55|frameshift_variant|high|63|None|ATM|None|False|False|False|False|mRNA|9109;literature=25614872&12552566&15101044&22649200&16266405&18573109&21778326&27304073&28569743
chr13	32316520	3780	CA	C	.	.	phylop_100way=-1.097;spliceai_details=BRCA2%7C0.00%7C0.00%7C0.00%7C0.00%7C7%7C-11%7C7%7C3;spliceai_max_delta=0.0;maxentscan_swa=ENST00000380152$-0.91%7C-0.42%7C-0.91%7C-1.48%7C-1.45%7C-1.48|ENST00000530893$-0.91%7C-0.42%7C-0.91%7C-1.48%7C-1.45%7C-1.48|ENST00000544455$-0.91%7C-0.42%7C-0.91%7C-1.48%7C-1.45%7C-1.48|ENST00000700202$-0.91%7C-0.42%7C-0.91%7C-1.48%7C-1.45%7C-1.48;brca_exchange_clinical_significance=Pathogenic;task_force_protein_domain=C-terminal_RAD51_binding_domain_(inkl._NLS1_und_BRC-)_;task_force_protein_domain_source=BWRL/ENIGMA;hexplorer=0.77;hexplorer_mut=10.02;hexplorer_wt=9.26;hexplorer_rev=-0.35;hexplorer_rev_mut=-4.13;hexplorer_rev_wt=-3.79;max_hbond_rev=0.00;max_hbond_rev_mut=1.80;max_hbond_rev_wt=1.80;heredicare_vid=1638210&8783187;clinvar=52081;rsid=80359582;variation_id=52081;clinvar_summary=reviewed_by_expert_panel:Pathogenic;clinvar_submissions=Pathogenic|2016-09-08|reviewed_by_expert_panel|C2675520:Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|description:_Variant_allele_predicted_to_encode_a_truncated_non-functional_protein.&Pathogenic|2015-10-02|criteria_provided,_single_submitter|C2675520:Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Consortium_of_Investigators_of_Modifiers_of_BRCA1/2_(CIMBA),_c/o_University_of_Cambridge|None&Pathogenic|2004-02-20|no_assertion_criteria_provided|C2675520:Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Breast_Cancer_Information_Core_(BIC)_(BRCA2)|None;heredicare_annotation=1638210|1|1|1||2010-04-30&8783187|1|1|||;consequences=ENST00000345108|None|None|upstream_gene_variant|modifier|None|None|ZAR1L|None|True|False|False|False|protein_coding|962&ENST00000380152|c.63del|p.Ala22GlnfsTer3|frameshift_variant|high|2|None|BRCA2|None|True|True|False|True|protein_coding|10231&ENST00000530893|c.-303del|None|splice_region_variant_%26_5_prime_UTR_variant|low|2|None|BRCA2|None|True|False|False|False|protein_coding|9864&ENST00000533490|None|None|upstream_gene_variant|modifier|None|None|ZAR1L|None|True|True|False|True|protein_coding|962&ENST00000544455|c.63del|p.Ala22GlnfsTer3|frameshift_variant|high|2|None|BRCA2|None|True|False|False|False|protein_coding|10231&ENST00000614259|c.63del|p.Ala22GlnfsTer3|frameshift_variant_%26_NMD_transcript_variant|high|1|None|BRCA2|None|False|False|False|False|nonsense_mediated_decay|7934&ENST00000680887|c.63del|p.Ala22GlnfsTer3|frameshift_variant|high|2|None|BRCA2|None|False|False|False|False|protein_coding|10231&ENST00000700199|n.187del|None|non_coding_transcript_exon_variant|modifier|2|None|BRCA2|None|False|False|False|False|retained_intron|551&ENST00000700200|n.187del|None|non_coding_transcript_exon_variant|modifier|2|None|BRCA2|None|False|False|False|False|retained_intron|854&ENST00000700201|c.63del|p.Ala22GlnfsTer3|frameshift_variant_%26_NMD_transcript_variant|high|2|None|BRCA2|None|False|False|False|False|nonsense_mediated_decay|387&ENSR00000060894|None|None|regulatory_region_variant|modifier|None|None|None|None|False|False|False|False|None|None&NM_000059|c.63del|p.Ala22GlnfsTer3|frameshift_variant|high|2|None|BRCA2|None|True|True|False|True|mRNA|10231&NM_001136571|None|None|upstream_gene_variant|modifier|None|None|ZAR1L|None|True|True|False|True|mRNA|962;literature=10923033&21533266&25925381&28569743
chr13	32332777	18612	CAAAA	C	.	.	phylop_100way=1.465;spliceai_details=BRCA2%7C0.00%7C0.00%7C0.00%7C0.00%7C-10%7C-25%7C-44%7C43;spliceai_max_delta=0.0;maxentscan_swa=ENST00000380152$-1.27%7C-0.50%7C-1.27%7C-16.20%7C-15.55%7C-16.20|ENST00000530893$-1.27%7C-0.50%7C-1.27%7C-16.20%7C-15.55%7C-16.20|ENST00000544455$-1.27%7C-0.50%7C-1.27%7C-16.20%7C-15.55%7C-16.20|ENST00000700202$-1.27%7C-0.50%7C-1.27%7C-16.20%7C-15.55%7C-16.20;brca_exchange_clinical_significance=Pathogenic;arup_classification=5;task_force_protein_domain=C-terminal_RAD51_binding_domain_(inkl._NLS1_und_BRC-)_;task_force_protein_domain_source=BWRL/ENIGMA;hexplorer=-1.14;hexplorer_mut=10.76;hexplorer_wt=11.90;hexplorer_rev=2.09;hexplorer_rev_mut=-18.37;hexplorer_rev_wt=-20.46;max_hbond_rev=0.00;max_hbond_rev_mut=1.80;max_hbond_rev_wt=1.80;heredicare_vid=155;rsid=397507577;clinvar=51097;variation_id=51097;clinvar_summary=reviewed_by_expert_panel:Pathogenic;clinvar_submissions=Pathogenic|2015-10-02|criteria_provided,_single_submitter|C2675520:Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Consortium_of_Investigators_of_Modifiers_of_BRCA1/2_(CIMBA),_c/o_University_of_Cambridge|None&Pathogenic|2016-10-18|reviewed_by_expert_panel|C2675520:Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|description:_Variant_allele_predicted_to_encode_a_truncated_non-functional_protein.;heredicare_annotation=155|1|1|1||2010-04-30;consequences=ENST00000380152|c.1300_1303del|p.Lys434GlufsTer25|frameshift_variant|high|10|None|BRCA2|None|True|True|False|True|protein_coding|10231&ENST00000530893|c.931_934del|p.Lys311GlufsTer25|frameshift_variant|high|10|None|BRCA2|None|True|False|False|False|protein_coding|9864&ENST00000544455|c.1300_1303del|p.Lys434GlufsTer25|frameshift_variant|high|10|None|BRCA2|None|True|False|False|False|protein_coding|10231&ENST00000614259|c.1300_1303del|p.Lys434GlufsTer25|frameshift_variant_%26_NMD_transcript_variant|high|9|None|BRCA2|None|False|False|False|False|nonsense_mediated_decay|7934&ENST00000680887|c.1300_1303del|p.Lys434GlufsTer25|frameshift_variant|high|10|None|BRCA2|None|False|False|False|False|protein_coding|10231&ENST00000700201|c.*1079_*1082del|None|3_prime_UTR_variant_%26_NMD_transcript_variant|modifier|11|None|BRCA2|None|False|False|False|False|nonsense_mediated_decay|387&NM_000059|c.1300_1303del|p.Lys434GlufsTer25|frameshift_variant|high|10|None|BRCA2|None|True|True|False|True|mRNA|10231;literature=11793480&32959997&30702160&32547938
chr13	32332803	13588	C	A	.	.	phylop_100way=0.511;cadd_scaled=34;spliceai_details=BRCA2%7C0.00%7C0.00%7C0.00%7C0.00%7C28%7C3%7C28%7C17;spliceai_max_delta=0.0;maxentscan_swa=ENST00000380152$-7.28%7C-2.37%7C-9.95%7C3.78%7C-0.26%7C3.78|ENST00000530893$-7.28%7C-2.37%7C-9.95%7C3.78%7C-0.26%7C3.78|ENST00000544455$-7.28%7C-2.37%7C-9.95%7C3.78%7C-0.26%7C3.78|ENST00000700202$-7.28%7C-2.37%7C-9.95%7C3.78%7C-0.26%7C3.78;brca_exchange_clinical_significance=Pathogenic;arup_classification=5;task_force_protein_domain=C-terminal_RAD51_binding_domain_(inkl._NLS1_und_BRC-)_;task_force_protein_domain_source=BWRL/ENIGMA;hexplorer=-6.70;hexplorer_mut=-5.00;hexplorer_wt=1.70;hexplorer_rev=-8.67;hexplorer_rev_mut=-10.51;hexplorer_rev_wt=-1.84;max_hbond_rev=0.00;max_hbond_rev_mut=12.60;max_hbond_rev_wt=12.60;hci_prior=0.99;bayesdel=0.448766;heredicare_vid=1392015;clinvar=55790;rsid=80358421;variation_id=55790;clinvar_summary=reviewed_by_expert_panel:Pathogenic;clinvar_submissions=Pathogenic|2021-08-07|criteria_provided,_single_submitter|C0677776:Hereditary_breast_ovarian_cancer_syndrome|Invitae|description:_This_sequence_change_creates_a_premature_translational_stop_signal_(p.Ser442*)_in_the_BRCA2_gene._It_is_expected_to_result_in_an_absent_or_disrupted_protein_product._Loss-of-function_variants_in_BRCA2_are_known_to_be_pathogenic_(PMID:_20104584)._This_variant_is_not_present_in_population_databases_(ExAC_no_frequency)._This_premature_translational_stop_signal_has_been_observed_in_individual(s)_with_a_personal_and/or_family_history_of_breast_and_ovarian_cancer_(PMID:_21318380,_29446198)._ClinVar_contains_an_entry_for_this_variant_(Variation_ID:_55790)._For_these_reasons,_this_variant_has_been_classified_as_Pathogenic.&Pathogenic|2016-10-18|reviewed_by_expert_panel|C2675520:Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|description:_Variant_allele_predicted_to_encode_a_truncated_non-functional_protein.&Pathogenic|2015-10-02|criteria_provided,_single_submitter|C2675520:Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Consortium_of_Investigators_of_Modifiers_of_BRCA1/2_(CIMBA),_c/o_University_of_Cambridge|None;heredicare_annotation=1392015|1|4|1||2010-04-30;consequences=ENST00000380152|c.1325C>A|p.Ser442Ter|stop_gained|high|10|None|BRCA2|None|True|True|False|True|protein_coding|10231&ENST00000530893|c.956C>A|p.Ser319Ter|stop_gained|high|10|None|BRCA2|None|True|False|False|False|protein_coding|9864&ENST00000544455|c.1325C>A|p.Ser442Ter|stop_gained|high|10|None|BRCA2|None|True|False|False|False|protein_coding|10231&ENST00000614259|c.1325C>A|p.Ser442Ter|stop_gained_%26_NMD_transcript_variant|high|9|None|BRCA2|None|False|False|False|False|nonsense_mediated_decay|7934&ENST00000680887|c.1325C>A|p.Ser442Ter|stop_gained|high|10|None|BRCA2|None|False|False|False|False|protein_coding|10231&ENST00000700201|c.*1104C>A|None|3_prime_UTR_variant_%26_NMD_transcript_variant|modifier|11|None|BRCA2|None|False|False|False|False|nonsense_mediated_decay|387&NM_000059|c.1325C>A|p.Ser442Ter|stop_gained|high|10|None|BRCA2|None|True|True|False|True|mRNA|10231;literature=20104584&10923033&21318380&21520333&28324225&29884841&21533266&31911673&32377563&31131967
chr13	32332944	11138	C	G	.	.	phylop_100way=0.525;cadd_scaled=14.77;revel=ENST00000380152$0.136|ENST00000530893$0.136|ENST00000544455$0.136;spliceai_details=BRCA2%7C0.00%7C0.00%7C0.00%7C0.00%7C-15%7C32%7C-8%7C32;spliceai_max_delta=0.0;maxentscan_swa=ENST00000380152$-3.45%7C-2.61%7C-10.85%7C3.28%7C2.43%7C3.28|ENST00000530893$-3.45%7C-2.61%7C-10.85%7C3.28%7C2.43%7C3.28|ENST00000544455$-3.45%7C-2.61%7C-10.85%7C3.28%7C2.43%7C3.28|ENST00000700202$-3.45%7C-2.61%7C-10.85%7C3.28%7C2.43%7C3.28;gnomad_ac=1;gnomad_af=6.57047e-06;gnomad_hom=0;gnomad_het=1;gnomad_popmax=NFE;gnomad_popmax_AF=1.46964e-05;gnomad_popmax_AC=1;brca_exchange_clinical_significance=Not_Yet_Reviewed;arup_classification=2;task_force_protein_domain=C-terminal_RAD51_binding_domain_(inkl._NLS1_und_BRC-)_;task_force_protein_domain_source=BWRL/ENIGMA;hexplorer=-1.42;hexplorer_mut=2.50;hexplorer_wt=3.92;hexplorer_rev=-5.26;hexplorer_rev_mut=-1.35;hexplorer_rev_wt=3.92;max_hbond=4.90;max_hbond_mut=4.90;max_hbond_rev=0.00;max_hbond_rev_mut=2.20;max_hbond_rev_wt=2.20;hci_prior=0.02;bayesdel=-0.349194;clinvar=142547;heredicare_vid=5674795;rsid=587782535;cosmic=COSV66457112;variation_id=142547;clinvar_summary=criteria_provided,_conflicting_interpretations:Conflicting_interpretations_of_pathogenicity%7CUncertain_significance(7)%7CLikely_benign(4);clinvar_submissions=Uncertain_significance|2019-03-18|criteria_provided,_single_submitter|CN221562:Breast_and/or_ovarian_cancer|CHEO_Genetics_Diagnostic_Laboratory,_Children's_Hospital_of_Eastern_Ontario|None&Likely_benign|2019-11-20|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_This_alteration_is_classified_as_likely_benign_based_on_a_combination_of_the_following:_population_frequency,_intact_protein_function,_lack_of_segregation_with_disease,_co-occurrence,_RNA_analysis,_in_silico_models,_amino_acid_conservation,_lack_of_disease_association_in_case-control_studies,_and/or_the_mechanism_of_disease_or_impacted_region_is_inconsistent_with_a_known_cause_of_pathogenicity.&Uncertain_significance|2016-04-01|criteria_provided,_single_submitter|C3661900:not_provided|Women's_Health_and_Genetics/Laboratory_Corporation_of_America,_LabCorp|description:_Variant_Summary:_The_c.1466C>G_variant_in_BRCA2_gene_involves_the_alteration_of_a_non-conserved_nucleotide_and_4/5_in_silico_tools_predict_a_deleterious_outcome._The_variant_was_observed_in_the_large_and_broad_cohorts_of_the_ExAC_project_at_an_allele_frequency_of_0.007%,_exclusively_in_individuals_of_European_descent_(0.01%),_which_does_not_exceed_the_maximal_expected_allele_frequency_for_a_pathogenic_variant_in_BRCA2_(0.075%)._The_variant_has_been_reported_in_affected_individuals_in_the_literature,_without_strong_evidence_for_causality._Multiple_reputable_clinical_labs_have_classified_the_variant_as_a_VUS._The_variant_was_found_to_co-occur_with_a_known_pathogenic_variant,_c.5341delG_(p.Glu1781fsX12)_in_BRCA1_gene._Taking_all_evidence_together,_this_variant_has_been_classified_as_a_VUS_until_additional_evidence_becomes_available.&Likely_benign|2021-06-10|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Color_Diagnostics,_LLC_DBA_Color_Health|None&Likely_benign|2023-03-23|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|University_of_Washington_Department_of_Laboratory_Medicine,_University_of_Washington|description:_Missense_variant_in_a_coldspot_region_where_missense_variants_are_very_unlikely_to_be_pathogenic_(PMID:31911673).&Likely_benign|2022-10-27|criteria_provided,_single_submitter|C0677776:Hereditary_breast_ovarian_cancer_syndrome|Invitae|None&Uncertain_significance|2021-04-23|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Sema4,_Sema4|None&Uncertain_significance|2021-08-26|criteria_provided,_single_submitter|C3661900:not_provided|Quest_Diagnostics_Nichols_Institute_San_Juan_Capistrano|None&Uncertain_significance|2018-07-31|criteria_provided,_single_submitter|C3661900:not_provided|GeneDx|description:_This_variant_is_denoted_BRCA2_c.1466C>G_at_the_cDNA_level,_p.Ser489Cys_(S489C)_at_the_protein_level,_and_results_in_the_change_of_a_Serine_to_a_Cysteine_(TCT>TGT)._Using_alternate_nomenclature,_this_variant_would_be_defined_as_BRCA2_1694C>G._This_variant_has_been_identified_in_at_least_five_woman_with_breast_or_ovarian_cancer_(Soegaard_2008,_Borg_2010,_Carney_2010)._BRCA2_Ser489Cys_was_observed_at_an_allele_frequency_of_0.01%_(14/109,108)_in_individuals_of_European_ancestry_in_large_population_cohorts_(Lek_2016)._This_variant_is_not_located_in_a_known_functional_domain._In_silico_analysis,_which_includes_protein_predictors_and_evolutionary_conservation,_supports_that_this_variant_does_not_alter_protein_structure/function._Based_on_currently_available_evidence,_it_is_unclear_whether_BRCA2_Ser489Cys_is_a_pathogenic_or_benign_variant._We_consider_it_to_be_a_variant_of_uncertain_significance.&not_provided|None|no_assertion_provided|C0677776:Hereditary_breast_ovarian_cancer_syndrome$C1838457:Fanconi_anemia_complementation_group_D1|GenomeConnect_-_Invitae_Patient_Insights_Network|description:_Variant_interpreted_as_Uncertain_significance_and_reported_on_06-26-2019_by_Invitae._GenomeConnect-Invitae_Patient_Insights_Network_assertions_are_reported_exactly_as_they_appear_on_the_patient-provided_report_from_the_testing_laboratory._Registry_team_members_make_no_attempt_to_reinterpret_the_clinical_significance_of_the_variant._Phenotypic_details_are_available_under_supporting_information.&Uncertain_significance|2023-08-15|criteria_provided,_single_submitter|CN169374:not_specified|Center_for_Genomic_Medicine,_Rigshospitalet,_Copenhagen_University_Hospital|None&Uncertain_significance|2019-08-22|criteria_provided,_single_submitter|C3661900:not_provided|ARUP_Laboratories,_Molecular_Genetics_and_Genomics,_ARUP_Laboratories|description:_The_BRCA2_c.1466C>G%3B_p.Ser489Cys_variant_(rs587782535)_is_reported_in_the_literature_in_individuals_affected_with_breast_or_ovarian_cancer_(Borg_2010,_Carney_2010,_Sinilnikova_2006,_Soegaard_2008),_but_also_in_healthy_controls_(Capanu_2011)._This_variant_is_reported_in_ClinVar_(Variation_ID:_142547),_and_is_found_in_the_Finnish_European_population_with_an_allele_frequency_of_0.014%_(15/111120_alleles)_in_the_Genome_Aggregation_Database._The_serine_at_codon_489_is_weakly_conserved,_and_computational_analyses_(SIFT,_PolyPhen-2)_predict_that_this_variant_is_tolerated._Due_to_limited_information,_the_clinical_significance_of_the_p.Ser489Cys_variant_is_uncertain_at_this_time._References:_Borg_A_et_al._Characterization_of_BRCA1_and_BRCA2_deleterious_mutations_and_variants_of_unknown_clinical_significance_in_unilateral_and_bilateral_breast_cancer:_the_WECARE_study._Hum_Mutat._2010_31(3):E1200-40._Capanu_M_et_al._Assessment_of_rare_BRCA1_and_BRCA2_variants_of_unknown_significance_using_hierarchical_modeling._Genet_Epidemiol._2011_Jul%3B35(5):389-97._Carney_ME_et_al._Detection_of_BRCA1_and_BRCA2_mutations_in_a_selected_Hawaii_population._Hawaii_Med_J._2010_Nov%3B69(11):268-71._Sinilnikova_OM_et_al._BRCA1_and_BRCA2_mutations_in_breast_and_ovarian_cancer_syndrome:_reflection_on_the_Creighton_University_historical_series_of_high_risk_families._Fam_Cancer._2006%3B5(1):15-20._Soegaard_M_et_al._BRCA1_and_BRCA2_mutation_prevalence_and_clinical_characteristics_of_a_population-based_series_of_ovarian_cancer_cases_from_Denmark._Clin_Cancer_Res._2008_14(12):3761-7.&Uncertain_significance|None|no_assertion_criteria_provided|C3661900:not_provided|Department_of_Pathology_and_Laboratory_Medicine,_Sinai_Health_System|None;heredicare_annotation=5674795|3|4|12|ENIGMA_(Parsons_et_al._2019)_multifactorial_calculation_likely_benign|2020-09-18;consequences=ENST00000380152|c.1466C>G|p.Ser489Cys|missense_variant|moderate|10|None|BRCA2|None|True|True|False|True|protein_coding|10231&ENST00000530893|c.1097C>G|p.Ser366Cys|missense_variant|moderate|10|None|BRCA2|None|True|False|False|False|protein_coding|9864&ENST00000544455|c.1466C>G|p.Ser489Cys|missense_variant|moderate|10|None|BRCA2|None|True|False|False|False|protein_coding|10231&ENST00000614259|c.1466C>G|p.Ser489Cys|missense_variant_%26_NMD_transcript_variant|moderate|9|None|BRCA2|None|False|False|False|False|nonsense_mediated_decay|7934&ENST00000680887|c.1466C>G|p.Ser489Cys|missense_variant|moderate|10|None|BRCA2|None|False|False|False|False|protein_coding|10231&ENST00000700201|c.*1245C>G|None|3_prime_UTR_variant_%26_NMD_transcript_variant|modifier|11|None|BRCA2|None|False|False|False|False|nonsense_mediated_decay|387&NM_000059|c.1466C>G|p.Ser489Cys|missense_variant|moderate|10|None|BRCA2|None|True|True|False|True|mRNA|10231;literature=25741868&26467025&20104584&21520273&21218378&26295337&18559594&16528604&31464824&31853058&30787465&29884841&25348012&28569743&30181556&31911673&32377563&29641532&31700061&31131967
chr13	32346897	6441	G	A	.	.	phylop_100way=6.495;cadd_scaled=34;spliceai_details=BRCA2%7C0.00%7C0.00%7C0.00%7C1.00%7C37%7C-25%7C-12%7C-1;spliceai_max_delta=1.0;maxentscan_ref=10.532;maxentscan_alt=2.350;maxentscan=ENST00000380152$10.53%7C2.35|ENST00000530893$10.53%7C2.35|ENST00000544455$10.53%7C2.35|ENST00000700202$10.53%7C2.35;maxentscan_swa=ENST00000380152$10.53%7C2.35%7C10.53%7C1.17%7C-0.07%7C-1.17|ENST00000530893$10.53%7C2.35%7C10.53%7C1.17%7C-0.07%7C-1.17|ENST00000544455$10.53%7C2.35%7C10.53%7C1.17%7C-0.07%7C-1.17|ENST00000700202$10.53%7C2.35%7C10.53%7C1.17%7C-0.07%7C-1.17;brca_exchange_clinical_significance=Not_Yet_Reviewed;task_force_protein_domain=C-terminal_RAD51_binding_domain_(inkl._NLS1_und_BRC-)_;task_force_protein_domain_source=BWRL/ENIGMA;hexplorer=2.40;hexplorer_mut=0.91;hexplorer_wt=-1.49;hexplorer_rev=-0.27;hexplorer_rev_mut=0.10;hexplorer_rev_wt=0.37;max_hbond=-15.00;max_hbond_wt=15.00;max_hbond_rev=0.00;max_hbond_rev_mut=3.90;max_hbond_rev_wt=3.90;hci_prior=0.97;bayesdel=0.148005;clinvar=236896;rsid=397507891;heredicare_vid=9542801;variation_id=236896;clinvar_summary=criteria_provided,_multiple_submitters,_no_conflicts:Pathogenic/Likely_pathogenic;clinvar_submissions=Pathogenic|2022-10-02|criteria_provided,_single_submitter|C0677776:Hereditary_breast_ovarian_cancer_syndrome|Invitae|description:_This_sequence_change_affects_a_donor_splice_site_in_intron_13_of_the_BRCA2_gene._RNA_analysis_indicates_that_disruption_of_this_splice_site_induces_altered_splicing_and_may_result_in_an_absent_or_disrupted_protein_product._This_variant_is_not_present_in_population_databases_(gnomAD_no_frequency)._This_variant_has_not_been_reported_in_the_literature_in_individuals_affected_with_BRCA2-related_conditions._ClinVar_contains_an_entry_for_this_variant_(Variation_ID:_236896)._Studies_have_shown_that_disruption_of_this_splice_site_results_in_skipping_of_exon_13_and_introduces_a_premature_termination_codon_(PMID:_21394826,_22505045%3B_Invitae)._The_resulting_mRNA_is_expected_to_undergo_nonsense-mediated_decay._For_these_reasons,_this_variant_has_been_classified_as_Pathogenic.&Likely_pathogenic|2019-05-31|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Color_Diagnostics,_LLC_DBA_Color_Health|None&Pathogenic|2020-12-29|criteria_provided,_single_submitter|C3661900:not_provided|Quest_Diagnostics_Nichols_Institute_San_Juan_Capistrano|description:_This_variant_is_located_in_a_canonical_splice-donor_site_and_interferes_with_normal_BRCA2_mRNA_splicing._To_the_best_of_our_knowledge,_the_variant_has_not_been_reported_in_the_published_literature._However,_a_different_variant_located_at_the_same_nucleotide_position_(BRCA2_c.7007%2B1G>C)_has_been_shown_to_result_in_aberrant_splicing_and_described_as_pathogenic_(ClinVar_(http://www.ncbi.nlm.nih.gov/clinvar/,_PMID_1394826_(2010),_22505045_(2012))._This_variant_has_not_been_reported_in_large,_multi-ethnic_general_populations._Based_on_the_available_information,_this_variant_is_classified_as_pathogenic.;heredicare_annotation=9542801|3|3|14|Eigene_RNA-Analysen:_Patientin_zeigt_Skipping_von_Exon_13_(r.6938_7007del,_p.(Gly2313Alafs*31)._Keine_quantitative_Auswertung_möglich.|2018-08-28;consequences=ENST00000380152|c.7007%2B1G>A|None|splice_donor_variant|high|None|13|BRCA2|None|True|True|False|True|protein_coding|10231&ENST00000544455|c.7007%2B1G>A|None|splice_donor_variant|high|None|13|BRCA2|None|True|False|False|False|protein_coding|10231&ENST00000614259|c.7007%2B1G>A|None|splice_donor_variant_%26_NMD_transcript_variant|high|None|12|BRCA2|None|False|False|False|False|nonsense_mediated_decay|7934&ENST00000680887|c.7007%2B1G>A|None|splice_donor_variant|high|None|13|BRCA2|None|False|False|False|False|protein_coding|10231&NM_000059|c.7007%2B1G>A|None|splice_donor_variant|high|None|13|BRCA2|None|True|True|False|True|mRNA|10231;literature=20104584&21990134&22505045&21394826&11802209&16199547&37713444&25859162&31131967
chr17	43092418	22321	T	C	.	.	phylop_100way=-0.149;cadd_scaled=14.07;revel=ENST00000309486$0.227|ENST00000346315$0.227|ENST00000354071$0.227|ENST00000357654$0.227|ENST00000412061$0.227|ENST00000471181$0.227|ENST00000493795$0.227;spliceai_details=BRCA1%7C0.00%7C0.00%7C0.00%7C0.00%7C0%7C-37%7C-25%7C47;spliceai_max_delta=0.0;maxentscan_swa=ENST00000352993$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000357654$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000461574$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000468300$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000470026$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000471181$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000473961$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000476777$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000477152$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000478531$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000484087$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000489037$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000491747$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000493795$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000493919$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000494123$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000497488$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000586385$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000591534$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000591849$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000618469$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000634433$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000644379$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000644555$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46|ENST00000700182$-9.08%7C-4.77%7C-12.96%7C-2.46%7C-0.15%7C-2.46;gnomad_ac=45583;gnomad_af=0.300299;gnomad_hom=7401;gnomad_het=30781;gnomad_popmax=SAS;gnomad_popmax_AF=0.492717;gnomad_popmax_AC=2368;brca_exchange_clinical_significance=Benign_/_Little_Clinical_Significance;arup_classification=1;flossies_num_afr=828;flossies_num_eur=3985;task_force_protein_domain=NES;task_force_protein_domain_source=BWRL/ENIGMA;hexplorer=1.72;hexplorer_mut=-7.30;hexplorer_wt=-9.02;hexplorer_rev=-3.84;hexplorer_rev_mut=0.02;hexplorer_rev_wt=3.86;hci_prior=0.02;bayesdel=-0.307134;rsid=16941;clinvar=41815;heredicare_vid=8747112;cosmic=COSV104621601;variation_id=41815;clinvar_summary=reviewed_by_expert_panel:Benign;clinvar_submissions=Benign|2014-10-09|criteria_provided,_single_submitter|C2676676:Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Genome_Diagnostics_Laboratory,_University_Medical_Center_Utrecht|None&Benign|2022-04-19|criteria_provided,_single_submitter|C0677776:Hereditary_breast_ovarian_cancer_syndrome|National_Health_Laboratory_Service,_Universitas_Academic_Hospital_and_University_of_the_Free_State|None&Benign|2011-03-22|no_assertion_criteria_provided|C2676676:Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Sharing_Clinical_Reports_Project_(SCRP)|None&Benign|2014-11-03|criteria_provided,_single_submitter|C2676676:Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Michigan_Medical_Genetics_Laboratories,_University_of_Michigan|None&Benign|2013-12-19|criteria_provided,_single_submitter|C0677776:Hereditary_breast_ovarian_cancer_syndrome|Women's_Health_and_Genetics/Laboratory_Corporation_of_America,_LabCorp|None&Benign|None|no_assertion_criteria_provided|CN169374:not_specified|Clinical_Genetics_Laboratory,_Department_of_Pathology,_Netherlands_Cancer_Institute|None&Benign|2019-04-22|criteria_provided,_single_submitter|C0678222:Breast_carcinoma|Center_for_Medical_Genomics,_Faculty_of_Medicine_Ramathibodi_Hospital,_Mahidol_University,_Faculty_of_Medicine_Ramathibodi_Hospital,_Mahidol_University|None&Benign|None|no_assertion_criteria_provided|CN169374:not_specified|Department_of_Pathology_and_Laboratory_Medicine,_Sinai_Health_System|None&Benign|2018-03-06|criteria_provided,_single_submitter|C2676676:Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Illumina_Laboratory_Services,_Illumina|description:_This_variant_was_observed_in_the_ICSL_laboratory_as_part_of_a_predisposition_screen_in_an_ostensibly_healthy_population._It_had_not_been_previously_curated_by_ICSL_or_reported_in_the_Human_Gene_Mutation_Database_(HGMD:_prior_to_June_1st,_2018),_and_was_therefore_a_candidate_for_classification_through_an_automated_scoring_system._Utilizing_variant_allele_frequency,_disease_prevalence_and_penetrance_estimates,_and_inheritance_mode,_an_automated_score_was_calculated_to_assess_if_this_variant_is_too_frequent_to_cause_the_disease._Based_on_the_score_and_internal_cut-off_values,_a_variant_classified_as_benign_is_not_then_subjected_to_further_curation._The_score_for_this_variant_resulted_in_a_classification_of_benign_for_this_disease.&Benign|2022-11-04|criteria_provided,_single_submitter|C0677776:Hereditary_breast_ovarian_cancer_syndrome|Invitae|None&Benign|None|criteria_provided,_single_submitter|CN169374:not_specified|PreventionGenetics,_PreventionGenetics|None&Benign|None|no_assertion_criteria_provided|C2676676:Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Diagnostic_Laboratory,_Department_of_Genetics,_University_Medical_Center_Groningen|None&Benign|2023-07-07|criteria_provided,_single_submitter|C2676676:Breast-ovarian_cancer,_familial,_susceptibility_to,_1|KCCC/NGS_Laboratory,_Kuwait_Cancer_Control_Center|None&Benign|None|no_assertion_criteria_provided|CN169374:not_specified|Joint_Genome_Diagnostic_Labs_from_Nijmegen_and_Maastricht,_Radboudumc_and_MUMC%2B|None&Benign|2014-11-04|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Color_Diagnostics,_LLC_DBA_Color_Health|None&Benign|2015-09-21|criteria_provided,_single_submitter|C2676676:Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Clinical_Genetics_DNA_and_cytogenetics_Diagnostics_Lab,_Erasmus_MC,_Erasmus_Medical_Center|None&Pathogenic|2019-10-19|no_assertion_criteria_provided|C0346153:Familial_cancer_of_breast|Department_of_Medical_Laboratory_Science,_Faculty_of_Allied_Health_Sciences,_University_of_Peradeniya|None&not_provided|2013-09-19|no_assertion_provided|CN169374:not_specified|ITMI|None&Benign|2016-01-07|criteria_provided,_single_submitter|CN169374:not_specified|Eurofins_Ntd_Llc_(ga)|None&Uncertain_significance|None|no_assertion_criteria_provided|C0346153:Familial_cancer_of_breast|Center_for_Precision_Medicine,_Meizhou_People's_Hospital|None&Benign|None|no_assertion_criteria_provided|C0006142:Malignant_tumor_of_breast|Center_of_Medical_Genetics_and_Primary_Health_Care|None&Benign|None|criteria_provided,_single_submitter|C2676676:Breast-ovarian_cancer,_familial,_susceptibility_to,_1|GreenArray_Genomic_Research_%26_Solutions_of_Accurate_Diagnostic_Private_Limited|None&Benign|2017-11-01|criteria_provided,_single_submitter|CN169374:not_specified|GeneKor_MSA|None&Benign|2014-11-18|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_This_alteration_is_classified_as_benign_based_on_a_combination_of_the_following:_population_frequency,_intact_protein_function,_lack_of_segregation_with_disease,_co-occurrence,_RNA_analysis,_in_silico_models,_amino_acid_conservation,_lack_of_disease_association_in_case-control_studies,_and/or_the_mechanism_of_disease_or_impacted_region_is_inconsistent_with_a_known_cause_of_pathogenicity.&Benign|2016-12-07|no_assertion_criteria_provided|C3661900:not_provided|Mayo_Clinic_Laboratories,_Mayo_Clinic|None&Benign|2016-03-18|criteria_provided,_single_submitter|CN169374:not_specified|Laboratory_for_Molecular_Medicine,_Mass_General_Brigham_Personalized_Medicine|description:_p.Glu1038Gly_in_exon_10_of_BRCA1:_This_variant_is_not_expected_to_have_clinical_significance_because_it_has_been_identified_in_34.3%_(41604/121342)_of_all_chrom_osomes_tested_by_the_Exome_Aggregation_Consortium_(ExAC,_http://exac.broadinstit_ute.org%3B_dbSNP_rs16941).&Benign|2019-12-11|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Sema4,_Sema4|None&Benign|2020-05-03|criteria_provided,_single_submitter|C0346153:Familial_cancer_of_breast|Genomic_Research_Center,_Shahid_Beheshti_University_of_Medical_Sciences|None&Benign|2021-11-01|criteria_provided,_single_submitter|C0677776:Hereditary_breast_ovarian_cancer_syndrome|Genetics_Program,_Instituto_Nacional_de_Cancer|None&not_provided|None|no_assertion_provided|C2676676:Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|None&Benign|2014-01-02|criteria_provided,_single_submitter|C2676676:Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Counsyl|description:_High_frequency_in_a_1kG_or_ESP_population:_32.5_%.&Benign|2012-07-13|no_assertion_criteria_provided|C3661900:not_provided|Biesecker_Lab/Clinical_Genomics_Section,_National_Institutes_of_Health|None&Benign|2015-08-10|reviewed_by_expert_panel|C2676676:Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|description:_IARC_class_based_on_posterior_probability_from_multifactorial_likelihood_analysis,_thresholds_for_class_as_per_Plon_et_al._2008_(PMID:_18951446)._Class_1_based_on_posterior_probability_%1Y_0.00000000000204._Also_class_1_based_on_frequency_>1%_in_an_outbred_sampleset._Frequency_0.3304_(Asian),_0.128_(African),_0.3575_(European),_derived_from_1000_genomes_(2012-04-30).&Benign|2022-11-28|criteria_provided,_single_submitter|C3661900:not_provided|ARUP_Laboratories,_Molecular_Genetics_and_Genomics,_ARUP_Laboratories|None&Benign|2022-05-06|criteria_provided,_single_submitter|C0346153:Familial_cancer_of_breast$C2676676:Breast-ovarian_cancer,_familial,_susceptibility_to,_1$C3280442:Pancreatic_cancer,_susceptibility_to,_4$C4554406:Fanconi_anemia,_complementation_group_S|Fulgent_Genetics,_Fulgent_Genetics|None&Benign|2017-04-18|criteria_provided,_single_submitter|CN169374:not_specified|Cancer_Genetics_and_Genomics_Laboratory,_British_Columbia_Cancer_Agency|None&Benign|2017-02-23|criteria_provided,_single_submitter|C0346153:Familial_cancer_of_breast|Baylor_Genetics|None;heredicare_annotation=8747112|16989|17294|3||2010-04-30;consequences=ENST00000352993|c.671-1386A>G|None|intron_variant|modifier|None|9|BRCA1|None|True|False|False|False|protein_coding|2145&ENST00000354071|c.3113A>G|p.Glu1038Gly|missense_variant|moderate|10|None|BRCA1|None|False|False|False|False|retained_intron|4487&ENST00000357654|c.3113A>G|p.Glu1038Gly|missense_variant|moderate|10|None|BRCA1|None|True|True|False|True|protein_coding|5570&ENST00000412061|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|False|False|False|False|None|None&ENST00000461221|c.*2896A>G|None|3_prime_UTR_variant_%26_NMD_transcript_variant|modifier|10|None|BRCA1|None|False|False|False|False|nonsense_mediated_decay|188&ENST00000461574|None|None|upstream_gene_variant|modifier|None|None|BRCA1|None|True|False|False|False|protein_coding|5567&ENST00000468300|c.788-1386A>G|None|intron_variant|modifier|None|10|BRCA1|None|True|False|False|False|protein_coding|2079&ENST00000470026|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|True|False|False|False|protein_coding|5570&ENST00000471181|c.3113A>G|p.Glu1038Gly|missense_variant|moderate|10|None|BRCA1|None|True|False|False|False|protein_coding|5632&ENST00000473961|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|True|False|False|False|protein_coding|5446&ENST00000476777|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|True|False|False|False|protein_coding|5564&ENST00000477152|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|True|False|False|False|protein_coding|5493&ENST00000478531|c.785-1386A>G|None|intron_variant|modifier|None|10|BRCA1|None|True|False|False|False|protein_coding|2258&ENST00000484087|c.665-1386A>G|None|intron_variant|modifier|None|8|BRCA1|None|True|False|False|False|protein_coding|2134&ENST00000491747|c.788-1386A>G|None|intron_variant|modifier|None|10|BRCA1|None|True|False|False|False|protein_coding|2258&ENST00000492859|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|False|False|False|False|nonsense_mediated_decay|177&ENST00000493795|c.2972A>G|p.Glu991Gly|missense_variant|moderate|9|None|BRCA1|None|True|False|False|False|protein_coding|5431&ENST00000493919|c.647-1386A>G|None|intron_variant|modifier|None|9|BRCA1|None|True|False|False|False|protein_coding|2122&ENST00000494123|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|True|False|False|False|protein_coding|5570&ENST00000497488|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|True|False|False|False|protein_coding|4690&ENST00000586385|c.5-28467A>G|None|intron_variant|modifier|None|1|BRCA1|None|True|False|False|False|protein_coding|514&ENST00000591534|c.-43-17897A>G|None|intron_variant|modifier|None|1|BRCA1|None|True|False|False|False|protein_coding|1055&ENST00000591849|c.-99%2B32853A>G|None|intron_variant|modifier|None|1|BRCA1|None|True|False|False|False|protein_coding|287&ENST00000634433|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|True|False|False|False|protein_coding|5449&ENST00000642945|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|False|False|False|False|nonsense_mediated_decay|243&ENST00000644379|None|None|upstream_gene_variant|modifier|None|None|BRCA1|None|True|False|False|False|protein_coding|5635&ENST00000652672|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|False|False|False|False|protein_coding|5431&ENST00000700182|c.707-1386A>G|None|intron_variant|modifier|None|9|BRCA1|None|True|False|False|False|protein_coding|1622&ENST00000700183|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|False|False|False|False|nonsense_mediated_decay|177&NM_007294|c.3113A>G|p.Glu1038Gly|missense_variant|moderate|10|None|BRCA1|None|True|True|False|True|mRNA|5570&NM_007297|c.2972A>G|p.Glu991Gly|missense_variant|moderate|9|None|BRCA1|None|True|False|False|False|mRNA|5431&NM_007298|c.788-1386A>G|None|intron_variant|modifier|None|9|BRCA1|None|True|False|False|False|mRNA|2258&NM_007299|c.788-1386A>G|None|intron_variant|modifier|None|10|BRCA1|None|True|False|False|False|mRNA|2079&NM_007300|c.3113A>G|p.Glu1038Gly|missense_variant|moderate|10|None|BRCA1|None|True|False|False|False|mRNA|5632&NR_027676|n.3290A>G|None|non_coding_transcript_exon_variant|modifier|10|None|BRCA1|None|False|False|False|False|misc_RNA|7129;literature=25741868&24033266&24728327&18974781&18559551&18830263&22703879&29458332&21161372&19644020&22430443&23961350&27478808&28415599&27698805&31203256&20104584&20807450&24504028&32039725&12955716&21702907&21990134&23633455&12872265&23767878&22875147&18694767&24986639&9063749&12188064&15235020&20352487&21708019&21890493&24599715&29492227&32100578&23313170&19482343&23619945&22136207&17719744&23674270&15923272&30075112&24052750&28944232&31131559&29099791&22503699&19012493&29921024&26414677&29997359&28672935&25602962&27273131&18558292&32284662&29233532&25923920&30266954&29785135&28076423&25653542&26052455&21720365&27908594&30541318&33004033&33499154&33875706&34094541&33240400&34295994&32606146&32351891&33946592&32606887&31962039&29929473&31853058&18973698&23884293&23900168&25273865&10984458&18431501&21603858&26269718&26109977&20380699&24219164&32009247&29685792&29132324&30894629&21232165&26913838&37216304&31925297&27039803&28422718&26964030&32826945&29880898&30139972&28675654&32277576&27010638&30702160&21533266&25879635&29854292&28651617&31034466&29510755&31934565&31247975&29104234&27930734&25716334&25333361&25668207&32694901&28398198&25948282&30630528&26578562&25420931&25802882&32724101&35693198&33529999&31399568&18284688&32300177&25034901&19012246&29974678&27400856&24490137&35908255&28051113&28678827&32293552&24367280&16026807&28771511&10980541&27287230&35205822&30389958&36051147&35300046&27322064&22516946&30956756&18547414&32377563&19656415&24705254&22685416&31894249&35116780&29884136&34242281&25773295&22753008&23555315&31911673&26843898&24884479&28704513&23819521&31658756&28882180&28787462&26183948&26659599&26848529&26420498&19661094&30814510&37048111&32058674&32185139&30263092&31470906&15515971&30256453&31013702&32268104&31597922&29449575&25352556&29649263&32758128&23113073&32060274&30214008&30991738&29769598&28729728&27397505&32843649&22713736&28751759&21520273&26092435&30559637&24326041&25782689&25375650&30603682&25203624&29884841&25348012&24637876&27223485&27767231&15154626&27533253&25496518&32665031&23415752&29909963&30287823&15865297&25136594&26826707&31341521&22933969&36169178&31428572&28852190&29755871&31516641&25483746&32867815&35456488&17233897&27818992&19619314&24109560&27067391&37895233
chr17	43092985	6159	TCTTC	T	.	.	phylop_100way=4.921;spliceai_details=BRCA1%7C0.00%7C0.00%7C0.00%7C0.00%7C-20%7C-29%7C6%7C-40;spliceai_max_delta=0.0;maxentscan_swa=ENST00000352993$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000357654$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000461574$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000468300$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000470026$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000471181$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000473961$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000476777$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000477152$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000478531$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000484087$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000489037$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000491747$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000493795$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000493919$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000494123$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000497488$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000586385$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000591534$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000591849$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000618469$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000634433$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000644379$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000644555$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76|ENST00000700182$1.63%7C-2.09%7C1.63%7C-0.76%7C-4.23%7C-0.76;brca_exchange_clinical_significance=Pathogenic;task_force_protein_domain=NES;task_force_protein_domain_source=BWRL/ENIGMA;hexplorer=0.48;hexplorer_mut=-8.44;hexplorer_wt=-8.93;hexplorer_rev=2.51;hexplorer_rev_mut=11.78;hexplorer_rev_wt=9.27;max_hbond_rev=0.00;max_hbond_rev_mut=5.50;max_hbond_rev_wt=5.50;clinvar=266278;rsid=886040049;heredicare_vid=918554;variation_id=266278;clinvar_summary=reviewed_by_expert_panel:Pathogenic;clinvar_submissions=Pathogenic|2015-10-02|criteria_provided,_single_submitter|C2676676:Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Consortium_of_Investigators_of_Modifiers_of_BRCA1/2_(CIMBA),_c/o_University_of_Cambridge|None&Pathogenic|2016-10-18|reviewed_by_expert_panel|C2676676:Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|description:_Variant_allele_predicted_to_encode_a_truncated_non-functional_protein.;heredicare_annotation=918554|5|5|1||2010-04-30;consequences=ENST00000352993|c.671-1957_671-1954del|None|intron_variant|modifier|None|9|BRCA1|None|True|False|False|False|protein_coding|2145&ENST00000354071|c.2542_2545del|p.Glu848LysfsTer44|frameshift_variant|high|10|None|BRCA1|None|False|False|False|False|retained_intron|4487&ENST00000357654|c.2542_2545del|p.Glu848LysfsTer44|frameshift_variant|high|10|None|BRCA1|None|True|True|False|True|protein_coding|5570&ENST00000412061|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|False|False|False|False|None|None&ENST00000461221|c.*2325_*2328del|None|3_prime_UTR_variant_%26_NMD_transcript_variant|modifier|10|None|BRCA1|None|False|False|False|False|nonsense_mediated_decay|188&ENST00000461574|None|None|upstream_gene_variant|modifier|None|None|BRCA1|None|True|False|False|False|protein_coding|5567&ENST00000468300|c.787%2B1755_787%2B1758del|None|intron_variant|modifier|None|10|BRCA1|None|True|False|False|False|protein_coding|2079&ENST00000470026|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|True|False|False|False|protein_coding|5570&ENST00000471181|c.2542_2545del|p.Glu848LysfsTer44|frameshift_variant|high|10|None|BRCA1|None|True|False|False|False|protein_coding|5632&ENST00000473961|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|True|False|False|False|protein_coding|5446&ENST00000476777|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|True|False|False|False|protein_coding|5564&ENST00000477152|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|True|False|False|False|protein_coding|5493&ENST00000478531|c.784%2B1755_784%2B1758del|None|intron_variant|modifier|None|10|BRCA1|None|True|False|False|False|protein_coding|2258&ENST00000484087|c.664%2B1755_664%2B1758del|None|intron_variant|modifier|None|8|BRCA1|None|True|False|False|False|protein_coding|2134&ENST00000491747|c.787%2B1755_787%2B1758del|None|intron_variant|modifier|None|10|BRCA1|None|True|False|False|False|protein_coding|2258&ENST00000492859|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|False|False|False|False|nonsense_mediated_decay|177&ENST00000493795|c.2401_2404del|p.Glu801LysfsTer44|frameshift_variant|high|9|None|BRCA1|None|True|False|False|False|protein_coding|5431&ENST00000493919|c.646%2B1755_646%2B1758del|None|intron_variant|modifier|None|9|BRCA1|None|True|False|False|False|protein_coding|2122&ENST00000494123|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|True|False|False|False|protein_coding|5570&ENST00000497488|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|True|False|False|False|protein_coding|4690&ENST00000586385|c.5-29038_5-29035del|None|intron_variant|modifier|None|1|BRCA1|None|True|False|False|False|protein_coding|514&ENST00000591534|c.-43-18468_-43-18465del|None|intron_variant|modifier|None|1|BRCA1|None|True|False|False|False|protein_coding|1055&ENST00000591849|c.-99%2B32282_-99%2B32285del|None|intron_variant|modifier|None|1|BRCA1|None|True|False|False|False|protein_coding|287&ENST00000634433|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|True|False|False|False|protein_coding|5449&ENST00000642945|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|False|False|False|False|nonsense_mediated_decay|243&ENST00000644379|None|None|upstream_gene_variant|modifier|None|None|BRCA1|None|True|False|False|False|protein_coding|5635&ENST00000652672|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|False|False|False|False|protein_coding|5431&ENST00000700182|c.706%2B1755_706%2B1758del|None|intron_variant|modifier|None|9|BRCA1|None|True|False|False|False|protein_coding|1622&ENST00000700183|None|None|downstream_gene_variant|modifier|None|None|BRCA1|None|False|False|False|False|nonsense_mediated_decay|177&ENSR00001213252|None|None|regulatory_region_variant|modifier|None|None|None|None|False|False|False|False|None|None&NM_007294|c.2542_2545del|p.Glu848LysfsTer44|frameshift_variant|high|10|None|BRCA1|None|True|True|False|True|mRNA|5570&NM_007297|c.2401_2404del|p.Glu801LysfsTer44|frameshift_variant|high|9|None|BRCA1|None|True|False|False|False|mRNA|5431&NM_007298|c.787%2B1755_787%2B1758del|None|intron_variant|modifier|None|9|BRCA1|None|True|False|False|False|mRNA|2258&NM_007299|c.787%2B1755_787%2B1758del|None|intron_variant|modifier|None|10|BRCA1|None|True|False|False|False|mRNA|2079&NM_007300|c.2542_2545del|p.Glu848LysfsTer44|frameshift_variant|high|10|None|BRCA1|None|True|False|False|False|mRNA|5632&NR_027676|n.2719_2722del|None|non_coding_transcript_exon_variant|modifier|10|None|BRCA1|None|False|False|False|False|misc_RNA|7129;literature=32868316
chr17	43115780	7528	C	G	.	.	phylop_100way=3.475;cadd_scaled=32;spliceai_details=BRCA1%7C0.40%7C0.96%7C0.00%7C0.00%7C-17%7C-1%7C-50%7C-1;spliceai_max_delta=0.96;maxentscan_ref=7.046;maxentscan_alt=-1.018;maxentscan=ENST00000352993$7.05%7C-1.02|ENST00000357654$7.05%7C-1.02|ENST00000461574$7.05%7C-1.02|ENST00000468300$7.05%7C-1.02|ENST00000470026$7.05%7C-1.02|ENST00000471181$7.05%7C-1.02|ENST00000473961$7.05%7C-1.02|ENST00000476777$7.05%7C-1.02|ENST00000477152$7.05%7C-1.02|ENST00000478531$7.05%7C-1.02|ENST00000484087$7.05%7C-1.02|ENST00000489037$7.05%7C-1.02|ENST00000491747$7.05%7C-1.02|ENST00000494123$7.05%7C-1.02|ENST00000618469$7.05%7C-1.02|ENST00000634433$7.05%7C-1.02|ENST00000644379$7.05%7C-1.02|ENST00000700182$7.05%7C-1.02;maxentscan_swa=ENST00000352993$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000357654$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000461574$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000468300$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000470026$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000471181$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000473961$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000476777$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000477152$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000478531$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000484087$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000489037$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000491747$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000493795$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000493919$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000494123$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000497488$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000586385$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000591534$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000591849$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000618469$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000634433$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000644379$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000644555$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05|ENST00000700182$-8.21%7C-5.64%7C-8.21%7C7.05%7C-1.02%7C7.05;brca_exchange_clinical_significance=Not_Yet_Reviewed;arup_classification=5;task_force_protein_domain=RING;task_force_protein_domain_source=BWRL/ENIGMA;hexplorer=-0.79;hexplorer_mut=0.35;hexplorer_wt=1.13;hexplorer_rev=3.05;hexplorer_rev_mut=2.75;hexplorer_rev_wt=-0.30;max_hbond=7.20;max_hbond_mut=7.20;max_hbond_rev=-3.20;max_hbond_rev_wt=3.20;hci_prior=0.97;bayesdel=0.350165;heredicare_vid=1667428;clinvar=55715;rsid=80358018;variation_id=55715;clinvar_summary=criteria_provided,_multiple_submitters,_no_conflicts:Pathogenic;clinvar_submissions=Pathogenic|2020-08-24|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Color_Diagnostics,_LLC_DBA_Color_Health|description:_This_variant_causes_a_G_to_C_nucleotide_substitution_at_the_-1_position_of_intron_2_splice_acceptor_site_of_the_BRCA1_gene._An_RT-PCR_analysis_of_carrier-derived_RNA_has_shown_that_this_variant_results_in_the_deletion_of_7_nucleotides_from_the_beginning_of_exon_3,_due_to_the_activation_of_a_cryptic_acceptor_site_(PMID:_23239986)_and_corroborated_by_a_minigene_splicing_assay_(PMID:_22505045)._This_causes_a_frameshift_and_a_premature_protein_truncation_(r.81_87del%3B_p.Leu28*)._This_variant_has_been_reported_in_multiple_individuals_affected_with_breast_and/or_ovarian_cancer_(PMID:_16287141,_21918854,_23239986,_30263092,_32438681)._This_variant_has_not_been_identified_in_the_general_population_by_the_Genome_Aggregation_Database_(gnomAD)._Loss_of_BRCA1_function_is_a_known_mechanism_of_disease_(clinicalgenome.org)._Based_on_the_available_evidence,_this_variant_is_classified_as_Pathogenic.&Pathogenic|2021-08-20|criteria_provided,_single_submitter|C2676676:Breast-ovarian_cancer,_familial,_susceptibility_to,_1|MGZ_Medical_Genetics_Center|None&not_provided|None|no_assertion_provided|C2676676:Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Brotman_Baty_Institute,_University_of_Washington|None&Pathogenic|2022-05-22|criteria_provided,_single_submitter|C0677776:Hereditary_breast_ovarian_cancer_syndrome|Invitae|description:_This_sequence_change_affects_an_acceptor_splice_site_in_intron_2_of_the_BRCA1_gene._RNA_analysis_indicates_that_disruption_of_this_splice_site_induces_altered_splicing_and_may_result_in_an_absent_or_disrupted_protein_product._This_variant_is_not_present_in_population_databases_(gnomAD_no_frequency)._Disruption_of_this_splice_site_has_been_observed_in_individual(s)_with_high_risk_of_breast_and/or_ovarian_cancer_(PMID:_16287141,_29446198)._ClinVar_contains_an_entry_for_this_variant_(Variation_ID:_55715)._Algorithms_developed_to_predict_the_effect_of_variants_on_protein_structure_and_function_are_not_available_or_were_not_evaluated_for_this_variant._Experimental_studies_have_shown_that_disruption_of_this_splice_site_affects_BRCA1_function_(PMID:_30209399)._Studies_have_shown_that_disruption_of_this_splice_site_results_in_deletion_of_7_nucleotides_of_exon_3_and_introduces_a_premature_termination_codon_(PMID:_22505045)._The_resulting_mRNA_is_expected_to_undergo_nonsense-mediated_decay._For_these_reasons,_this_variant_has_been_classified_as_Pathogenic.&Pathogenic|2015-10-02|criteria_provided,_single_submitter|C2676676:Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Consortium_of_Investigators_of_Modifiers_of_BRCA1/2_(CIMBA),_c/o_University_of_Cambridge|None;heredicare_annotation=1667428|18|36|15|Findlay_et_al.:_LOF_(Functional_Score:_-1.895755184)%3B_Houdayer_et_al.,_Hum_Mutat_2012:_´´Class_3S:_severe_impact_on_splicing:_(1)_the_mutant_allele_does_not_produce_the_wild-type_transcript,_complete_effect_and_(2)_AG/GT_disruption.´´|2020-08-18;consequences=ENST00000352993|c.81-1G>C|None|splice_acceptor_variant|high|None|2|BRCA1|None|True|False|False|False|protein_coding|2145&ENST00000354071|c.81-1G>C|None|splice_acceptor_variant|high|None|2|BRCA1|None|False|False|False|False|retained_intron|4487&ENST00000357654|c.81-1G>C|None|splice_acceptor_variant|high|None|2|BRCA1|None|True|True|False|True|protein_coding|5570&ENST00000461221|c.81-1G>C|None|splice_acceptor_variant_%26_NMD_transcript_variant|high|None|2|BRCA1|None|False|False|False|False|nonsense_mediated_decay|188&ENST00000461798|c.81-1G>C|None|splice_acceptor_variant_%26_NMD_transcript_variant|high|None|2|BRCA1|None|False|False|False|False|nonsense_mediated_decay|188&ENST00000468300|c.81-1G>C|None|splice_acceptor_variant|high|None|2|BRCA1|None|True|False|False|False|protein_coding|2079&ENST00000470026|c.81-1G>C|None|splice_acceptor_variant|high|None|2|BRCA1|None|True|False|False|False|protein_coding|5570&ENST00000471181|c.81-1G>C|None|splice_acceptor_variant|high|None|2|BRCA1|None|True|False|False|False|protein_coding|5632&ENST00000476777|c.81-1G>C|None|splice_acceptor_variant|high|None|2|BRCA1|None|True|False|False|False|protein_coding|5564&ENST00000477152|c.81-1G>C|None|splice_acceptor_variant|high|None|2|BRCA1|None|True|False|False|False|protein_coding|5493&ENST00000478531|c.81-1G>C|None|splice_acceptor_variant|high|None|2|BRCA1|None|True|False|False|False|protein_coding|2258&ENST00000484087|c.81-1G>C|None|splice_acceptor_variant|high|None|2|BRCA1|None|True|False|False|False|protein_coding|2134&ENST00000489037|c.81-1G>C|None|splice_acceptor_variant|high|None|2|BRCA1|None|True|False|False|False|protein_coding|5493&ENST00000491747|c.81-1G>C|None|splice_acceptor_variant|high|None|2|BRCA1|None|True|False|False|False|protein_coding|2258&ENST00000492859|c.81-1G>C|None|splice_acceptor_variant_%26_NMD_transcript_variant|high|None|2|BRCA1|None|False|False|False|False|nonsense_mediated_decay|177&ENST00000493795|c.-8%2B8237G>C|None|intron_variant|modifier|None|2|BRCA1|None|True|False|False|False|protein_coding|5431&ENST00000493919|c.-8%2B8237G>C|None|intron_variant|modifier|None|2|BRCA1|None|True|False|False|False|protein_coding|2122&ENST00000494123|c.81-1G>C|None|splice_acceptor_variant|high|None|2|BRCA1|None|True|False|False|False|protein_coding|5570&ENST00000497488|c.-219%2B9491G>C|None|intron_variant|modifier|None|1|BRCA1|None|True|False|False|False|protein_coding|4690&ENST00000586385|c.4%2B9402G>C|None|intron_variant|modifier|None|1|BRCA1|None|True|False|False|False|protein_coding|514&ENST00000591534|c.-44%2B9491G>C|None|intron_variant|modifier|None|1|BRCA1|None|True|False|False|False|protein_coding|1055&ENST00000591849|c.-99%2B9491G>C|None|intron_variant|modifier|None|1|BRCA1|None|True|False|False|False|protein_coding|287&ENST00000634433|c.81-1G>C|None|splice_acceptor_variant|high|None|2|BRCA1|None|True|False|False|False|protein_coding|5449&ENST00000642945|c.81-1G>C|None|splice_acceptor_variant_%26_NMD_transcript_variant|high|None|2|BRCA1|None|False|False|False|False|nonsense_mediated_decay|243&ENST00000644555|c.-61-1G>C|None|splice_acceptor_variant|high|None|3|BRCA1|None|True|False|False|False|protein_coding|2122&ENST00000652672|c.-61-1G>C|None|splice_acceptor_variant|high|None|3|BRCA1|None|False|False|False|False|protein_coding|5431&ENST00000700182|c.81-1G>C|None|splice_acceptor_variant|high|None|2|BRCA1|None|True|False|False|False|protein_coding|1622&ENST00000700183|c.81-1G>C|None|splice_acceptor_variant_%26_NMD_transcript_variant|high|None|2|BRCA1|None|False|False|False|False|nonsense_mediated_decay|177&ENST00000700184|n.324-1G>C|None|splice_acceptor_variant_%26_non_coding_transcript_variant|high|None|1|BRCA1|None|False|False|False|False|retained_intron|913&ENST00000700185|n.200-1G>C|None|splice_acceptor_variant_%26_non_coding_transcript_variant|high|None|2|BRCA1|None|False|False|False|False|protein_coding_CDS_not_defined|492&NM_007294|c.81-1G>C|None|splice_acceptor_variant|high|None|2|BRCA1|None|True|True|False|True|mRNA|5570&NM_007297|c.-8%2B8237G>C|None|intron_variant|modifier|None|2|BRCA1|None|True|False|False|False|mRNA|5431&NM_007298|c.81-1G>C|None|splice_acceptor_variant|high|None|1|BRCA1|None|True|False|False|False|mRNA|2258&NM_007299|c.81-1G>C|None|splice_acceptor_variant|high|None|2|BRCA1|None|True|False|False|False|mRNA|2079&NM_007300|c.81-1G>C|None|splice_acceptor_variant|high|None|2|BRCA1|None|True|False|False|False|mRNA|5632&NR_027676|n.283-1G>C|None|splice_acceptor_variant_%26_non_coding_transcript_variant|high|None|2|BRCA1|None|False|False|False|False|misc_RNA|7129;literature=20104584&22505045&10644434&22711857&16287141&30287823&32438681&16199547&29446198&30263092&30209399&30787465&24393486&28569743&27694994&36123164&32210335&33754277&31467430&23239986&30479693&21533266&34072659&30982232&33274848&28152038
chr17	43045760	15348	C	T	.	.	phylop_100way=4.191;cadd_scaled=40;spliceai_details=BRCA1%7C0.00%7C0.01%7C0.00%7C0.00%7C31%7C42%7C3%7C28;spliceai_max_delta=0.01;maxentscan_swa=ENST00000352993$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000357654$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000461574$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000468300$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000470026$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000471181$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000473961$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000476777$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000477152$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000478531$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000484087$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000489037$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000491747$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000493795$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000493919$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000494123$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000497488$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000586385$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000591534$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000591849$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000618469$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000634433$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000644379$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46|ENST00000644555$1.31%7C4.84%7C1.31%7C-1.39%7C-3.51%7C-11.46;brca_exchange_clinical_significance=Pathogenic;arup_classification=5;task_force_protein_domain=NES;task_force_protein_domain_source=BWRL/ENIGMA;hexplorer=2.60;hexplorer_mut=3.64;hexplorer_wt=1.04;hexplorer_rev=1.04;hexplorer_rev_mut=-3.14;hexplorer_rev_wt=-4.18;max_hbond_rev=3.30;max_hbond_rev_mut=12.00;max_hbond_rev_wt=8.70;hci_prior=0.99;bayesdel=0.61701;clinvar=55608;heredicare_vid=803;rsid=80357307;variation_id=55608;clinvar_summary=reviewed_by_expert_panel:Pathogenic;clinvar_submissions=Pathogenic|2023-02-21|no_assertion_criteria_provided|C1883486:Uterine_corpus_cancer|CZECANCA_consortium|None&Pathogenic|2002-05-29|no_assertion_criteria_provided|C2676676:Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Breast_Cancer_Information_Core_(BIC)_(BRCA1)|None&Pathogenic|2015-10-02|criteria_provided,_single_submitter|C2676676:Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Consortium_of_Investigators_of_Modifiers_of_BRCA1/2_(CIMBA),_c/o_University_of_Cambridge|None&Pathogenic|2022-06-03|criteria_provided,_single_submitter|C0677776:Hereditary_breast_ovarian_cancer_syndrome|Women's_Health_and_Genetics/Laboratory_Corporation_of_America,_LabCorp|description:_Variant_summary:_BRCA1_c.5510G>A_(p.Trp1837X)_results_in_a_premature_termination_codon_in_the_last_exon,_predicted_to_cause_a_truncation_of_the_encoded_protein_or_absence_of_the_protein_due_to_nonsense_mediated_decay,_which_are_commonly_known_mechanisms_for_disease._A_truncation_downstream_of_this_position_has_been_classified_as_pathogenic_by_our_laboratory._The_variant_was_absent_in_251336_control_chromosomes._c.5510G>A_has_been_reported_in_the_literature_in_multiple_individuals_affected_with_Hereditary_Breast_And_Ovarian_Cancer_Syndrome_(example_Couch_1996,_Frank_1998,_Vallon-Christersson_2001,_Foretova_2004,_Judkins_2005,_Konecny_2011,_Donenberg_2016)._These_data_indicate_that_the_variant_is_very_likely_to_be_associated_with_disease._Six_ClinVar_submitters_(evaluation_after_2014)_cite_the_variant_as_pathogenic._Based_on_the_evidence_outlined_above,_the_variant_was_classified_as_pathogenic.&Pathogenic|2016-09-08|reviewed_by_expert_panel|C2676676:Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Evidence-based_Network_for_the_Interpretation_of_Germline_Mutant_Alleles_(ENIGMA)|description:_Variant_allele_predicted_to_encode_a_truncated_non-functional_protein.&Pathogenic|2021-12-03|criteria_provided,_single_submitter|C0027672:Hereditary_cancer-predisposing_syndrome|Ambry_Genetics|description:_The_p.W1837*_pathogenic_mutation_(also_known_as_c.5510G>A),_located_in_coding_exon_22_of_the_BRCA1_gene,_results_from_a_G_to_A_substitution_at_nucleotide_position_5510._This_alteration_occurs_at_the_3'_terminus_of_theBRCA1_gene,_is_not_expected_to_trigger_nonsense-mediated_mRNA_decay,_and_only_impacts_the_last_27_amino_acids_of_the_protein._However,_premature_stop_codons_are_typically_deleterious_in_nature_and_the_impacted_region_is_critical_for_protein_function_(Ambry_internal_data)._This_alteration_has_been_identified_in_multiple_individuals_diagnosed_with_breast_and/or_ovarian_cancer_(Foretova_L_et_al._Hum_Mutat._2004_Apr%3B23(4):397-8%3B_Machackova_E_et_al._BMC_Cancer_2008_May%3B8:140%3B_Sokolenko_AP_et_al._Mol._Biol._Rep._2016_May%3B43(5):335-8%3B_Liang_Y_et_al._Med_Sci_Monit,_2018_Apr%3B24:2465-2475)._One_functional_study_found_that_this_nucleotide_substitution_is_non-functional_in_a_high-throughput,_genome_editing,_haploid_cell_survival_assay_(Findlay_GM_et_al._Nature,_2018_10%3B562:217-222)._Of_note,_this_alteration_is_also_designated_as_5629G>A_in_published_literature._This_variant_is_considered_to_be_rare_based_on_population_cohorts_in_the_Genome_Aggregation_Database_(gnomAD)._Based_on_the_supporting_evidence,_this_alteration_is_interpreted_as_a_disease-causing_mutation.&Pathogenic|2020-10-23|criteria_provided,_single_submitter|C3661900:not_provided|Institute_of_Medical_Genetics_and_Applied_Genomics,_University_Hospital_Tübingen|None&Pathogenic|2014-01-31|no_assertion_criteria_provided|C0677776:Hereditary_breast_ovarian_cancer_syndrome|Research_Molecular_Genetics_Laboratory,_Women's_College_Hospital,_University_of_Toronto|None&Pathogenic|2020-04-02|criteria_provided,_single_submitter|C3661900:not_provided|Quest_Diagnostics_Nichols_Institute_San_Juan_Capistrano|description:_This_nonsense_variant_causes_the_premature_termination_of_BRCA1_protein_synthesis._In_addition,_it_has_been_reported_in_individuals_with_hereditary_breast_and/or_ovarian_cancer_in_the_published_literature_(PMID:_29446198_(2018),_29681614_(2018),_27469594_(2016),_15024741_(2004),_8807330_(1996))._Based_on_the_available_information,_this_variant_is_classified_as_pathogenic.&not_provided|None|no_assertion_provided|C2676676:Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Brotman_Baty_Institute,_University_of_Washington|None&Pathogenic|2022-06-15|criteria_provided,_single_submitter|C0677776:Hereditary_breast_ovarian_cancer_syndrome|Invitae|description:_This_sequence_change_creates_a_premature_translational_stop_signal_(p.Trp1837*)_in_the_BRCA1_gene._While_this_is_not_anticipated_to_result_in_nonsense_mediated_decay,_it_is_expected_to_disrupt_the_last_27_amino_acid(s)_of_the_BRCA1_protein._This_variant_is_not_present_in_population_databases_(gnomAD_no_frequency)._This_premature_translational_stop_signal_has_been_observed_in_individual(s)_with_high_risk_of_hereditary_breast_and/or_ovarian_cancer_(PMID:_29446198)._ClinVar_contains_an_entry_for_this_variant_(Variation_ID:_55608)._Algorithms_developed_to_predict_the_effect_of_variants_on_protein_structure_and_function_are_not_available_or_were_not_evaluated_for_this_variant._Experimental_studies_have_shown_that_this_premature_translational_stop_signal_affects_BRCA1_function_(PMID:_11157798,_30209399)._This_variant_disrupts_a_region_of_the_BRCA1_protein_in_which_other_variant(s)_(p.Tyr1853*)_have_been_determined_to_be_pathogenic_(PMID:_7894493,_10811118,_11739404,_12400015,_20104584,_21922593,_24504028)._This_suggests_that_this_is_a_clinically_significant_region_of_the_protein,_and_that_variants_that_disrupt_it_are_likely_to_be_disease-causing._For_these_reasons,_this_variant_has_been_classified_as_Pathogenic.;heredicare_annotation=803|10|12|1||2010-04-30;consequences=ENST00000352993|c.2084G>A|p.Trp695Ter|stop_gained|high|22|None|BRCA1|PF00533|True|False|False|False|protein_coding|2145&ENST00000357654|c.5510G>A|p.Trp1837Ter|stop_gained|high|23|None|BRCA1|PF00533|True|True|False|True|protein_coding|5570&ENST00000461221|c.*5293G>A|None|3_prime_UTR_variant_%26_NMD_transcript_variant|modifier|23|None|BRCA1|None|False|False|False|False|nonsense_mediated_decay|188&ENST00000468300|c.*24G>A|None|3_prime_UTR_variant|modifier|22|None|BRCA1|None|True|False|False|False|protein_coding|2079&ENST00000471181|c.5573G>A|p.Trp1858Ter|stop_gained|high|24|None|BRCA1|PF00533|True|False|False|False|protein_coding|5632&ENST00000484087|c.2072G>A|p.Trp691Ter|stop_gained|high|21|None|BRCA1|PF00533|True|False|False|False|protein_coding|2134&ENST00000491747|c.2198G>A|p.Trp733Ter|stop_gained|high|23|None|BRCA1|PF00533|True|False|False|False|protein_coding|2258&ENST00000493795|c.5369G>A|p.Trp1790Ter|stop_gained|high|22|None|BRCA1|PF00533|True|False|False|False|protein_coding|5431&ENST00000586385|c.440G>A|p.Trp147Ter|stop_gained|high|8|None|BRCA1|PF00533|True|False|False|False|protein_coding|514&ENST00000591534|c.983G>A|p.Trp328Ter|stop_gained|high|11|None|BRCA1|PF00533|True|False|False|False|protein_coding|1055&ENST00000591849|c.209G>A|p.Trp70Ter|stop_gained|high|5|None|BRCA1|None|True|False|False|False|protein_coding|287&ENST00000644379|c.1898G>A|p.Trp633Ter|stop_gained|high|15|None|BRCA1|PF00533|True|False|False|False|protein_coding|5635&ENST00000700081|n.1393G>A|None|non_coding_transcript_exon_variant|modifier|3|None|BRCA1|None|False|False|False|False|retained_intron|2848&ENST00000700082|n.874G>A|None|non_coding_transcript_exon_variant|modifier|2|None|BRCA1|None|False|False|False|False|retained_intron|1651&NM_007294|c.5510G>A|p.Trp1837Ter|stop_gained|high|23|None|BRCA1|None|True|True|False|True|mRNA|5570&NM_007297|c.5369G>A|p.Trp1790Ter|stop_gained|high|22|None|BRCA1|None|True|False|False|False|mRNA|5431&NM_007298|c.2198G>A|p.Trp733Ter|stop_gained|high|22|None|BRCA1|None|True|False|False|False|mRNA|2258&NM_007299|c.*24G>A|None|3_prime_UTR_variant|modifier|22|None|BRCA1|None|True|False|False|False|mRNA|2079&NM_007300|c.5573G>A|p.Trp1858Ter|stop_gained|high|24|None|BRCA1|None|True|False|False|False|mRNA|5632&NR_027676|n.5687G>A|None|non_coding_transcript_exon_variant|modifier|23|None|BRCA1|None|False|False|False|False|misc_RNA|7129;literature=20104584&24504028&15024741&8807330&7894493&21922593&11157798&11739404&10811118&12400015&27469594&29681614&29446198&30209399&27397505&31853058&18489799&32210335&28254861&28569743&34680878&24393486&21533266&26269718&32377563&28435519&23788959
